# Chapter 123: Major or Mild Neurocognitive Disorder Due to Alzheimer’s Disease

Here is the comprehensive academic chapter on the biological and neurological basis of Major or Mild Neurocognitive Disorder Due to Alzheimer’s Disease, citing exclusively from the 2000 research papers provided.

## **The Biological and Neurological Basis of Neurocognitive Disorder Due to Alzheimer’s Disease**

## Introduction

Major or Mild Neurocognitive Disorder Due to Alzheimer’s Disease (AD) represents the most common cause of dementia in mid- and late life, accounting for a significant majority of cases worldwide (Wierenga & Bondi, 2011; Knopman, 2021). It is a progressive, irreversible neurodegenerative disorder defined clinically by a gradual and insidious decline in cognitive functions, most prototypically beginning with impairment in the ability to learn and recall new information (Knopman, 2021; Wierenga & Bondi, 2011). As the disease progresses, deficits extend to other cognitive domains, including language, executive function, and visuospatial abilities, culminating in a state of global cognitive impairment that severely compromises an individual's capacity for independent daily functioning (Love & Geldmacher, 2018; Knopman, 2021). The clinical syndrome of dementia is the final stage of a long pathological process; AD is the underlying disease that causes this syndrome (Knopman, 2021; Arvanitakis et al., 2019).

From a biological perspective, AD is characterized by two core neuropathological hallmarks: the extracellular deposition of beta-amyloid (Aβ) peptides into senile plaques and the intracellular accumulation of hyperphosphorylated tau protein in the form of neurofibrillary tangles (NFTs) (Wierenga & Bondi, 2011; Schultz et al., 2004; Butterfield, 2000). This pathological cascade is believed to begin years, or even decades, before the initial clinical symptoms become manifest, a period referred to as the preclinical or "brain AD stage" (Wierenga & Bondi, 2011; Sadowski, 2010; Stella et al., 2014). This long prodromal phase involves the gradual accrual of Aβ pathology, followed by a variable lag time after which neuronal dysfunction, synapse loss, and neurodegeneration become the dominant pathological processes (Wierenga & Bondi, 2011; Sadowski, 2010). While Aβ deposition is widely considered a primary causal event, the severity of clinical symptoms correlates more closely with the burden of NFTs and synaptic loss than with amyloid plaque density (Wierenga & Bondi, 2011; Dickson & Orr, 2011).

The progression of AD pathology follows a relatively predictable neuroanatomical pattern, typically originating in medial temporal lobe structures, such as the entorhinal cortex and hippocampus, before spreading to involve multimodal association cortices of the frontal, temporal, and parietal lobes (Wierenga & Bondi, 2011; Schultz et al., 2004; Love & Geldmacher, 2018). This anatomical progression mirrors the clinical evolution of the disease, from early episodic memory loss to a more global dementia syndrome (Schultz et al., 2004; Love & Geldmacher, 2018). Beyond the core cognitive deficits, a wide array of neuropsychiatric symptoms, including apathy, depression, anxiety, agitation, and psychosis, are nearly universal features of the disease, contributing significantly to patient disability and caregiver burden (Lyketsos et al., 2002; Burns, 2001; Teixeira et al., 2023).

This chapter will provide a comprehensive overview of the biological and neurological underpinnings of AD. It will explore the complex interplay of neurotransmitter system dysfunction, genetic predispositions, and molecular pathways involving Aβ and tau. Furthermore, it will examine the cellular and synaptic mechanisms of neurodegeneration, the structural and functional brain changes revealed by neuroimaging, and the concepts of neuroplasticity and cognitive reserve that modulate the clinical expression of the disease. Finally, the chapter will address the recognized biological and clinical heterogeneity of AD, which presents significant challenges for diagnosis and the development of effective, disease-modifying therapies (Jellinger, 2020; Paraskevas et al., 2020).

## Neurobiological Systems

The pathophysiology of Alzheimer's disease is multifaceted, involving the disruption of numerous integrated neurobiological systems. These disturbances are not limited to the classic proteinopathies but extend to profound alterations in neurotransmitter signaling, neuroinflammation, oxidative stress, and cellular energy metabolism. The complex interplay between these systems drives the progressive neuronal dysfunction and death that underlies the clinical syndrome.

### Neurotransmitter Systems and Neuropharmacology

The most extensively studied and clinically relevant neurochemical disturbance in AD is the profound deficit in the brain's cholinergic system (Gottfries, 1990; Wu et al., 2007). This deficit stems from the degeneration of cholinergic neurons in the basal forebrain, particularly the nucleus basalis of Meynert, which provide the primary cholinergic innervation to the hippocampus and cerebral cortex (Sunderland et al., 1997; Gu, 2013). This neuronal loss leads to reduced synthesis and release of the neurotransmitter acetylcholine (ACh), a molecule critical for learning, memory, and attention (Singh & Jha, 2021; Wu et al., 2007; Morais, 2004). The severity of this cholinergic deficit correlates with the degree of cognitive impairment in AD patients (Gottfries, 1990; Hornykiewicz & Kish, 1984). The "cholinergic hypothesis" of AD posits that this loss of cholinergic neurotransmission contributes significantly to the cognitive symptoms of the disease (Singh & Jha, 2021; Morais, 2004). This hypothesis provides the rationale for the primary symptomatic treatment strategy for mild to moderate AD: the use of acetylcholinesterase (AChE) inhibitors such as donepezil, rivastigmine, and galantamine (Pereira & Marinho, 2015; Grossberg, 2005; Singh & Jha, 2021). By inhibiting the enzyme that breaks down ACh in the synaptic cleft, these drugs increase the availability of ACh and enhance cholinergic transmission, offering modest but measurable benefits for cognitive function (Gauthier et al., 1994; Corey‐Bloom et al., 2006; Singh & Jha, 2021). Galantamine also modulates nicotinic acetylcholine receptors (nAChRs), which may facilitate the release of other neurotransmitters (Alagiakrishnan, 2010).

While the cholinergic system is severely affected, AD is not a single-transmitter disease (Gottfries, 1990; Sunderland et al., 1997). Disturbances in other major neurotransmitter systems are also well-documented. The dopaminergic system, for instance, shows dysfunction that may contribute to both cognitive and non-cognitive symptoms (Moreira et al., 2025). Degeneration of dopaminergic neurons in the substantia nigra and ventral tegmental area, while most characteristic of Parkinson's disease, also occurs in AD (Hornykiewicz & Kish, 1984; Mann & Yates, 1983). This dopaminergic dysfunction has been linked to extrapyramidal signs, as well as neuropsychiatric symptoms like apathy and depression (Moreira et al., 2025; Sunderland et al., 1997).

The noradrenergic system, originating in the locus coeruleus, and the serotonergic system, arising from the dorsal raphe nuclei, also undergo significant degeneration in AD (Gottfries, 1990; Mann & Yates, 1983). The loss of these monoaminergic neurons contributes to the high prevalence of affective and behavioral disturbances, such as depression, anxiety, and agitation, that are common throughout the course of the disease (Gottfries, 1990; Sunderland et al., 1997; Teixeira et al., 2023). Indeed, the complex interplay between cholinergic, serotonergic, and dopaminergic systems may underlie many of the cognitive and behavioral deficits seen in AD (Sunderland et al., 1997).

The glutamatergic system, the primary excitatory neurotransmitter system in the brain, is also critically implicated in AD pathogenesis (Kumar & Bansal, 2021). Glutamate is essential for synaptic plasticity, learning, and memory, primarily through its action on N-methyl-D-aspartate (NMDA) receptors (Córdova Neira & López Ortega, 2004). However, excessive glutamate release can lead to excitotoxicity, a process of neuronal injury and death caused by overstimulation of glutamate receptors and subsequent calcium overload (Volpe, 1997; Yu et al., 2024). This excitotoxic cascade is thought to be a key mechanism of neuronal death in AD (Yu et al., 2024). This understanding forms the basis for the use of memantine, a non-competitive NMDA receptor antagonist, in the treatment of moderate to severe AD (Pereira & Marinho, 2015; Zanni & Wick, 2007). By modulating glutamatergic transmission, memantine is thought to protect neurons from excitotoxicity (Córdova Neira & López Ortega, 2004; Kumar & Bansal, 2021).

Finally, neuropeptide systems are also disturbed in AD, although their specific contributions are less clear (Gottfries, 1990). The multiplicity of neurotransmitter deficits underscores the complexity of AD and suggests that multi-target pharmacological strategies may ultimately be more effective than those targeting a single system (Gottfries, 1990; Sunderland et al., 1997).

### Neuroinflammation and Immune Responses

A growing body of evidence indicates that neuroinflammation is not merely a consequence of the neurodegenerative process in AD but is an active contributor to its pathogenesis and progression (Daulatzai, 2014; Stamouli & Politis, 2016). The brains of AD patients show prominent signs of a chronic, non-resolved inflammatory response centered around amyloid plaques (Stamouli & Politis, 2016; Selles M. Clara et al., 2018). This response is mediated by the brain's resident immune cells, microglia and astrocytes, which become activated in the presence of Aβ aggregates (Stamouli & Politis, 2016).

Activated glial cells release a host of pro-inflammatory mediators, including cytokines such as interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α), as well as complement factors and reactive oxygen species (ROS) (Daulatzai, 2014; Stamouli & Politis, 2016; Marinescu et al., 2017). While this inflammatory response may initially be a protective mechanism aimed at clearing Aβ deposits, its chronic and unabated nature becomes detrimental (Daulatzai, 2014). Sustained overproduction of pro-inflammatory cytokines can suspend the phagocytic activity of microglia, thereby impairing the effective removal of plaques and promoting further Aβ accumulation (Stamouli & Politis, 2016). Furthermore, these inflammatory factors can directly contribute to neuronal dysfunction, synaptic injury, and eventual cell death, creating a self-perpetuating cycle of neuroinflammation and neurodegeneration (Stamouli & Politis, 2016; Selles M. Clara et al., 2018; Martin, 2002). This neuroinflammatory cascade is increasingly recognized as a mechanistic link connecting cognitive symptoms with the common non-cognitive, neuropsychiatric symptoms of AD, such as apathy and depression (Selles M. Clara et al., 2018; Teixeira et al., 2023). Systemic inflammation and comorbidities like cardiovascular disease may further exacerbate these central inflammatory processes (Daulatzai, 2014; Uzoni et al., 2015).

### Oxidative Stress and Mitochondrial Dysfunction

Oxidative stress, defined as an imbalance between the production of reactive oxygen species (ROS) and the capacity of biological systems to detoxify these reactive intermediates, is another fundamental mechanism implicated in AD pathogenesis (Kumar & Bansal, 2021; Harman, 2006). The brain is particularly vulnerable to oxidative damage due to its high metabolic rate, high concentration of peroxidizable lipids, and relatively low levels of antioxidant enzymes (Butterfield, 2000). In AD, there is extensive evidence of oxidative damage, including lipid peroxidation in brain membranes and protein oxidation (Butterfield, 2000; Kumar & Bansal, 2021).

The Aβ peptide itself is a significant source of oxidative stress (Butterfield, 2000). Aggregated Aβ can generate free radicals, leading to lipid peroxidation and the formation of neurotoxic byproducts that damage neuronal membranes and impair the function of membrane-bound proteins, such as ion-motive ATPases and glucose transporters (Butterfield, 2000). This Aβ-associated oxidative stress is considered a key event that contributes to synaptic dysfunction and neuronal death in AD (Butterfield, 2000; Harman, 2006).

Mitochondrial dysfunction is both a source and a target of oxidative stress in AD (Santos et al., 2010; Kumar & Bansal, 2021). Mitochondria are the primary sites of cellular energy production and also the main source of intracellular ROS (Santos et al., 2010). In AD, there is evidence of impaired mitochondrial function, including reduced energy metabolism and increased ROS generation (Perez‐Polo, 1991; Santos et al., 2010). This dysfunction is exacerbated by Aβ, which can accumulate within mitochondria and directly inhibit key respiratory chain enzymes (Santos et al., 2010). The resulting energy deficit and increased oxidative stress can trigger downstream pathological events, including synaptic failure and apoptosis (programmed cell death) (Martin, 2002; Santos et al., 2010). A synergistic dysfunction involving impaired mitochondrial dynamics (fission and fusion) and mitophagy (the selective removal of damaged mitochondria) further contributes to the accumulation of dysfunctional mitochondria and exacerbates the neurodegenerative process (Santos et al., 2010). The normal process of aging is itself associated with progressive increases in systemic oxidative stress, which may create a vulnerable background upon which AD-specific pathologies develop (Harman, 2006; Perez‐Polo, 1991).

## Genetic and Molecular Basis

Alzheimer's disease is a complex and heterogeneous disorder with a strong genetic component (Constantinidis, 1986; Kumar et al., 2017). The genetic architecture of AD can be broadly divided into two categories: rare, high-penetrance mutations that cause early-onset familial AD (FAD), and common, low-penetrance susceptibility variants that modulate the risk for the more prevalent late-onset sporadic AD (SAD).

### Heritability and Familial Alzheimer's Disease

A small fraction of AD cases, typically with an onset before the age of 65, are inherited in an autosomal dominant fashion (Constantinidis, 1986; Kumar et al., 2017). These familial forms are caused by mutations in one of three genes: the amyloid precursor protein (APP) gene on chromosome 21, the presenilin 1 (PSEN1) gene on chromosome 14, and the presenilin 2 (PSEN2) gene on chromosome 1 (Kumar et al., 2017; Castro‐Suárez et al., 2015). Mutations in these genes are highly penetrant, meaning that individuals who inherit them are almost certain to develop AD, often at a very early age (Constantinidis, 1986). A family history of dementia is a significant risk factor, supporting the role of heredity (Thai et al., 1988; Constantinidis, 1986). The discovery of these genes was pivotal, as they all directly impact the processing of APP and the production of the Aβ peptide, providing strong evidence for the centrality of the amyloid pathway in AD pathogenesis (Selkoe, 2009). For instance, many FAD mutations increase the total amount of Aβ produced or, more specifically, increase the ratio of the more aggregation-prone Aβ42 peptide relative to the Aβ40 peptide (Chukwu et al., 2023).

### Susceptibility Genes and Sporadic Alzheimer's Disease

The vast majority of AD cases are sporadic, with a late onset (after age 65), and are thought to result from a complex interaction between genetic and environmental factors (Ansar, 2014; Kumar et al., 2017). The most significant and well-replicated genetic risk factor for SAD is the apolipoprotein E (APOE) gene on chromosome 19 (Nisa et al., 2016; Mendez, 2017). The APOE gene exists in three common alleles: ε2, ε3, and ε4. The APOE ε4 allele is strongly associated with an increased risk and an earlier age of onset for SAD (Mendez, 2017; Jellinger, 2020). Individuals carrying one copy of the ε4 allele have a significantly elevated risk of developing AD, and those with two copies have an even higher risk (Mendez, 2017). Conversely, the ε2 allele appears to confer some degree of protection (Nisa et al., 2016). Apolipoprotein E is involved in lipid transport, but in the brain, it also plays roles in Aβ aggregation and clearance, synaptic function, and neuroinflammation, providing several plausible mechanisms through which the ε4 allele could increase AD risk (Kumar & Bansal, 2021). For example, ApoE4 is less efficient at mediating Aβ clearance than other isoforms and may promote Aβ aggregation (Daulatzai, 2014).

Beyond APOE, large-scale genome-wide association studies (GWAS) have identified numerous other common genetic variants that are associated with a smaller but significant increase in AD risk (Leffa et al., 2024). These genes are involved in diverse biological pathways, including lipid metabolism, immune response and inflammation, and endocytosis, further highlighting the multifactorial nature of AD pathogenesis (Kumar & Bansal, 2021).

### The Amyloid Cascade Hypothesis

The dominant molecular theory of AD pathogenesis for the past several decades has been the amyloid cascade hypothesis (Selkoe, 2009; Chukwu et al., 2023). This hypothesis posits that the initiating event in AD is the abnormal processing of the amyloid precursor protein (APP), a transmembrane protein of uncertain function (Wierenga & Bondi, 2011; Kumar et al., 2017). In the amyloidogenic pathway, APP is sequentially cleaved by two enzymes, β-secretase (BACE1) and γ-secretase (a complex that includes presenilins) (Chukwu et al., 2023; Selkoe, 2009). This cleavage releases Aβ peptides of varying lengths, most commonly Aβ40 and Aβ42 (Wierenga & Bondi, 2011).

According to the hypothesis, an imbalance between the production and clearance of Aβ, particularly the more hydrophobic and aggregation-prone Aβ42 isoform, leads to its accumulation in the brain (Selkoe, 2009; Chukwu et al., 2023). These Aβ monomers then self-assemble into soluble oligomers, which are now considered the most neurotoxic species, and eventually aggregate into the large, insoluble fibrils that form the core of senile plaques (Selkoe, 2009; Wierenga & Bondi, 2011). These soluble Aβ oligomers are thought to directly cause synaptic dysfunction, disrupt neuronal signaling, trigger neuroinflammation, and promote a cascade of downstream events that ultimately lead to widespread neuronal death and the clinical symptoms of dementia (Selkoe, 2009; Siao & Tsirka, 2002). The genetic evidence from FAD strongly supports a primary role for Aβ, as mutations in APP, PSEN1, and PSEN2 all perturb this pathway (Selkoe, 2009).

### Tau Pathology and Neurofibrillary Tangles

The second pathological hallmark of AD is the neurofibrillary tangle (NFT), which are intracellular aggregates of hyperphosphorylated tau protein (Wierenga & Bondi, 2011; Schultz et al., 2004). Tau is a microtubule-associated protein that, in its normal state, stabilizes the microtubules that form the cytoskeleton of neurons, essential for maintaining cell structure and axonal transport (Chukwu et al., 2023). In AD, tau becomes abnormally hyperphosphorylated, causing it to detach from microtubules and aggregate into paired helical filaments, which then form the NFTs inside neurons (Chukwu et al., 2023; Jellinger, 2020).

The formation of NFTs leads to the collapse of the microtubule network, disrupting axonal transport and impairing synaptic function (Kumar & Bansal, 2021). This process contributes directly to neuronal dysfunction and death (Chukwu et al., 2023). While the amyloid cascade hypothesis suggests that tau pathology is downstream of Aβ accumulation, the relationship is complex (Wierenga & Bondi, 2011). Aβ oligomers can accelerate tau pathology, but tau pathology can also spread through the brain in a prion-like fashion, seemingly independent of Aβ in later stages (Jellinger, 2020). Importantly, the spatial distribution and density of NFTs correlate much more strongly with the degree of cognitive impairment and neuronal loss in AD patients than does the Aβ plaque load, suggesting that tau pathology is a more direct mediator of neurodegeneration and clinical symptoms (Wierenga & Bondi, 2011; Dickson & Orr, 2011).

## Brain Structure and Function

The molecular and cellular pathologies of Alzheimer's disease translate into macroscopic changes in brain structure and large-scale disruptions in neural network function. These changes can be visualized in vivo using modern neuroimaging techniques, which are crucial for diagnosis, tracking disease progression, and understanding the neuroanatomical basis of the cognitive and behavioral symptoms of AD.

### Neuroanatomical Progression and Atrophy

The pathological process of AD does not affect the brain uniformly. Instead, it follows a characteristic spatiotemporal pattern of progression (Schultz et al., 2004; Love & Geldmacher, 2018). Neuropathological studies have established that the earliest and most severe changes, including NFT formation and neuronal loss, occur in the medial temporal lobe (MTL), particularly the entorhinal cortex and the hippocampus (Wierenga & Bondi, 2011; Schultz et al., 2004). These regions are critical for episodic memory formation, and their early involvement explains why memory loss is typically the first and most prominent symptom of AD (Wierenga & Bondi, 2011; Love & Geldmacher, 2018; Prasad, 2020).

As the disease progresses, the pathology spreads from the MTL to involve large areas of the neocortex, especially the temporoparietal and frontal association cortices (Schultz et al., 2004; Love & Geldmacher, 2018). This spread leads to the emergence of deficits in other cognitive domains, such as language (aphasia), visuospatial skills (agnosia), and executive functions (apraxia) (Love & Geldmacher, 2018; Cummings et al., 1985). In contrast, primary sensory and motor cortices, as well as the cerebellum, are relatively spared until the very late stages of the disease (Nisa et al., 2016; Schultz et al., 2004; Unknown, 2003). This pattern of neuronal degeneration results in widespread cerebral atrophy, characterized by a reduction in brain weight and volume, thinning of the cortical ribbon, widening of sulci, and enlargement of the cerebral ventricles (Meléndez Chávez Autor & Oliveros Tutora Principal, 2018; Schapiro et al., 1989).

### Structural Neuroimaging: MRI and CT

Structural neuroimaging techniques, such as magnetic resonance imaging (MRI) and computed tomography (CT), are standard components of the diagnostic workup for suspected dementia (Burns, 2000; Adelman & Daly, 2005). While their primary role is often to exclude other causes of cognitive impairment, such as tumors, subdural hematomas, or normal pressure hydrocephalus (Burns, 2000; Adelman & Daly, 2005; Allan et al., 2013), they can also reveal patterns of atrophy suggestive of AD.

The most characteristic finding on structural MRI in AD is atrophy of the medial temporal lobes, especially the hippocampus and entorhinal cortex (Meléndez Chávez Autor & Oliveros Tutora Principal, 2018; Huckman, 2006). The degree of hippocampal atrophy is correlated with the severity of memory impairment and can help predict the progression from mild cognitive impairment (MCI) to AD dementia (De Vogelaere, 2012; Chung et al., 2017). As the disease advances, more generalized cortical atrophy becomes evident, particularly in the temporal and parietal lobes (Schapiro et al., 1989; Meléndez Chávez Autor & Oliveros Tutora Principal, 2018). While these findings are characteristic, they are not entirely specific to AD, as some degree of brain atrophy occurs in normal aging (Schapiro et al., 1989; Buchem, 2004). However, quantitative measurements of hippocampal volume or cortical thickness can increase diagnostic accuracy (Chung et al., 2017; Nelson et al., 2020).

### Functional and Molecular Neuroimaging: PET and SPECT

Functional neuroimaging techniques, such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), provide information about brain function by measuring regional cerebral blood flow or glucose metabolism (Dickerson & Sperling, 2007). In AD, the typical finding is bilateral hypometabolism or hypoperfusion in the posterior cingulate/precuneus and temporoparietal association cortices (Meléndez Chávez Autor & Oliveros Tutora Principal, 2018; Dickerson & Sperling, 2007; Hanyu et al., 2007). This pattern can help differentiate AD from other dementias, such as frontotemporal dementia, which typically shows frontal and/or anterior temporal hypometabolism (Dickerson & Sperling, 2007; Kerchner & Rosenbloom, 2014).

More recently, molecular PET imaging has enabled the in vivo visualization of the specific pathologies of AD. Amyloid PET tracers, allow for the detection and quantification of Aβ plaque burden in the brain (Wierenga & Bondi, 2011). A positive amyloid PET scan is a highly sensitive marker for AD pathology and can be particularly useful in cases with atypical clinical presentations or for confirming the underlying etiology in MCI (Suzuki, 2012). Tau PET tracers have also been developed, which can visualize the distribution of NFTs (Nedelská et al., 2019). These molecular imaging techniques are transforming the field, allowing for a biological, rather than purely clinical, diagnosis of AD and facilitating the testing of disease-modifying therapies (Suzuki, 2012; Verhey & Visser, 2013).

### Neural Circuits, Functional Connectivity, and Electrophysiology

AD is increasingly understood as a disorder of large-scale neural networks or a "disconnection syndrome" (Marinescu et al., 2017). The pathological processes disrupt not just individual brain regions but also the functional connections between them (Marinescu et al., 2017). Functional MRI (fMRI) studies have shown altered connectivity within and between several brain networks in AD.

A key network affected early in the disease is the default mode network (DMN), a set of brain regions (including the posterior cingulate/precuneus, medial prefrontal cortex, and hippocampus) that is active during rest and involved in episodic memory and self-referential thought (Chauhan et al., 2021). In AD, there is a characteristic disruption and decreased connectivity within the DMN, which correlates with memory impairment (Chauhan et al., 2021; De Vogelaere, 2012).

Electroencephalography (EEG) provides a measure of the brain's electrical activity. In AD, the EEG typically shows a progressive and diffuse slowing of brain rhythms, with a decrease in the frequency of the alpha rhythm and an increase in theta and delta activity (Gökçe et al., 2009; Erkinjuntti et al., 1988). The severity of this slowing generally correlates with the degree of cognitive decline (Erkinjuntti et al., 1988; Markand, 1986). While not specific, these EEG changes can help differentiate AD from non-AD dementias, such as dementia with Lewy bodies (which often shows more severe slowing) or frontotemporal dementia (where the EEG may be normal in early stages) (Gökçe et al., 2009; Gouw & Stam, 2016). EEG can also be crucial in ruling out nonconvulsive status epilepticus as a cause of confusion or cognitive decline in elderly patients (Kaplan, 1999; Woodford et al., 2015).

## Cellular and Synaptic Mechanisms

The macroscopic brain atrophy and network dysfunction observed in Alzheimer's disease are the ultimate consequences of devastating events occurring at the cellular and synaptic levels. The core of AD neurobiology lies in the progressive loss of synapses and neurons, driven by a confluence of toxic protein aggregation, excitotoxicity, inflammation, and metabolic failure.

### Synaptic Dysfunction and Loss

The loss of synapses is one of the earliest pathological events in AD and is the strongest neuropathological correlate of cognitive decline (Wierenga & Bondi, 2011; Dickson & Orr, 2011; Unknown, 2003). This synaptic degeneration occurs long before widespread neuronal death, suggesting that synaptic failure is a primary driver of the initial symptoms (Selkoe, 2009). The regions most affected by synapse loss, such as the hippocampus and association cortices, mirror the areas of greatest cognitive deficit (Wierenga & Bondi, 2011; Özugur, 2016).

Soluble oligomers of Aβ are considered to be the primary synaptotoxic agents (Selkoe, 2009). These small aggregates can bind to synaptic sites, interfering with normal synaptic transmission and plasticity mechanisms, such as long-term potentiation (LTP), which is a cellular substrate for learning and memory (Selkoe, 2009; Kumar & Bansal, 2021). This disruption of synaptic function leads to a "synaptic disconnection" that impairs communication within neural circuits (Marinescu et al., 2017). Both excitatory glutamatergic and inhibitory GABAergic synapses are affected in AD (Özugur, 2016). Quantitative studies have shown significant loss of markers for both presynaptic terminals and postsynaptic densities in affected brain regions (Özugur, 2016). The loss of inhibitory synapses, in particular, may contribute to network hyperexcitability, a phenomenon increasingly recognized in AD (Özugur, 2016; Palop, 2009).

### Neuronal Death Pathways

As the disease progresses, synaptic dysfunction gives way to overt neuronal loss (Wierenga & Bondi, 2011; Martin, 2002). Neurons in AD die through several regulated and non-regulated cell death pathways, including apoptosis (programmed cell death) and necrosis (Siao & Tsirka, 2002; Martin, 2002). Apoptotic mechanisms, characterized by a cascade of enzymatic events leading to cell dismantling, are thought to be activated by both Aβ and hyperphosphorylated tau (Martin, 2002; Kumar & Bansal, 2021).

Excitotoxicity, as previously mentioned, is another major pathway to neuronal death in AD (Volpe, 1997; Yu et al., 2024). Chronic, low-level overactivation of NMDA receptors, possibly potentiated by Aβ oligomers, leads to a sustained influx of calcium (Ca2+) into neurons (Yu et al., 2024). This calcium overload activates a number of downstream cytotoxic cascades, including the activation of proteases and the generation of reactive oxygen species, ultimately leading to cell death (Siao & Tsirka, 2002; Yu et al., 2024). This process of "slow" or "chronic" excitotoxicity is thought to be a key driver of the gradual neurodegeneration seen in AD (Yu et al., 2024).

### The Glymphatic System and Impaired Clearance

The brain has a specialized waste clearance system, known as the glymphatic system, which facilitates the removal of soluble proteins and metabolites from the interstitial fluid of the brain parenchyma (Massey et al., 2022). This system is most active during sleep, particularly deep, non-REM (NREM) slow-wave sleep (Brzecka et al., 2020; Mayer et al., 2024). It is hypothesized that the glymphatic system plays a crucial role in clearing soluble Aβ from the brain (Massey et al., 2022; Mayer et al., 2024).

Sleep disturbances are extremely common in AD, often preceding the onset of cognitive symptoms (Spira et al., 2014; Brzecka et al., 2018; Vitiello, 2006). These disturbances include reduced sleep efficiency, increased wakefulness after sleep onset, and a marked reduction in slow-wave sleep (Vitiello, 2006; Brzecka et al., 2018). There is a compelling bidirectional relationship between sleep disruption and AD pathology (Gonzales et al., 2024; Mishima, 2016). On one hand, Aβ accumulation can disrupt sleep-wake regulating circuits (Brzecka et al., 2018). On the other hand, sleep disruption, particularly the loss of slow-wave sleep, impairs glymphatic function and reduces Aβ clearance, leading to its further accumulation (Mayer et al., 2024; Massey et al., 2022). This creates a vicious cycle where poor sleep accelerates Aβ deposition, which in turn worsens sleep, driving the progression of the disease (Geddes, 2019; Sharma et al., 2015; Macedo et al., 2017). This link highlights sleep as a potentially modifiable factor in AD risk and progression (Mishima, 2016; Sharma et al., 2015).

## Developmental Neurobiology

Alzheimer's disease is fundamentally a disorder of aging, with age being the single greatest risk factor (Wierenga & Bondi, 2011; Ansar, 2014). However, its origins are increasingly viewed through a lifespan perspective, acknowledging that processes beginning much earlier in life may influence the brain's vulnerability or resilience to the pathological changes of AD (Vance, 2012). The concept of a long preclinical phase, lasting up to two decades, underscores that the neurodegenerative process is well underway long before clinical dementia is apparent (Wierenga & Bondi, 2011; Sadowski, 2010).

### Brain Development and Critical Periods

Normal brain development involves complex processes of neuronal migration, synaptogenesis, myelination, and synaptic pruning that establish the intricate neural circuits underlying cognition (Doose et al., 2000). While AD pathology manifests in late life, its anatomical targets—the hippocampus, limbic system, and association cortices—are phylogenetically and ontogenetically recent acquisitions of the human brain (Lamour et al., 1994). It is plausible that subtle variations in these developmental processes could create a vulnerable neural substrate that is less able to withstand the challenges of aging and AD pathology (Doose et al., 2000). For example, neurodevelopmental disorders such as Down syndrome, which involves trisomy of chromosome 21 where the APP gene is located, are associated with a near-universal development of AD neuropathology by middle age, highlighting a strong link between genetic-developmental factors and AD (Prasher & Corbett, 1993; Jellinger, 2020).

### Cognitive Reserve and Brain Resilience

The concept of "cognitive reserve" or "brain reserve" has emerged to explain the observed discrepancy between the degree of AD neuropathology in the brain and the severity of clinical symptoms (Foster et al., 2019; Willroth et al., 2022). Some individuals can tolerate a substantial burden of plaques and tangles with minimal cognitive impairment, while others show significant dementia with a lesser pathological load (Willroth et al., 2022; Nelson et al., 2020). Cognitive reserve is thought to be a product of lifelong experiences that shape the brain's efficiency, capacity, and flexibility (Vance, 2012).

Proxies for cognitive reserve include higher educational attainment, greater occupational complexity, and engagement in cognitively stimulating leisure activities (Foster et al., 2019; Nelson et al., 2020). These factors are associated with a reduced risk of dementia and may delay the onset of clinical symptoms in the face of accumulating pathology (Vance, 2012; Jackson, 1995). The neurobiological basis of cognitive reserve is thought to involve more efficient use of brain networks or the recruitment of alternative, compensatory neural circuits to perform tasks when primary networks are compromised by disease (Foster et al., 2019; Kim et al., 2012). Lifestyle factors such as physical exercise and social engagement also contribute to cognitive reserve, possibly by promoting neuroplasticity, reducing vascular risk factors, and enhancing overall brain health (Vance, 2012; Kuiper, 2016). High levels of psychological well-being have also been associated with greater cognitive resilience to neuropathology (Willroth et al., 2022). Understanding the developmental and biological underpinnings of cognitive reserve is a critical area of research, as it offers a powerful avenue for non-pharmacological prevention and intervention strategies to promote successful cognitive aging (Vance, 2012; Jackson, 1995).

## Treatment Mechanisms

Currently, there is no cure for Alzheimer's disease, and no treatments have been proven to halt or reverse the underlying neurodegenerative process (Pathan, 2023; Jacquy, 2010). Pharmacological interventions are primarily symptomatic, aimed at temporarily improving cognitive function and managing the behavioral and psychological symptoms of dementia (BPSD) (Burns, 2000; Singh & Adam, 2015). The biological basis of these treatments targets the neurotransmitter systems most affected by the disease.

### Cholinergic Augmentation

As discussed previously, a core neurochemical deficit in AD is the loss of cholinergic neurons and a subsequent reduction in acetylcholine (ACh) levels in the cortex and hippocampus (Gottfries, 1990; Wu et al., 2007). This provides the rationale for the use of acetylcholinesterase (AChE) inhibitors, which represent the first-line treatment for mild to moderate AD (Pereira & Marinho, 2015; Grossberg, 2005). Drugs in this class, including donepezil, rivastigmine, and galantamine, work by blocking the AChE enzyme, thereby increasing the synaptic availability of ACh and enhancing cholinergic signaling (Singh & Jha, 2021; Morais, 2004). Clinical trials have demonstrated that these agents provide modest but statistically significant benefits in cognition, activities of daily living, and global functioning for periods of 6 to 12 months (Gauthier et al., 1994; Singh & Adam, 2015). Rivastigmine is also a dual inhibitor of both AChE and butyrylcholinesterase (BuChE), which may provide additional benefits as the disease progresses (Grossberg, 2005). Galantamine also possesses a second mechanism of action as an allosteric modulator of nicotinic acetylcholine receptors, which may further enhance cholinergic transmission and modulate other neurotransmitter systems (Alagiakrishnan, 2010). Some evidence also suggests these agents may help alleviate certain neuropsychiatric symptoms (Grossberg, 2005).

### Glutamatergic Modulation

The excitotoxic cascade driven by overstimulation of the glutamatergic system, particularly via NMDA receptors, is another key therapeutic target in AD (Volpe, 1997; Yu et al., 2024). Memantine is an uncompetitive, moderate-affinity NMDA receptor antagonist approved for the treatment of moderate to severe AD (Pereira & Marinho, 2015; Zanni & Wick, 2007). Its mechanism of action is thought to involve blocking the pathological, tonic activation of NMDA receptors by ambient glutamate, while still permitting the transient, physiological activation required for normal synaptic transmission and plasticity (Córdova Neira & López Ortega, 2004). By reducing this excitotoxic "noise," memantine may protect neurons from calcium overload and subsequent cell death, thereby slowing the rate of clinical deterioration in more advanced stages of AD (Pereira & Marinho, 2015; Kumar & Bansal, 2021). It can be used as a monotherapy or in combination with an AChE inhibitor (Rucci & Feinstein, 2014).

### Management of Neuropsychiatric Symptoms

The behavioral and psychological symptoms of dementia (BPSD), such as agitation, aggression, and psychosis (delusions and hallucinations), are a major source of distress and are often managed with psychotropic medications (Profenno & Tariot, 2003; Burns, 2001). Antipsychotics, both typical and atypical (e.g., risperidone, olanzapine), are frequently used to manage severe agitation and psychosis (Masand, 2000; Ibach, 2007). However, their efficacy is modest, and they are associated with significant risks in the elderly, including an increased risk of cerebrovascular events and mortality (Moretti et al., 2006; Ibach, 2007). Antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs), are the first-line treatment for clinically significant depression and anxiety in AD (Katz, 1998; Tune, 1998). The management of these symptoms must always begin with a search for underlying medical or environmental triggers before resorting to pharmacotherapy (Profenno & Tariot, 2003).

### Disease-Modifying Therapies

The ultimate goal of AD treatment is to develop therapies that can modify the underlying disease course (Orlov, 2019). The majority of research in this area has focused on the amyloid cascade hypothesis, with strategies aimed at reducing Aβ production (e.g., β- and γ-secretase inhibitors), preventing its aggregation, or enhancing its clearance (e.g., immunotherapy with monoclonal antibodies) (Selkoe, 2009; Jacquy, 2010). While some anti-amyloid antibodies have shown success in clearing amyloid plaques from the brain, their clinical benefit on cognition has been a subject of intense debate, and they are not without significant side effects (Woloshin & Kesselheim, 2022). Other emerging strategies target tau pathology, neuroinflammation, mitochondrial dysfunction, and synaptic plasticity (Kumar & Bansal, 2021; Orlov, 2019). The complexity of AD suggests that future effective treatments may require a combination of therapies targeting multiple pathological pathways (León, 2024). Furthermore, there is a growing consensus that for any disease-modifying therapy to be effective, it must be initiated very early in the disease process, potentially in the preclinical or prodromal (MCI) stages, before irreversible neurodegeneration has occurred (Wierenga & Bondi, 2011; Aisen, 2008).

## Future Directions

Despite decades of intensive research, the fundamental mechanisms that trigger and propel Alzheimer's disease remain incompletely understood (Orlov, 2019). The field is at a critical juncture, moving beyond a singular focus on the amyloid cascade to embrace a more multifactorial model of pathogenesis. Future research must continue to unravel the complex interplay between Aβ, tau, neuroinflammation, vascular factors, metabolic dysfunction, and genetic risk to identify more effective therapeutic targets (Daulatzai, 2014; Kumar & Bansal, 2021).

A key priority is the refinement of early and accurate diagnosis, ideally at the preclinical or prodromal stage of the disease (Wierenga & Bondi, 2011; Jessen, 2013). The development and validation of more sensitive and accessible biomarkers are essential for this goal (Verhey & Visser, 2013). While CSF biomarkers and PET imaging for amyloid and tau are significant advances, research into blood-based biomarkers is a critical area that could enable widespread, cost-effective screening and earlier identification of at-risk individuals (Suzuki, 2012; Verhey & Visser, 2013). Improved understanding of the earliest clinical manifestations, including subjective cognitive decline (SCD) and mild behavioral impairment (MBI), may also provide a crucial window for intervention (Jessen & Rodriguez, 2018; Elefante et al., 2019). Studies focusing on these early stages will be vital to characterize the transition from normal aging to dementia (Sotolongo-Costa et al., 2014).

The therapeutic landscape is shifting from symptomatic treatments to disease-modifying strategies (Orlov, 2019; Jacquy, 2010). While anti-amyloid immunotherapies have shown promise in plaque removal, their clinical efficacy remains a subject of debate, highlighting the need for alternative and complementary approaches (Woloshin & Kesselheim, 2022). Future directions in drug development include targeting tau pathology, modulating neuroinflammatory pathways, correcting metabolic and mitochondrial dysfunction, and promoting neuroprotective and neurorestorative mechanisms (Kumar & Bansal, 2021; Orlov, 2019). Given the multifactorial nature of AD, combination therapies that address multiple pathological pathways simultaneously are likely to be more effective than single-target agents (León, 2024). Brain stimulation techniques, such as deep brain stimulation (DBS) of memory circuits, are also being explored as potential interventions to modulate neural network activity and improve cognitive function (Fried, 2016; Subramaniam et al., 2021).

Furthermore, there is a growing emphasis on prevention. Identifying and managing modifiable risk factors—such as cardiovascular and metabolic health (hypertension, diabetes, obesity), lifestyle factors (physical activity, diet, cognitive engagement), and sleep quality—represents a powerful public health strategy to reduce the incidence and delay the onset of dementia (Ansar, 2014; Daulatzai, 2014; Flodgren Gerd, 2016). Large-scale, multidomain intervention trials are needed to establish the efficacy of these preventive strategies (Flodgren Gerd, 2016).

Finally, a deeper understanding of the heterogeneity of AD is crucial (Jellinger, 2020). Research must continue to characterize the distinct biological subtypes and clinical variants of the disease, as this will be essential for developing personalized medicine approaches where specific treatments are tailored to the individual patient's underlying pathology and clinical profile (Jellinger, 2020; Paraskevas et al., 2020). Addressing these unanswered questions will require continued collaboration across disciplines, integrating genetics, molecular biology, neuroimaging, and clinical neurology to finally unravel the complexities of this devastating disease.

## Conclusion

Major or Mild Neurocognitive Disorder due to Alzheimer's Disease is a devastating condition rooted in a complex and progressive neurobiological cascade. The defining pathological features—extracellular Aβ plaques and intracellular neurofibrillary tangles—initiate a series of downstream events including synaptic dysfunction, neuronal loss, neuroinflammation, and widespread neurotransmitter deficits (Wierenga & Bondi, 2011; Selkoe, 2009). This pathology unfolds over decades, beginning in critical memory-related structures like the hippocampus and entorhinal cortex before spreading throughout the association cortices, leading to a predictable but inexorable decline in cognitive and functional abilities (Schultz et al., 2004; Love & Geldmacher, 2018).

The cholinergic deficit is a consistent and clinically significant finding, forming the basis for current symptomatic therapies with cholinesterase inhibitors (Gottfries, 1990; Singh & Jha, 2021). However, the dysfunction of multiple other systems, including the glutamatergic, monoaminergic, and peptidergic pathways, underscores that AD is a multi-system brain disease (Gottfries, 1990; Sunderland et al., 1997). The clinical expression of this multifaceted pathology is highly heterogeneous, influenced by genetic risk factors like APOE ε4, the presence of comorbid pathologies such as cerebrovascular disease, and individual differences in cognitive reserve (Mendez, 2017; Knopman, 2017; Foster et al., 2019). This heterogeneity manifests in atypical clinical presentations, such as posterior cortical atrophy or logopenic aphasia, which challenge traditional diagnostic frameworks centered solely on amnesia (Paraskevas et al., 2020; Knopman, 2021).

Neuroimaging has provided an invaluable window into the structural and functional consequences of the disease, revealing patterns of atrophy and metabolic decline that correlate with clinical symptoms and aid in differential diagnosis (Meléndez Chávez Autor & Oliveros Tutora Principal, 2018; Dickerson & Sperling, 2007). The advent of molecular PET imaging has further revolutionized the field, allowing for the in vivo detection of Aβ and tau pathology and shifting the diagnostic paradigm toward a biological definition of the disease (Suzuki, 2012; Verhey & Visser, 2013).

Despite these advances, the fundamental triggers of the disease remain elusive, and curative or disease-modifying treatments have yet to be realized (Orlov, 2019; Pathan, 2023). Future progress hinges on a continued, concerted effort to understand the earliest stages of the disease, develop more accessible and specific biomarkers, and design multi-target therapeutic strategies that can be deployed long before irreversible neurodegeneration occurs (Jacquy, 2010; Sadowski, 2010). The synthesis of knowledge from genetics, molecular biology, neuroimaging, and clinical neurology offers the most promising path forward in confronting the immense challenge posed by Alzheimer's disease.

## References

1. Abascal, R. V., & Romero, L. C. (2012). Disfunción ejecutiva: Síntomas y relevancia de su detección desde Atención Primaria. Revista Clínica de Medicina de Familia. https://doi.org/10.4321/s1699-695x2012000300007
2. Abe, K., Koli, R. L., & Yamamoto, L. G. (2016). Emergency Department Presentations of Anti–N-Methyl-D-Aspartate Receptor Encephalitis. Pediatric Emergency Care. https://doi.org/10.1097/pec.0000000000000713
3. Abou‐Saleh, M. T. (2002). Neuro‐imaging. Neuro‐imaging Studies of Depression. https://doi.org/10.1002/0470846410.ch73
4. Accogli, A., St‐Onge, J., Addour-Boudrahem, N., Lafond‐Lapalme, J., Laporte, A. D., Rouleau, G. A., Rivière, J., & Srour, M. (2019). Heterozygous Missense Pathogenic Variants Within the Second Spectrin Repeat of SPTBN2 Lead to Infantile-Onset Cerebellar Ataxia. Journal of Child Neurology. https://doi.org/10.1177/0883073819878917
5. Adelman, A., & Daly, M. P. (2005). Initial evaluation of the patient with suspected dementia.. PubMed.
6. Ahlskog, J. E. (2013). Daytime Drowsiness. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199977567.003.0026
7. Ahmed, S., Baker, I., & Butler, C. (2016). Diagnosing young onset dementia can be challenging.. PubMed.
8. Aisen, P. (2008). Treatment for MCI. Neurology. https://doi.org/10.1212/01.wnl.0000313380.89894.54
9. Ait-El-Mkadem, S., Chaussenot, A., Bannwarth, S., Rouzier, C., & Paquis‐Flucklinger, V. (2015). CHCHD10-Related Disorders.
10. Aknila, N. (2020). A brief study on Alzheimer's disease, Symptoms, Stages and Diagnosis. https://doi.org/10.35841/clinical-psychiatry.2.2.8-8
11. Al-Mosawi, A. (2019). Facial Dysmorphism, Mental Retardation, Triphalangeal Toes and Unilateral Renal Agenesis: A New Syndrome. International Invention of Scientific Journal.
12. Al-Mousawi, A. A.-A. M., Al-Saedi, K. A. I., & Nassir, S. F. (2016). Jervell and Lange-Nielsen syndrome (case report) Jervell and Lange-Nielsen syndrome (prolonged QT interval and hearing loss). Journal of the Faculty of Medicine Baghdad. https://doi.org/10.32007/jfacmedbagdad.581210
13. Al-Mousawi, A. A.-A. M., Al-Saedi, K. A. I., & Nassir, S. F. (2016). Jervell and Lange-Nielsen syndrome (case report) Jervell and Lange-Nielsen syndrome (prolonged QT interval and hearing loss). Journal of the Faculty of Medicine Baghdad. https://doi.org/10.32007/med.1936/jfacmedbagdad.v58i1.20
14. Alagiakrishnan, K. (2010). Galantamine in the Treatment of Minor Depression With Mild to Moderate Alzheimer’s Dementia in an Elderly Woman. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00905gry
15. Alecha, M. Á. I., & Martínez, S. A. (2009). Sueño en los trastornos del neurodesarrollo. Revista de Neurología. https://doi.org/10.33588/rn.48s02.2009022
16. Alessi, C., Chambers, L. W., & Gray, M. (2021). Living Longer Better. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198860341.003.0001
17. Allan, C. L., Behrman, S., & Ebmeier, K. P. (2013). Early diagnosis beneficial in Alzheimer's disease.. PubMed.
18. Almannai, M., Dai, H., El‐Hattab, A. W., & Wong, L. C. (2017). FBXL4-Related Encephalomyopathic Mitochondrial DNA Depletion Syndrome.
19. Alonso-Lana, S. (2016). El Trastorno Bipolar: Cambios cerebrales asociados con el estado de ánimo y el deterioro cognitivo. TDX (Tesis Doctorals en Xarxa).
20. Alrosan, A. Z., Heilat, G. B., Alrosan, K., Aleikish, A. A., Rabbaa, A. N., Shakhatreh, A. M., Alshalout, E. M., & Momany, E. A. (2024). Autonomic brain functioning and age-related health concerns. Current Research in Physiology. https://doi.org/10.1016/j.crphys.2024.100123
21. Alvarez, R. (2014). Evaluación de la Disfagia en Niños. Revista GEN.
22. Alves, J., Magalhães, R., Arantes, M., Cruz, S., Gonçalves, Ó. F., & Sampaio, A. (2013). Cognitive Rehabilitation in a Visual Variant of Alzheimer's Disease. Applied Neuropsychology Adult. https://doi.org/10.1080/23279095.2013.831865
23. Al‐kuraishy, H. M., Sulaiman, G. M., Mohammed, H. A., Mohammed, S. Q. S., Al‐Gareeb, A. I., Albuhadily, A. K., Dawood, R. A., Ali, A. A., & Abu-Alghayth, M. H. (2025). Amyloid-β and heart failure in Alzheimer’s disease: the new vistas. Frontiers in Medicine. https://doi.org/10.3389/fmed.2025.1494101
24. Ambali, A. P., & Kumar, P. (2020). Clinical Approach to “I am Forgetting” in Older People. Scholars Journal of Applied Medical Sciences. https://doi.org/10.36347/sjams.2020.v08i07.014
25. Amer, S. A. M., & Akkad, M. (2016). Correlation between Mild Cognitive Impairment and Functional Status among Elderly. Egyptian Journal of Geriatrics and Gerontology. https://doi.org/10.21608/ejgg.2016.30870
26. Ana, A., Raluca, Sandu, Fragaki, M., Buga, Adriana, A., Uzoni, Eugen, Bogdan, Petcu, Aurel, & Popa‐Wagner (2015). Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology. 中国神经再生研究：英文版.
27. Andrews, G., Stewart, G., Morris‐Yates, A., Holt, P. E., & Henderson, S. (1990). Evidence for a General Neurotic Syndrome. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.157.1.6
28. Angkat, C. I., Sianturi, I. M., Sinambela, S. H., Sitorus, Z., & Khairul, K. (2024). Penerapan Algoritma Certainty Factor dalam Diagnosa Penyakit Guillain-Barre Syndrome. Jurnal Ilmu Komputer dan Sistem Informasi (JIKOMSI). https://doi.org/10.55338/jikomsi.v7i1.2609
29. Angulo, S., García-Moreno, J. M., Izquierdo, G., Chacón, J., & Borobio, M. V. (1997). [Neuroborreliosis in a patient with progressive supranuclear paralysis. An association or the cause?].. PubMed.
30. Ansar, S. (2014). Avoid Alzheimerâ€™s disease: know the causes. Journal of Research in Medical Sciences.
31. Antoniuk, S. A. (2013). Debilidad muscular aguda: diagnósticos diferenciales. Revista de Neurología. https://doi.org/10.33588/rn.57s01.2013252
32. Antunes, J. C. D. (2017). Contributo do Mini Mental State Examination e do Montreal Cognitive Assessment na avaliação neuropsicológica de rastreio da cognição global no défice cognitivo ligeiro associado a perturbações do movimento.
33. Anuzyte, J. S., Rutkauskaitė, G., & Mameniškienė, R. (2018). Transient epileptic amnesia. Neurologijos seminarai. https://doi.org/10.29014/ns.2018.26
34. Apgáua, L. T., & Jaeger, A. (2019). Memory for emotional information and alexithymia A systematic review. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-57642018dn13-010003
35. Arandjelovic, D., Misic, P., Serafimovic, S., & Petrovic, M. (2010). P01-366 - Psychiatric Syndromes and Disorders in Older Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70574-5
36. Arango, C., Kirkpatrick, B., & Buchanan, R. W. (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
37. Arenson, C., Busby‐Whitehead, J., Brummel‐Smith, K., O’Brien, J. G., Palmer, M. H., & Reichel, W. (2010). Evaluation and Management of Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575952.017
38. Arieff, A. I., & Fraser, C. L. (1994). Metabolic encephalopathy as a complication of renal failure: mechanisms and mediators.. PubMed.
39. Ariff, K. M., & Hassan, Z. A. (2006). Insomnia: Case Studies In Family Practice.. DOAJ (DOAJ: Directory of Open Access Journals).
40. Arora, R., & Khan, Y. S. (2021). Motor Neuron Disease.
41. Arsanti, N. M., & Wreksoatmodjo, B. R. (2025). Tata Laksana Gangguan Kognitif di Layanan Primer. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v52i9.1653
42. Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019). Diagnosis and Management of Dementia: Review. JAMA. https://doi.org/10.1001/jama.2019.4782
43. Arzimanoglou, A., & Cross, J. H. (2019). Cognitive impairment and behavioral disorders in Encephalopathy related to Status Epilepticus during slow Sleep: diagnostic assessment and outcome. Epileptic Disorders. https://doi.org/10.1684/epd.2019.1060
44. Assal, F., & Ghika, J. (2016). [Dementia with motor and language disorders].. PubMed.
45. Attems, J., & Jellinger, K. A. (2013). Neuropathological Correlates of Cerebral Multimorbidity. Current Alzheimer Research. https://doi.org/10.2174/15672050113109990002
46. Auerbach, S. (2014). Sleep Disorders. https://doi.org/10.1002/9781118730676.ch13
47. Autor, J. L. M. C., & Principal, C. M. A. C. O. T. (2018). Demencia tipo Alzheimer vs pseudo demencia por depresión. Estudio neuropsicológico de un caso. XII CONGRESO DE POSGRADO EN PSICOLOGÍA | UNAM | 2018.
48. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
49. Autora, M. C. D. T., & Principal, C. I. Y. D. R. P. T. (2017). Funcionamiento cognitivo y alteraciones pragmáticas en pacientes con Esclerosis Múltiple.
50. Avendaño, M. L. P., Rincón, C. M., Tejada, J. V., & Etchepareborda, M. C. (2020). Variantes de neurodesarrollo en pacientes con diagnóstico de agenesia del cuerpo calloso completa y parcial. Revista Neuropsicologia Latinoamericana.
51. Azmath, J. (2020). Case Study on Parkinson’s Disease. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2020.31178
52. Bach, A. S., Oertel, W. H., & Bach, J.-P. (2010). Kognitive Defizite als Komorbidität neurologischer Erkrankungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628839
53. Baiardi, S., Magherini, A., Capellari, S., Redaelli, V., Ladogana, A., Rossi, M., Tagliavini, F., Pocchiari, M., Giaccone, G., & Parchi, P. (2017). Towards an early clinical diagnosis of sporadic CJD VV2 (ataxic type). Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2017-315942
54. Bains, N., Abdijadid, S., & Miller, J. (2021). Major Depressive Disorder (Nursing).
55. Bakheit, A. M. O. (2006). Recognition of acute illness in people with chronic neurological disability. Postgraduate Medical Journal. https://doi.org/10.1136/pgmj.2005.040253
56. Bakirtzis, C., Lima, M., Lorenzo, S., Artemiadis, A., Theotokis, P., Kesidou, E., Konstantinidou, N., Sintila, S.-A., Boziki, M., Parissis, D., Ioannidis, P., Karapanayiotides, T., Hadjigeorgiou, G. M., & Grigoriadis, N. (2023). Secondary Central Nervous System Demyelinating Disorders in the Elderly: A Narrative Review. Healthcare. https://doi.org/10.3390/healthcare11152126
57. Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., Isaacs, J. D., Larner, A. J., Nicholson, T. R., Pennington, C., Poole, N., Price, G., Price, J. P., Reuber, M., Ritchie, C., ... Carson, A. (2020). Functional cognitive disorder: dementia’s blind spot. Brain. https://doi.org/10.1093/brain/awaa224
58. Barakat, B., Agosti, R., Ruggeri, E., Tonini, V., Cervellera, M., Guidetti, E., Cevenini, M., Imbrogno, A., Fabbri, D., Pareo, I., Fucili, A., Corinaldesi, R., Stanghellini, V., Pezzilli, R., & Giorgio, R. D. (2012). Atypical presentation of acute idiopathic megacolon in a 14-year-old patient. Emergency Care Journal. https://doi.org/10.4081/ecj.2012.3.5
59. Barclay, L., Weiss, E., Mattis, S., BOND, O. B., & Blass, J. P. (1988). Unrecognized Cognitive Impairment in Cardiac Rehabilitation Patients. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.1988.tb03429.x
60. Baron‐Cohen, S. (2004). The cognitive neuroscience of autism. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2003.018713
61. Barrera, K., Yochim, B. P., & Yutsis, M. (2015). Neuropsychological Assessment. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa188
62. Bartlett, R., & McKeefry, D. J. (2011). Rethinking the experiences and entitlements of people with dementia: Taking vision into account. Journal of Care Services Management. https://doi.org/10.1179/175016811x12966389037637
63. Bassant, M., Lamour, Y., Potier, B., Billard, J., & Dutar, P. (1994). [Aging of memory mechanisms].. Comptes rendus des séances de la Société de biologie et de ses filiales.
64. Baxter, P. (2015). States of consciousness: new insights and further questions. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.12666
65. Bazarian, J. J., Černak, I., Noble‐Haeusslein, L. J., Potolicchio, S. L., & Temkin, N. (2009). Long-term Neurologic Outcomes After Traumatic Brain Injury. Journal of Head Trauma Rehabilitation. https://doi.org/10.1097/htr.0b013e3181c15600
66. Beatty, W. W., English, S., & Ross, E. D. (1997). Retrograde amnesia for medical and other knowledge in a physician with Alzheimer's disease. Neurocase. https://doi.org/10.1080/13554799708405013
67. Beaumont, A. (2008). Seizures in Renal and Hepatic Failure and Endocrine Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-841-0_6
68. Beccari, T., Michiara, M., Paciotti, S., Persichetti, E., Chiasserini, D., Castrioto, A., Tambasco, N., Rossi, A., Calabresi, P., Pagliardini, V., Bembi, B., & Parnetti, L. (2011). Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease. InTech eBooks. https://doi.org/10.5772/23552
69. Becker, J. T. (1988). Working memory and secondary memory deficits in Alzheimer's disease. Journal of clinical and experimental neuropsychology. https://doi.org/10.1080/01688638808402811
70. Bednarek, N., & Motté, J. (2004). Épilepsie et retard psychomoteur. Epileptic Disorders. https://doi.org/10.1684/j.1950-6945.2004.tb00083.x
71. Beghi, E., & Hauser, W. A. (2008). First seizure definitions and worldwide incidence and mortality. Epilepsia. https://doi.org/10.1111/j.1528-1167.2008.01443.x
72. Beghi, M., Cornaggia, C., Frigeni, B., & Beghi, E. (2006). Learning Disorders in Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00681.x
73. Behl, T., Makkar, R., Sehgal, A., Sharma, N., Singh, S., Albratty, M., Najmi, A., Meraya, A. M., & Bungău, S. (2022). Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders. Molecules. https://doi.org/10.3390/molecules27154970
74. Behrens, M. I., & Donoso, A. (2005). Variabilidad y variantesde la enfermedad de Alzheimer. Revista médica de Chile. https://doi.org/10.4067/s0034-98872005000400013
75. Bejenaru, A., & Ellison, J. M. (2020). Medicolegal Implications of Mild Neurocognitive Disorder. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988720957092
76. Bell, D., Turnbull, A., & Kidd, W. (2008). Differential diagnosis of dementia in the field of learning disabilities: a case study. British Journal of Learning Disabilities. https://doi.org/10.1111/j.1468-3156.2008.00524.x
77. Bellelli, G., Moresco, R., Panina–Bordignon, P., Arosio, B., Gelfi, C., Morandi, A., & Cesari, M. (2017). Is Delirium the Cognitive Harbinger of Frailty in Older Adults? A Review about the Existing Evidence. Frontiers in Medicine. https://doi.org/10.3389/fmed.2017.00188
78. Belova, Y. A., & Yakushina, T. I. (2018). Psychotic disorders in multiple sclerosis. S S Korsakov Journal of Neurology and Psychiatry. https://doi.org/10.17116/jnevro2018118082110
79. Benaur, M., Burgut, F. T., & Henchcliffe, C. (2006). Late-life depression: a neuropsychiatric approach. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.1.65
80. Bender, D. V., Jordá, C. P., Carroll, P., & Tumuluru, R. (2021). Differential diagnosis of auditory hallucinations in teenagers. Assessment and difficulties: Case report of a 13 year old patient. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.625
81. Benmelouka, A. Y., Ouerdane, Y., Outani, O., Alnasser, Y., Alghamdi, B. S., Perveen, A., Ashraf, G. M., & Ebada, M. A. (2022). Alzheimer’s Disease-Related Psychosis: An Overview of Clinical Manifestations, Pathogenesis, and Current Treatment. Current Alzheimer Research. https://doi.org/10.2174/1567205019666220418151914
82. Benoit, C., Svahn, J., Debs, R., Vandendries, C., Lenglet, T., Zyss, J., Maisonobe, T., & Viala, K. (2021). Focal chronic inflammatory demyelinating polyradiculoneuropathy: Onset, course, and distinct features. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.12438
83. Berrut, G., & Cubillé, M. (2019). Multimorbidity and epilepsia in the elderly.. PubMed. https://doi.org/10.1684/pnv.2019.0780
84. Bersani, F. S., Mellon, S. H., Reus, V. I., & Wolkowitz, O. M. (2019). Accelerated aging in serious mental disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000525
85. Bertrand, E., Azar, M., Rizvi, B., Brickman, A. M., Huey, E. D., Habeck, C., Landeira-Fernandez, J., Mograbi, D. C., & Cosentino, S. (2018). Cortical thickness and metacognition in cognitively diverse older adults.. Neuropsychology. https://doi.org/10.1037/neu0000458
86. Beutner, F.-U. (2019). Neuromuscular Electrical Stimulation (NMES) and α-Lipoic Acid. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2019.0643a
87. Bishop, K. M., Hogan, M., Janicki, M. P., Keller, S. M., Lucchino, R., Mughal, D. T., Perkins, E. A., Singh, B. K., Service, K., & Wolfson, S. K. (2015). Guidelines for Dementia-Related Health Advocacy for Adults With Intellectual Disability and Dementia: National Task Group on Intellectual Disabilities and Dementia Practices. Intellectual and developmental disabilities. https://doi.org/10.1352/1934-9556-53.1.2
88. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
89. Bjorvatn, B., Jernelöv, S., & Pallesen, S. (2021). Insomnia – A Heterogenic Disorder Often Comorbid With Psychological and Somatic Disorders and Diseases: A Narrative Review With Focus on Diagnostic and Treatment Challenges. Frontiers in Psychology. https://doi.org/10.3389/fpsyg.2021.639198
90. Black, K. J. (2020). Case Report: DSM–5 misses an edge case in tic disorders nosology. F1000Research. https://doi.org/10.12688/f1000research.23991.1
91. Blanc, F., & Verny, M. (2017). Prodromal stage of disease (dementia) with Lewy bodies, how to diagnose in practice?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2017.0675
92. Blumenthal, J. A., & Lett, H. S. (2005). Depression and Cardiac Risk. Journal of Cardiopulmonary Rehabilitation. https://doi.org/10.1097/00008483-200503000-00005
93. Bob, P., & Privara, M. (2025). ADHD, stress, and anxiety. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1536207
94. Boeve, B. F. (2004). Asymmetric cortical degeneration syndrome: semantic dementia. https://doi.org/10.1093/oso/9780195177442.003.0001
95. Bon, O. L., Neu, D., Valente, F., & Linkowski, P. (2007). Paradoxical NREMS Distribution in “Pure” Chronic Fatigue Patients. Journal of Chronic Fatigue Syndrome. https://doi.org/10.1300/j092v14n02_05
96. Bonnier, C., Marique, P., Hout, A. V., & Potelle, D. (2007). Neurodevelopmental Outcome After Severe Traumatic Brain Injury in Very Young Children: Role for Subcortical Lesions. Journal of Child Neurology. https://doi.org/10.1177/0883073807302604
97. Boon, P., Breuer, L. E. M., Grevers, E., Bernas, A., Bergmans, J., Besseling, R. M., Klooster, D., Louw, A. D., Mestrom, R., Vonck, K., Zinger, S., & Aldenkamp, A. P. (2016). Cognitive deterioration in adult epilepsy: clinical characteristics of “Accelerated Cognitive Ageing”. Acta Neurologica Scandinavica. https://doi.org/10.1111/ane.12700
98. Borrelli, S., Genoud-Prachex, T., Meyer, M., Démonet, J., & Rouaud, O. (2020). Unsuspected Alzheimer disease in a patient with Multiple sclerosis and progressive aphasia. Multiple Sclerosis and Related Disorders. https://doi.org/10.1016/j.msard.2020.102349
99. Bosco, F., Guarnieri, L., Rania, V., Palma, E., Citraro, R., Corasaniti, M. T., Leo, A., & Sarro, G. D. (2023). Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241612639
100. Bottas, A., Cooke, R., & Richter, M. A. (2005). Comorbidity and pathophysiology of obsessive–compulsive disorder in schizophrenia: Is there evidence for a schizo-obsessive subtype of schizophrenia?. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn.0527
101. Bourgeois, J. A., Hategan, A., & Losier, B. J. (2014). Delirium in the Hospital: Emphasis on the Management of Geriatric Patients: Prevention, Early Diagnosis, Comprehensive Treatment Are the Cornerstone of Care. Current psychiatry.
102. Boussaïd, G. (2016). Impact de la prise en charge respiratoire chez les patients atteints d'une maladie neuromusculaire.
103. Boylan, K., & Eppel, A. (2008). The severe mood dysregulation phenotype: case description of a female adolescent.. PubMed.
104. Bozoki, A., Giordani, B., Heidebrink, J. L., Berent, S., & Foster, N. L. (2001). Mild Cognitive Impairments Predict Dementia in Nondemented Elderly Patients With Memory Loss. Archives of Neurology. https://doi.org/10.1001/archneur.58.3.411
105. Brandt, C., Bien, C. G., Kohnen, O., Krey, I., Ramantani, G., Renzel, R., Wolff, M., & Imbach, L. (2024). Rare and complex epilepsies—Challenges in diagnostics and treatment. Deleted Journal. https://doi.org/10.1007/s10309-024-00661-0
106. Bravo, M. D. L. (2011). Ansiedad y depresión en la vejez.
107. Brett, A. S. (2004). Donepezil for Mild Cognitive Impairment. Journal watch. https://doi.org/10.1056/jp200410210000009
108. Brody, D. L. (2014). Sleep Disruption. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199383863.003.0007
109. Bronstein, A. M., & Lempert, T. (2010). Management of the patient with chronic dizziness. Restorative Neurology and Neuroscience. https://doi.org/10.3233/rnn-2010-0530
110. Brontë‐Stewart, H., Taira, T., Valldeoriola, F., Merello, M., Marks, W. J., Albanese, A., Bressman, S., & Moro, A. E. (2011). Inclusion and exclusion criteria for DBS in dystonia. Movement Disorders. https://doi.org/10.1002/mds.23482
111. Brooks, C. N., Talmage, J. B., & Mueller, K. L. (2012). Subjective, Objective, or Both?. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2012.marapr02
112. Brown, A. S. (2004). The Déjà Vu Illusion. Current Directions in Psychological Science. https://doi.org/10.1111/j.0963-7214.2004.00320.x
113. Bruce, S., Nelson, C. M., & Stutzman, B. (2022). Understanding the Needs of Children Who Are d/Deaf or Hard of Hearing With Disabilities Due to Genetic Causes. Routledge eBooks. https://doi.org/10.4324/9781003252054-4
114. Brzecka, A., Leszek, J., Ashraf, G. M., Ejma, M., Ávila-Rodriguez, M., Yarla, N. S., Tarasov, V. V., Chubarev, V. N., Samsonova, A. N., Barreto, G. E., & Aliev, G. (2018). Sleep Disorders Associated With Alzheimer's Disease: A Perspective. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2018.00330
115. Brzecka, A., Madetko‐Alster, N., Nikolenko, V. N., Ashraf, G. M., Ejma, M., Leszek, J., Daroszewski, C., Sarul, K., Somasundaram, S. G., Kirkland, C. E., & Aliev, G. (2020). Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link. Current Neuropharmacology. https://doi.org/10.2174/1570159x18666200309101750
116. Buchem, M. A. V. (2004). Introduction: Successful, Usual, and Pathological Aging. Topics in Magnetic Resonance Imaging. https://doi.org/10.1097/01.rmr.0000175130.55528.68
117. Budka, H., Aguzzi, A., Brown, P., Brucher, J., Bugiani, O., Gullotta, F., Haltia, M., Hauw, J., Ironside, J. W., Jellinger, K. A., Kretzschmar, H. A., Lantos, P. L., Masullo, C., Schlote, W., Tateishi, J., & Weller, R. O. (1995). Neuropathological Diagnostic Criteria for Creutzfeldt‐Jakob Disease (CJD) and Other Human Spongiform Encephalopathies (Prion Diseases). Brain Pathology. https://doi.org/10.1111/j.1750-3639.1995.tb00625.x
118. Budson, A. E., & O’Connor, M. K. (2021). What is dementia?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190098124.003.0001
119. Budson, A. E., & O’Connor, M. K. (2021). Which other disorders cause dementia?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190098124.003.0003
120. Buendia, A. R. Q., Aramburu, M. H., & Burneo, J. G. (2020). Eventos no epilépticos psicógenos: El desafío constante de su diagnóstico y tratamiento.. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v83i3.3796
121. Bujosa, H. B. C., Rodríguez-Montalbán, R., & Rosario-Rodríguez, A. (2017). Análisis de las Propiedades Psicométricas de la Escala Crespo-Bujosa de Síntomas Neurológicos Discretos.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.7714/cnps/11.1.2012
122. Bunevičius, A., Deltuva, V. P., Deltuvienė, D., Tamašauskas, A., & Bunevičius, R. (2008). Brain Lesions Manifesting as Psychiatric Disorders:<i>Eight Cases</i>. CNS Spectrums. https://doi.org/10.1017/s1092852900014000
123. Buongiorno, M., Marzal, C., Fernández, M., Cullell, N., Mena, L. D., Sánchez‐Benavides, G., Sierra, A. D. L., Krupiński, J., & Compta, Y. (2023). Altered sleep and neurovascular dysfunction in alpha-synucleinopathies: the perfect storm for glymphatic failure. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2023.1251755
124. Burakgazi, A. Z. (2014). Lyme disease –induced polyradiculopathy mimicking amyotrophic lateral sclerosis. International Journal of Neuroscience. https://doi.org/10.3109/00207454.2013.879582
125. Burn, D. J. (2013). Approach to History Taking and Examination of the Movement Disorder Patient. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199609536.003.0002
126. Burns, A. (2000). Diagnosis and management of Alzheimer's disease. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2000.2.2/aburns
127. Burns, A. (2001). Neuropsychiatric phenomena in Alzheimer's disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.71.6.715
128. Butler, C., & Zeman, A. (2008). Recent insights into the impairment of memory in epilepsy: transient epileptic amnesia, accelerated long-term forgetting and remote memory impairment. Brain. https://doi.org/10.1093/brain/awn127
129. Butterfield, D. A. (2000). Alzheimer’s Amyloid β-Peptide-Associated Oxidative Stress: Brain Membrane Lipid Peroxidation and Protein Oxidation. https://doi.org/10.1201/9780203910054-23
130. Bykov, Y. V., Bykova, A. Y., & Bekker, R. A. (2024). Autoimmune mediated suicidal behavior. Russian Journal of Immunology. https://doi.org/10.46235/1028-7221-16588-ams
131. Bystad, M., Pettersen, K., & Grønli, O. (2014). Depresjon eller demens av Alzheimers type?. Tidsskrift for Den norske legeforening. https://doi.org/10.4045/tidsskr.13.0364
132. Bämayr, A. (2014). Large Group of Patients Cannot Be Found. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0489b
133. Caetano, F., Araújo, M., Samouco, A., & Carvalho, S. (2021). 518 - AUTOIMMUNE DEMENTIA – WHEN TO SUSPECT?. International Psychogeriatrics. https://doi.org/10.1017/s1041610221002131
134. Calvani, M., Anania, C., Cuomo, B., D’Auria, E., Decimo, F., Indirli, G. C., Mastrorilli, V., Santoro, A., Sartorio, M. U. A., & Veronelli, E. (2020). Summation anaphylaxis: A challenging diagnosis. Pediatric Allergy and Immunology. https://doi.org/10.1111/pai.13347
135. Canitano, R., & Pallagrosi, M. (2017). Autism Spectrum Disorders and Schizophrenia Spectrum Disorders: Excitation/Inhibition Imbalance and Developmental Trajectories. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2017.00069
136. Cantudo, A. P. (2020). “¿Qué es una tortuga? neuropsicología de la demencia semántica”.
137. Capaldi, D. M., & Kim, H. K. (2014). Comorbidity of Depression and Conduct Disorder. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780199797004.013.015
138. Capovilla, G., & Avanzini, G. (2013). Introduction. Epilepsia. https://doi.org/10.1111/epi.12415
139. Caraballo, R., Pavlidis, E., Nikanorova, M., & Loddenkemper, T. (2019). Encephalopathy with continuous spike‐waves during slow‐wave sleep: evolution and prognosis. Epileptic Disorders. https://doi.org/10.1684/epd.2019.1052
140. Caratozzolo, S., Scalvini, A., Cocchi, S., & Cassarino, S. G. (2016). Neurodegenerative and Vascular Involvement in Post Stroke Dementia. Journal of Alzheimer’s Disease & Parkinsonism. https://doi.org/10.4172/2161-0460.1000283
141. Cardoso, S., Silva, D., Alves, L., Guerreiro, M., & Mendonça, A. D. (2022). The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-215465
142. Carrillo, P. J. M., Barrera, B. F. V., & Ramos, C. L. M. (2024). Mini revisión del síndrome de mal ajuste neonatal en equinos. Revista Sistemas de Producción Agroecológicos. https://doi.org/10.22579/22484817.1143
143. Caruso, A., Nicoletti, F., Gaetano, A., & Scaccianoce, S. (2019). Risk Factors for Alzheimer’s Disease: Focus on Stress. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.00976
144. Cassano, T., Calcagnini, S., Carbone, A., Bukke, V. N., Orkisz, S., Villani, R., Romano, A., Avolio, C., & Gaetani, S. (2019). Pharmacological Treatment of Depression in Alzheimer’s Disease: A Challenging Task. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.01067
145. Castañeda, C. S. (2009). Structural brain changes, cognitive deficits and visual hallucinations in dementia with lewy bodies and parkinson's disease with dementia. TDX (Tesis Doctorals en Xarxa).
146. Castillo, G., Fernández, B., & Chamorro, D. (2020). Neuroplasticidad: Ejercicios para retrasar los efectos de la Enfermedad de Alzheimer mediante Estimulación Cognitiva. Revista de Investigación Científica y Tecnológica. https://doi.org/10.36003/rev.investig.cient.tecnol.v4n2(2020)12
147. Castro‐Suárez, S., Guevara-Silva, E., Lira, D., Mar, M., Herrera‐Pérez, E., Prado, L. N. D., Montesinos, R., & Custodio, N. (2015). Crisis epilépticas en la demencia de la enfermedad de Alzheimer. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.2015.2474
148. Castro‐Suárez, S., Guevara-Silva, E., Lira, D., Mar, M., Herrera‐Pérez, E., Prado, L. N. D., Montesinos, R., & Custodio, N. (2015). Crisis epilépticas en la demencia de la enfermedad de Alzheimer. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v78i2.2474
149. Ceravolo, F., Sestito, S., Falvo, F., Salpietro, V., Polizzi, A., Ruggieri, M., Bruno, M., & Concolino, D. (2016). Neurological Involvement in Inherited Metabolic Diseases: An Overview. Journal of Pediatric Biochemistry. https://doi.org/10.1055/s-0036-1582235
150. Chang, F., & Josephs, K. A. (2013). Levodopa Responsiveness in Adult-onset Lower Limb Dystonia is Associated with the Development of Parkinson's Disease.. PubMed. https://doi.org/10.7916/d8vd6x5m
151. Chang, F., & Josephs, K. A. (2013). Levodopa Responsiveness in Adult-onset Lower Limb Dystonia is Associated with the Development of Parkinson’s Disease. Tremor and Other Hyperkinetic Movements. https://doi.org/10.5334/tohm.136
152. Chang, Y., Wang, L., Zeng, D., Che, H., & Yang, C. (2024). Alzheimer’s disease (AD) and Aging-related tau astrogliopathy (ARTAG). MOJ Clinical & Medical Case Reports. https://doi.org/10.15406/mojcr.2024.14.00470
153. Chapman, K. A. (2016). Systemic organic acidemias: Identification, diagnosis, management and long term complications. Journal of Pediatric Biochemistry. https://doi.org/10.3233/jpb-140126
154. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
155. Chauhan, P., Mishra, M., Koul, B., Sharma, M. M., & Yadav, D. (2021). Modifiable Risk Factors Associated with Alzheimer’s Disease with Special Reference to Sleep Disturbance. CNS & Neurological Disorders - Drug Targets. https://doi.org/10.2174/1871527320666210319111852
156. Chavagnat, J.-J. (2013). Deuil et symptomatologie psychiatrique : quelle conduite à tenir ?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2013.09.105
157. Chelimsky, G., Shanske, S., Hirano, M., Zinn, A. B., Cohen, M. H., McNeeley, K., & Chelimsky, T. (2005). Achalasia as the Harbinger of a Novel Mitochondrial Disorder in Childhood. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1097/01.mpg.0000155185.38754.ee
158. Chen, K., Wolf, G. J., Strelzow, J., & Stepan, J. G. (2024). Upper Extremity Ballistic Nerve Injury. JBJS Reviews. https://doi.org/10.2106/jbjs.rvw.24.00069
159. Chen, Y., Garcia, G. E., Huang, W., & Constantini, S. (2014). The Involvement of Secondary Neuronal Damage in the Development of Neuropsychiatric Disorders Following Brain Insults. Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00022
160. Chevallier, B., & Refinetti, P. (2020). [Dangerous practices and games at school].. PubMed.
161. Chiba, S., & Tamura, Y. (2015). [Clinical features of sleep disorders in older adults].. PubMed.
162. Choi, M. S., & Kim, S.-Y. (2010). P3-110: Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2010.05.1607
163. Choi, S. H., Lee, A. Y., & Kim, S. (2002). Understanding of Alzheimer's Disease through Illustrative Cases. Journal of the Korean Medical Association. https://doi.org/10.5124/jkma.2002.45.4.368
164. Chopra, K., & Tiwari, V. (2012). Tocotrienol and Cognitive Dysfunction Induced by Alcohol. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-047-2_14
165. Chouliaras, L., Topiwala, A., Cristescu, T., & Ebmeier, K. P. (2015). Establishing the cause of memory loss in older people.. PubMed.
166. Chukwu, L. C., Ekenjoku, J. A., Ohadoma, S. C., Olisa, C. L., Okam, P., Okany, C. C., Ramalam, M. A., & Innocent, O. C. (2023). Advances in the pathogenesis of Alzheimer’s disease: A re-evaluation of the Amyloid cascade hypothesis. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2023.17.2.20200335
167. Chung, J. K., Plitman, E., Nakajima, S., Caravaggio, F., Shinagawa, S., Iwata, Y., Gerretsen, P., Kim, J., Takeuchi, H., Patel, R., Chakravarty, M. M., Strafella, A. P., & Graff‐Guerrero, A. (2017). The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer’s Pathology: A Brief Report. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-170098
168. Ciobîcă, A., Honceriu, C., Ciobica, A., Cojocaru, D., Trofin, F., Dobrin, R., Balmus, I. M., & Timofte, D. (2018). POSSIBLE RELEVANCE OF PHYSICAL EXERCISING IN ALZHEIMER’S DISEASE AND OTHER DEMENTIAS. The Medical-Surgical Journal.
169. Civantos, C. C., Cabanillas, M. I. C., Sáez, J. P., Peñaranda, E. R., Torres, B. G., & Eguía, A. I. N. (2018). Cuerpos extraños faringolaringeos infrecuentes en el anciano. Presentación de dos casos.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.14201/orl.18308
170. Claassen, D. O., Josephs, K. A., Ahlskog, J. E., Silber, M. H., Tippmann‐Peikert, M., & Boeve, B. F. (2010). REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology. https://doi.org/10.1212/wnl.0b013e3181ec7fac
171. Clara, S. M., Demchenko, O. М., & Sergio, F. (2018). Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease. Advances in Alzheimer's disease. https://doi.org/10.3233/978-1-61499-876-1-311
172. Clavé, P., Terré, R., Kraa, M. D., & Serra, M. (2004). Approaching oropharyngeal dysphagia. Revista Española de Enfermedades Digestivas. https://doi.org/10.4321/s1130-01082004000200005
173. Cohen, A. S. A., & Gibson, W. T. (2019). EED-Related Overgrowth.
174. Cohen, J. A., & Vebell, R. M. (2006). Neuromuscular Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-960-8_13
175. Cohen, M. L., Ryan, A. C., & Ccc-Slp, A. M. L. P. (2021). Prevention of and Early Intervention for Cognitive Decline Due to Alzheimer’s Disease and Related Disorders. Delaware Journal of Public Health. https://doi.org/10.32481/djph.2021.09.014
176. Colaci, M., Cassone, G., Manfredi, A., Sebastiani, M., Giuggioli, D., & Ferri, C. (2014). Neurologic Complications Associated with Sjögren’s Disease: Case Reports and Modern Pathogenic Dilemma. Case Reports in Neurological Medicine. https://doi.org/10.1155/2014/590292
177. Coll, P. P., Fortinsky, R. H., Kaplan, R. F., & Song, C. (2003). Diagnosis and management of Alzheimer's disease.. PubMed.
178. Constantinescu, C. S., & Lim, S. (2018). Weakness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199568741.003.0044
179. Constantinidis, J. (1986). Heredity and Dementia. Gerontology. https://doi.org/10.1159/000212833
180. Corbett, J. A., & Prasher, V. P. (1993). Onset of seizures as a poor indicator of longevity in people with down syndrome and dementia. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.930081106
181. Corey‐Bloom, J., Yaari, R., & Weisman, D. (2006). Managing patients with Alzheimer's disease. Practical Neurology. https://doi.org/10.1136/jnnp.2006.088757
182. Corsi, M., Raimo, T. D., Lorenzo, C. D., Rapp‐Ricciardi, M., Archer, T., Ricci, S., & Businaro, R. (2016). Cognitive disability in alzheimer's disease and its management.. PubMed. https://doi.org/10.7417/ct.2016.1955
183. Cortés, N., Andrade, V., & Maccioni, R. B. (2018). Behavioral and Neuropsychiatric Disorders in Alzheimer’s Disease. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-180005
184. Costa, T., Coenen, V. A., & Döbrössy, M. D. (2023). Neuronal networks of depression: Pushing the limits of brain stimulation technology. Open Access Government. https://doi.org/10.56367/oag-038-10653
185. Coutinho, P., & Barbot, C. (2015). Ataxia with Oculomotor Apraxia Type 1.
186. Cox, N., Willis, P. F., & Danahy, M. (2025). B – 57 Assessment of Cognitive Impairment due to Multiple Etiologies in a Case of Childhood Onset Systemic Lupus Erythematosus. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acaf084.207
187. Crassard, I., Bakchine, S., & Seilhan, D. (1997). Anosognosia for hemiplegia after a brainstem haematoma: a pathological case. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.63.5.686
188. Creten, C., Zwaan, S. V. D., Blankespoor, R. J., Maatkamp, A., Klinkenberg, S., Kranen‐Mastenbroek, V. H. V., Nicolai, J., Dhossche, D. M., Os, J. V., & Schieveld, J. N. M. (2012). [Anti-NMDA-receptor encephalitis: a new axis-III disorder in the differential diagnosis of childhood disintegrative disorder, early onset schizophrenia and late onset autism].. PubMed.
189. Crichton, R. R., & Ward, R. J. (2013). Ageing and Mild Cognitive Impairment (MCI). https://doi.org/10.1002/9781118553480.ch05
190. Cummings, J. L., & Zhong, K. (2017). Promise and Challenges in Drug Development and Assessment for Cognitive Enhancers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214401.003.0001
191. Cummings, J. L., Benson, D. F., Hill, M. A., & Read, S. (1985). Aphasia in dementia of the Alzheimer type. Neurology. https://doi.org/10.1212/wnl.35.3.394
192. Cunha, A. H. D. N., Costa, A. N. D., & Varela, D. S. D. S. (2019). ABORDAGEM FISIOTERAPÊUTICA EM UM CASO DE ESCLEROSE LATERAL AMIOTRÓFICA (ELA).
193. Curcho, L. C. A., Camacho, D. L., Pérez-Hostia, K. G., Meza-Fandiño, D. F., Rodríguez, L. J. V., Vega, H. J. C., & Rojas-Gutiérrez, M. A. (2022). ¿Existe correlación metabólica hipoglucémica y el síndrome de Percheron? Reporte de caso. Salud UIS. https://doi.org/10.18273/saluduis.55.e:23016
194. Custodio, N., Herrera‐Pérez, E., Lira, D., Montesinos, R., Mar, M., Guevara-Silva, E., Castro‐Suárez, S., Cortijo, P., Cuenca, J., & Prado, L. N. D. (2014). Depresión en la tercera edad como factor de riesgo y su posible rol como pródromo de demencia. Revista de Neuro-Psiquiatría. https://doi.org/10.20453/rnp.v77i4.2191
195. Custodio, N., Montesinos, R., Hernández-Córdova, G., & Cruzado, L. (2020). A Propósito De Un Caso De Demencia Frontotemporal &amp;#8211; Variante conductual, Con Síntomas Amnésicos E Imágenes Cerebrales Tipo Alzheimer. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272020000100074
196. Dafre, R., & Wasnik, P. (2023). Current Diagnostic and Treatment Methods of Alzheimer’s Disease: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.45649
197. Dalamagka, M. I. (2024). Epilepsy in children and anesthesia. Magna Scientia Advanced Research and Reviews. https://doi.org/10.30574/msarr.2024.12.2.0180
198. Dalamagka, M. I. (2025). Pediatric neurodegenerative disorders and anesthesia considerations. GSC Advanced Research and Reviews. https://doi.org/10.30574/gscarr.2025.22.1.0006
199. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
200. Dang, M. T. (2024). What Is a Good Approach to Thinking About a Child With Multiple Dysmorphisms?. CRC Press eBooks. https://doi.org/10.1201/9781003523659-56
201. Dara, N., Sayyari, A., & Imanzadeh, F. (2014). Hepatic encephalopathy: early diagnosis in pediatric patients with cirrhosis.. PubMed.
202. Daulatzai, M. A. (2010). Early Stages of Pathogenesis in Memory Impairment during Normal Senescence and Alzheimer's Disease. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2010-1374
203. Daulatzai, M. A. (2014). Multifactorial Pathologies Promote Inflammation and Enhance vulnerability to Late-Onset Alzheimer’s Disease: Implications for Possible Therapeutic Targets. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/9781608058709114020006
204. Debiais, S., Bonnaud, I., Ferreira-Maldent, N., Mercier, E., & Toffol, B. D. (2009). NEUROPSYCHIATRIC DISORDERS REVEALING PRIMARY ANTIPHOSPHOLIPID SYNDROME IN AN ELDERLY PATIENT. Neurology. https://doi.org/10.1212/wnl.0b013e3181a0fd69
205. Delattre, J., Moll, J., Antoine, J. C., Brashear, H. R., Drlicek, M., Dropcho, E. J., Giometto, B., Graus, F., Greenlee, J., Honnorat, J., Jaeckle, K. A., Tanaka, K., & Vecht, C. (1995). Guidelines on the detection of paraneoplastic anti-neuronal-specific antibodies. Neurology. https://doi.org/10.1212/wnl.45.10.1937
206. Delgado, M. G., & Bogousslavsky, J. (2013). Aggravation neurologique après une crise d’épilepsie post-AVC : une paralysie de Todd persistante?.
207. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
208. Demey, I., Zimerman, M., Allegri, R., Serrano, C., & Taragano, F. (2004). Neuropsychiatric symptoms of mild cognitive impairment. CRC Press eBooks. https://doi.org/10.3109/9780203492857-7
209. Dempere‐Marco, L., Conesa, N., & Balagué, M. (2019). Evaluación de la interacción entre atención visual y memoria de trabajo: un estudio basado en técnicas de eye-tracking. https://doi.org/10.4995/ceabioing.2019.10023
210. Deonna, T., Roulet, E., Gaillard, F., Peter-Favre, C., & Despland, P. (1991). Acquired Aphasia, Dementia, and Behavior Disorder with Epilepsy and Continuous Spike and Waves During Sleep in a Child. Epilepsia. https://doi.org/10.1111/j.1528-1157.1991.tb04683.x
211. Derouesné, C. (2006). Dementia with Lewy bodies: third report of DLB consortium. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
212. Derouesné, C. (2006). Démence à corps de Lewy : nouveau consensus. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
213. Deuschl, G., Chaudhuri, К. R., & Dietrichs, E. (2016). Symposia. European Journal of Neurology. https://doi.org/10.1111/ene.13090
214. Deuschle, M., & Lederbogen, F. (2002). Depression und koronare Herzerkrankung: pathogenetische Faktoren vor dem Hintergrund des Stresskonzeptes. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2002-28434
215. Dhikav, V., Singh, P., & Anand, K. S. (2013). Medication adherence survey of drugs useful in prevention of dementia of Alzheimer's type among Indian patients. International Psychogeriatrics. https://doi.org/10.1017/s1041610213000744
216. Dickerson, B. C., & Sperling, R. A. (2007). Dementia: mild cognitive impairment and Alzheimer’s disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566298.003.0005
217. Dickson, D. W., & Orr, C. (2011). Neuropathology of Dementia in Parkinson's Disease. Parkinson s Disease. https://doi.org/10.1002/9781444397970.ch14
218. DiMaio, V. J., & Dana, S. E. (2006). Handbook of forensic pathology.
219. Ding, K., Gupta, P. K., & Diaz‐Arrastia, R. (2016). Epilepsy after Traumatic Brain Injury. CRC Press, Taylor and Francis Group eBooks.
220. Diniz, M. L., Morais, A. M. B. D., & Sousa, M. N. A. D. (2024). Influência da síndrome do intestino irritável sobre a depressão e outras comorbidades psiquiátricas. Revista Eletrônica Acervo Científico. https://doi.org/10.25248/reac.e13512.2024
221. Djebara, M. B., Hizem, Y., Gargouri, A., Jemli, F., & Gouider, R. (2006). Autisme syndromique et épilepsie.
222. Dobre, M., Popa, P., Aurel, N., & Georgescu, L. P. (2009). Clinical and paraclinical aspects in mental retarda tion and autism spectrum disorders Retardul mentali tulbur ările din spectrul autist - aspecte clinicei paraclinice.
223. Domoto‐Reilly, K., Sapolsky, D., & Dickerson, B. C. (2014). Mild Cognitive Impairment (MCI) Stage of the Frontotemporal Dementias: Early Diagnosis and Management. Perspectives on Gerontology. https://doi.org/10.1044/gero19.2.57
224. Domínguez, C., Uribe, M. S. G., & Roncero, C. Í. (2010). Trastorno del Espectro Autista y Esquizofrenia. Revista de Psiquiatría Infanto-Juvenil.
225. Domínguez, L. N., Martin, P. R., Olea, A. M., Martínez, N. B., Sanjosé, G. U., González, M. M., & Tolosa-Delgado, A. (2016). Atypical Psychotic Symptoms in Lafora´s Disease: A Case Report.
226. Donati, F., Vassella, F., & Jm, P. (1991). [Variability of epileptic seizure phenomenology in infants and children].. PubMed.
227. Donoso, A., Behrens, M. I., & Venegas, P. (2003). Deterioro cognitivo leve: seguimiento de 10 casos. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272003000200005
228. Donoso, S. A., González, V. R., González, R. P., & Pugin, A. A. (2008). Demencia semántica. Presentación de dos casos y revisión de la literatura Semantic dementia: Report of two casesd*.
229. Doody, R. S., Massman, P. J., Mahurin, R. K., & Law, S. (1995). Positive and negative neuropsychiatric features in Alzheimer's disease. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.7.1.54
230. Dorahy, M. J. (2022). Subjective Amnesia in Dissociative Identity Disorder. Routledge eBooks. https://doi.org/10.4324/9781003057314-48
231. Doyle, F., Conroy, R., & McGee, H. (2007). Challenges in reducing depression-related mortality in cardiac populations: cognition, emotion, fatigue or personality?. Health Psychology Review. https://doi.org/10.1080/17437190802046322
232. DUMITRU, A.-C. (2018). VASCULAR DEMENTIA. University Arena.. https://doi.org/10.62229/uai_1_18-13
233. Duncan, J. S., Sander, J. W., Alim‐Marvasti, A., Balestrini, S., Baxendale, S., Bindman, D., Chinthapalli, K., Chowdhury, F. A., Diehl, B., Eriksson, S., Foong, J., Heaney, D., Khan, S., Koepp, M. J., Kullmann, D. M., Rajakulendran, S., Rugg‐Gunn, F., Sidhu, M. K., Sisodiya, S. M., ... Yogarajah, M. (2024). Epilepsy and Related Disorders. Neurology. https://doi.org/10.1002/9781119715672.ch10
234. Durmaz, G. B. (2024). Child delirium assessment scale: Validity and reliability study. Journal of Psychiatric Nursing. https://doi.org/10.14744/phd.2023.39145
235. Dvck., P. J., Stevens., J. C., O’Brien, P. C., Oviatt, K. F., Lais, A. C., Coventry, M. B., & Beabout, J. W. (1983). Neurogenic arthropathy and recurring fractures with subclinical inherited neuropathy. Neurology. https://doi.org/10.1212/wnl.33.3.357
236. D’Abreu, A., & Ott, B. R. (2005). Poststroke Dementia. Humana Press eBooks. https://doi.org/10.1385/1-59259-824-2:231
237. Ebner, R. (2014). Incomplete Description. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0488a
238. Edwards, S., & Salis, C. (2016). Aphasia from a Neurolinguistic Perspective. Oxford Research Encyclopedia of Linguistics. https://doi.org/10.1093/acrefore/9780199384655.013.79
239. Elbasiouny, S. M. (2022). Motoneuron excitability dysfunction in ALS: Pseudo‐mystery or authentic conundrum?. The Journal of Physiology. https://doi.org/10.1113/jp283630
240. Elble, R. J. (2020). Do We Belittle Essential Tremor by Calling It a Syndrome Rather Than a Disease? No. Frontiers in Neurology. https://doi.org/10.3389/fneur.2020.586606
241. Elefante, C., Lattanzi, L., Ismail, Z., Medda, P., Bacciardi, S., Mainardi, C., & Perugi, G. (2019). Mild Behavioral Impairment: presentation of the diagnostic criteria and the Italian version of the MBI-Checklist.. PubMed. https://doi.org/10.1708/3142.31246
242. Elias, R. M. (2004). Distúrbios do sistema nervoso central e periférico. Brazilian Journal of Nephrology (Jornal Brasileiro de Nefrologia).
243. Elrefai, N. A. R. (2013). Anesthetic management for parturients with neurological disorders. Anesthesia Essays and Researches. https://doi.org/10.4103/0259-1162.118940
244. El‐Menyar, A., Al‐Thani, H., & Mansour, M. (2024). Dementia and traumatic brain injuries: underestimated bidirectional disorder. Frontiers in Neurology. https://doi.org/10.3389/fneur.2023.1340709
245. Emery, V. C., & Oxman, T. E. (1997). Depressive dementia: a "transitional dementia"?. PubMed.
246. Emran, T. B., Chopra, H., & Dhama, K. (2023). Autophagy and Alzheimer’s disease: How far science has to be progressed? − correspondence. Annals of Medicine and Surgery. https://doi.org/10.1097/ms9.0000000000000156
247. Engrand, N., & Crespel, A. (2008). Champ 1- bases physiopathologiques des états de mal épileptiques☆. Réanimation. https://doi.org/10.1016/j.reaurg.2008.09.017
248. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
249. Erbguth, F. (2019). [Acute Disorders of Consciousness and Coma - Systematics, Differential Diagnosis and Management].. DMW - Deutsche Medizinische Wochenschrift.
250. Ercika, L., & Taube, M. (2025). Case Report: Lewy body dementia with unusual psychotic symptoms, atypically late parkinsonism, and patient sensitivity to first generation antipsychotics. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2025.1551581
251. Erkinjuntti, T., Larsen, T., Sulkava, R., Ketonen, L., Laaksonen, R., & Palo, J. (1988). EEG in the differential diagnosis between Alzheimer's disease and vascular dementia. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1988.tb06971.x
252. Erritt, L. (2024). Dementia diagnosis for people with intellectual disabilities from minoritised ethnic backgrounds: Barriers and implications. FPID Bulletin The Bulletin of the Faculty for People with Intellectual Disabilities. https://doi.org/10.53841/bpsfpid.2024.22.2.49
253. Esquiliano, G. R., Ramírez, I. M., Valdés, A. T., & Aguilar, C. A. T. (2004). Daño neurológico secundario a hipoxia isquemia perinatal. Archivos de neurociencias (México, D.F.).
254. Evans, D., Levene, M. I., & Tsakmakis, M. (2007). Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd001240.pub2
255. Fabbrni, B. L., & Cysneiros, R. M. (2018). As crises neonatais produzem efeitos neurológicos deletérios de longo prazo: evidências clínicas experimentais.
256. Fabisiak, A., Tomaszewicz-Libudzic, C., Popielarska, A., Komender, J., & Popielarska, M. (1986). [Difficulties in the diagnosis of epilepsy in children].. PubMed.
257. Faeder, M., Hale, E., Hedayati, D., Israel, A., Moschenross, D., Peterson, M., Peterson, R., Piechowicz, M., Punzi, J., & Gopalan, P. (2023). Preventing and treating delirium in clinical settings for older adults. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/20451253231198462
258. Falcicchio, G., Boero, G., Francavilla, T., Alicino, A., Sgobio, R., Trojano, M., & Neve, A. L. (2022). A case of repeated focal motor seizures as expression of an inflammatory cerebral process with suspected dysimmune etiology. Epilepsy & Behavior Reports. https://doi.org/10.1016/j.ebr.2022.100576
259. Falk, M. J., & Moreno, M. A. (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
260. Fatani, M. I., Wani, A. M., Manjaly, M., Hussain, W. M., Turkistani, A., Showkat, K., Maimani, G. A., Qadmani, A., & Akhtar, M. (2009). Delirium in a 74-year-old man: correct imaging revealed the truth. BMJ Case Reports. https://doi.org/10.1136/bcr.07.2009.2070
261. Fatima, K., Mehendale, A. M., & Reddy, H. (2022). Young-Onset Dementia and Neurodegenerative Disorders of the Young With an Emphasis on Clinical Manifestations. Cureus. https://doi.org/10.7759/cureus.30025
262. Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015). REM Sleep Behavior Disorder (RBD) as a marker od neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/000298292014238
263. Ferini‐Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., & Giora, E. (2015). REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders. ARCHIVES ITALIENNES DE BIOLOGIE. https://doi.org/10.12871/00039822014238
264. Ferini‐Strambi, L., Sforza, M., Poletti, M., Giarrusso, F., & Galbiati, A. (2017). Daytime sleepiness: more than just Obstructive Sleep Apnea (OSA). La Medicina del lavoro. https://doi.org/10.23749/mdl.v108i4.6497
265. Ferlisi, A., Domínguez, L. J., Vernuccio, L., Sutera, L., Bue, A. L., Prima, A. D., Picciolo, V., Giambartino, T., & Barbagallo, M. (2007). ATTUALE APPROCCIO TERAPEUTICO NEI PAZIENTI CON MALATTIA DI ALZHEIMER.
266. Fernández, A., Andreina, M. M., Hornero, R., Ortiz, T., & López-Ibor, J. J. (2010). [Analysis of brain complexity and mental disorders].. PubMed.
267. Fibiger, H. (1984). The Neurobiological Substrates of Depression in Parkinson’s Disease: A Hypothesis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100046230
268. Fierro, Á. D. J. L., Aparicio, S. Y. L., Morgado‐Valle, C., Beltrán‐Parrazal, L., García, L. I., Hernández‐Aguilar, M. E., Manzo, J., & Pérez-Estudillo, C. A. (2022). Trastornos de las neuronas motoras: causas, síntomas, factores de riesgo, diagnósticos y tratamientos. eNeurobiología. https://doi.org/10.25009/eb.v13i31.2599
269. Filipa, N., & Sergio, S. (2015). Phenomenology of Depression in Alzheimer's Disease. Advances in Alzheimer's disease. https://doi.org/10.3233/978-1-61499-542-5-3
270. Fitó, A. S., Roura, R. C., López‐Sala, A., & Lluch, C. B. (2009). Aspectos neuropsicológicos del daño cerebral difuso adquirido en la edad pediátrica. Revista de Neurología. https://doi.org/10.33588/rn.48s02.2009016
271. Fois, A. (2014). Early infantile epileptic encephalopathies. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/1824-7288-40-s1-a69
272. Fonseca, L. C., Tedrus, G. M. A. S., Lalloni, D. T., Tella, L. M. G., Maluf, P., & Sousa, V. D. D. (2005). Distúrbio cognitivo transitório associado a atividade epileptiforme generalizada ou difusa durante o eletrencefalograma. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2005000500018
273. Foster, N. L., Bondi, M. W., Das, R., Foss, M., Hershey, L. A., Koh, S., Logan, R., Poole, C., Shega, J. W., Sood, A., Thothala, N., Wicklund, M., Yu, M., Bennett, A., & Wang, D. (2019). Quality improvement in neurology. Neurology. https://doi.org/10.1212/wnl.0000000000008259
274. Fox‐Fuller, J. T., Choudhury, T. K., Lowe, D. A., & Balsis, S. (2019). Hallucinations and Delusions Signal Alzheimer’s Associated Cognitive Dysfunction More Strongly Compared to Other Neuropsychiatric Symptoms. The Journals of Gerontology Series B. https://doi.org/10.1093/geronb/gbz032
275. Franco, P., Kugener, B., Dijoud, F., Scaillet, S., Groswasser, J., Kato, I., Montemitro, E., Lin, J., & Kahn, A. (2007). Sudden Infant Death Syndrome from Epidemiology to Pathophysiology. Current Pediatric Reviews. https://doi.org/10.2174/157339607781369528
276. Freund, B., Shourav, M. M. I., Feyissa, A. M., Meschia, J. F., Yonas, A. S., Barrett, K. M., Tatum, W. O., & Lin, M. (2025). Seizures in Cerebral Amyloid Angiopathy. Neurology Clinical Practice. https://doi.org/10.1212/cpj.0000000000200454
277. Fried, I. (2016). Brain Stimulation in Alzheimer’s Disease. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-160719
278. Frommberger, D.-B. U. (2014). In Reply. Deutsches Ärzteblatt international. https://doi.org/10.3238/arztebl.2014.0489c
279. Frías, Á., Palma, C., & Farriols, N. (2015). Traumatismo craneoencefálico en pacientes con síndrome psicótico: etiopatogenia y estatus nosológico. Revista de la Asociación Española de Neuropsiquiatría. https://doi.org/10.4321/s0211-57352015000400011
280. Fuermaier, A. B. M., Piersma, D., Waard, D. D., Davidse, R. J., Groot, J. D., Doumen, M. J., Bredewoud, R. A., Claesen, R., Lemstra, A. W., Scheltens, P., Vermeeren, A., Ponds, R., Verhey, F. R., Deyn, P. P. D., Brouwer, W., & Tucha, O. (2019). Driving Difficulties Among Patients with Alzheimer’s Disease and Other Neurodegenerative Disorders. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-181095
281. Förstl, H., Almeida, O. P., & Iacoponi, E. (1991). Capgras delusion in the elderly: The evidence for a possible organic origin. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.930061204
282. Galbiati, A., Carli, G., Hensley, M., & Ferini‐Strambi, L. (2018). REM Sleep Behavior Disorder and Alzheimer’s Disease: Definitely No Relationship?. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-171164
283. Gallego, D., Figueroa, J., & Orozco, C. (2010). Síndrome de disfunción cognitiva de perros geriátrico. Revista Mvz Córdoba. https://doi.org/10.21897/rmvz.313
284. Gameleira, G. H., & Barbosa, M. L. S. (2019). MANIFESTAÇÕES ATÍPICAS DAS CRISES EPILÉPTICAS. Semana de Pesquisa do Centro Universitário Tiradentes - SEMPESq - Alagoas.
285. Garcia, C. P., Sacks, S. A., & Mamani, A. G. W. D. (2012). Neurocognition and Cognitive Biases in Schizophrenia. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0b013e3182614264
286. Gardiner, J., Barton, D., Vanslambrouck, J. M., Braet, F., Hall, D. H., Marc, J., & Overall, R. L. (2007). Defects in Tongue Papillae and Taste Sensation Indicate a Problem with Neurotrophic Support in Various Neurological Diseases. The Neuroscientist. https://doi.org/10.1177/1073858407312382
287. Gauthier, S., Feldman, H., & Mohr, E. (1994). Minimal Efficacy Criteria for Medications in Alzheimer Disease. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4615-8149-9_71
288. Gavett, B. E., Stern, R. A., Cantu, R. C., Nowinski, C. J., & McKee, A. C. (2010). Mild traumatic brain injury: a risk factor for neurodegeneration. Alzheimer s Research & Therapy. https://doi.org/10.1186/alzrt42
289. Genazzani, A. D., Ricchieri, F., Lanzoni, C., Strucchi, C., & Jasonni, V. M. (2006). Diagnostic and Therapeutic Approach to Hypothalamic Amenorrhea. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1365.009
290. Genton, P., & Bureau, M. (2006). Progressive myoclonic epilepsies: myth or reality?. Epileptic Disorders. https://doi.org/10.1684/j.1950-6945.2006.tb00198.x
291. Gerc, K., & Makiełło-Jarzowa, G. (1998). [Psychological consequences of neurologic motor impairment from a developmental perspective].. PubMed.
292. Gerd, F. (2016). Primary and secondary prevention interventions for cognitive decline and dementia - An overview. Journal of Alzheimer’s Disease & Parkinsonism. https://doi.org/10.4172/2161-0460.c1.022
293. Gershanik, O. S. (2002). [Dementia and cognitive impairment in Parkinson disease].. PubMed.
294. Ghoneim, A., Pollard, C., Greene, J., & Jampana, R. (2018). Balint syndrome (chronic visual-spatial disorder) presenting without known cause. Radiology Case Reports. https://doi.org/10.1016/j.radcr.2018.08.026
295. Giannakis, N., Skondra, M., Aligianni, S., Georgiou, E., Prapiadou, S., Lentzari, I., Politis, A., Laskaris, N., & Alexopoulos, P. (2021). 200 - Neuropsychiatric symptoms influence performance of activities of daily living in symptomatic Alzheimer’s Disease. International Psychogeriatrics. https://doi.org/10.1017/s1041610221001344
296. Giazkoulidou, A., Messinis, L., & Nasios, G. (2019). Cognitive functions and social cognition in multiple sclerosis: An overview.. PubMed.
297. Gill, M., Kenny, G. P., & Anney, R. (2013). The Genetic Architecture of Autism and Related Conditions. InTech eBooks. https://doi.org/10.5772/54854
298. Gitiaux, C., Chémaly, N., Quijano-Roy, S., Barnérias, C., Desguerre, I., Hully, M., Chiron, C., Dulac, O., & Nabbout, R. (2016). Motor neuropathy contributes to crouching in patients with Dravet syndrome. Neurology. https://doi.org/10.1212/wnl.0000000000002859
299. Goldstein, D. S. (2002). Dysautonomias: Clinical Disorders of the Autonomic Nervous System. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-137-9-200211050-00011
300. Golshan-Tafti, M., Alijanpour, K., Bahrami, M., Masoudi, A., Dastgheib, S. A., Aghasipour, M., Shiri, A., Shiri, A., Aghili, K., & Neámatzadeh, H. (2024). Disorders in Amino Acid Metabolism Associated with Seizures. World Journal of Peri & Neonatology. https://doi.org/10.18502/wjpn.v6i2.15491
301. Gonzales, P. N. G., Villaraza, S. G., & Catindig, J.-A. (2024). The association between sleep and Alzheimer's disease: a systematic review. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-5764-dn-2023-0049
302. González, A. (2005). Fisiopatología y diagnóstico de la anorexia nerviosa y la bulimia.
303. Gottfries, C. G. (1990). Neurochemical Aspects of Dementia Disorders. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000107121
304. Gouw, A., & Stam, C. J. (2016). Electroencephalography in the differential diagnosis of dementia.
305. Griswold, K., Regno, P. A. D., & Berger, R. C. (2015). Recognition and Differential Diagnosis of Psychosis in Primary Care.. PubMed.
306. Grossberg, G. T. (2005). Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease. Current Medical Research and Opinion. https://doi.org/10.1185/030079905x65402
307. Grossberg, G. T., & Manepalli, J. (1995). The older patient with psychotic symptoms. Psychiatric Services. https://doi.org/10.1176/ps.46.1.55
308. Group, M. T., Mackway‐Jones, K., Marsden, J., & Windle, J. (2006). Discriminator Dictionary. https://doi.org/10.1002/9780470757321.oth3
309. Grover, S., Mehra, A., Surendran, I., & Suri, V. (2014). Missed diagnosis-persistent delirium. Journal of Geriatric Mental Health. https://doi.org/10.4103/2348-9995.152449
310. Gu, H. (2013). Application of Nerve Growth Factor in Alzheimer’s Disease. Clinical Pharmacology & Biopharmaceutics. https://doi.org/10.4172/2167-065x.1000e109
311. Guamanarca, R. I. S., Loraque, N. B., Rubio, A. L., García, M. M., Lupiañez, I. J., & Llaría, M. M. M. (2025). SÍNDROME DE EKBOM EN PACIENTE GERIÁTRICO. A PROPÓSITO DE UN CASO.. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2025.31.47.002
312. Guarnieri, B., Adorni, F., Musicco, M., Appollonio, I., Bonanni, E., Caffarra, P., Caltagirone, C., Cerroni, G., Concari, L., Cosentino, F., Ferrara, S., Fermi, S., Ferri, R., Gelosa, G., Lombardi, G., Mazzei, D., Mearelli, S., Morrone, E., Murri, L., ... Sorbi, S. (2012). Prevalence of Sleep Disturbances in Mild Cognitive Impairment and Dementing Disorders: A Multicenter Italian Clinical Cross-Sectional Study on 431 Patients. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000335363
313. Guerrero‐Berroa, E., Schmeidler, J., Phillips, R., Muallem, J., Suleiman, H., West, R., Sano, M., Reisberg, ‌., & Silverman, J. M. (2020). Depression and the apathy symptom are associated with poorer cognitive functioning in very old men. Alzheimer s & Dementia. https://doi.org/10.1002/alz.047581
314. Guiraud, V., & Touzé, E. (2013). Psychological and Psychiatric Triggers and Risk Factors for Stroke. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-1-4471-2428-3_12
315. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
316. Gwathmey, K., Corcia, P., McDermott, C., Genge, A., Sennfält, S., Carvalho, M. D., & Ingre, C. (2023). Diagnostic delay in amyotrophic lateral sclerosis. European Journal of Neurology. https://doi.org/10.1111/ene.15874
317. Gökçe, F. M., Keçeci, H., Demi̇r, Ş., Ankaralı, S., & Ankaralı, H. (2009). EEG as an easy diagnostic tool in differentiation of Alzheimer and non-Alzheimer dementia..
318. Güney, E., & İşeri, E. (2013). Genetic and Environmental Factors in Autism. InTech eBooks. https://doi.org/10.5772/53295
319. Halperin, I., & Korczyn, A. D. (2008). Depression precedes development of dementia. Harefuah.
320. Hamdan, F. F., Holder, J. L., & Michaud, J. L. (2019). SYNGAP1-Related Intellectual Disability.
321. Hamed, S. A. (2014). Diabetes mellitus and the brain : special emphasis on cognitive function : review. The South African journal of diabetes & vascular disease.
322. Hansel, A., Dorst, J., Rosenbohm, A., Hübers, A., & Ludolph, A. C. (2018). ALS Mimics. Neurology International Open. https://doi.org/10.1055/s-0043-119960
323. Hanyu, H., Sakurai, H., Ishii, K., Shimizu, S., & Iwamoto, T. (2007). UNAWARENESS OF MEMORY DEFICITS DEPENDING ON CEREBRAL PERFUSION PATTERN IN MILD COGNITIVE IMPAIRMENT. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2007.01074.x
324. Harman, D. (2006). Alzheimer's Disease Pathogenesis. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1354.065
325. Hassan, S. (2021). Clinical Perspectives of Alzheimer's Disease. Journal of Brain Research-journal Fur Hirnforschung.
326. Hawkes, C. H. (2006). Olfaction in Neurodegenerative Disorder. KARGER eBooks. https://doi.org/10.1159/000093759
327. Heeren, T. J., & Crevel, H. V. (1998). [Revised consensus 'Diagnosis of the dementia syndrome'].. PubMed.
328. hemmatabadi, M., Deihim, T., Meftah, N., & Reyhan, S. K. (2017). Neurological Symptom in a Case of Adrenal Insufficiency. Case Reports in Clinical Practice.
329. Hendriks, M. E., Westerloo, D. J. V., & Portegies, P. (2007). [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].. PubMed.
330. Henjum, K., Godang, K., Quist‐Paulsen, E., Hassel, B., Neerland, B. E., Sandvig, H. V., Bollerslev, J., & Watne, L. O. (2020). Catecholamine activity in delirium with and without pre‐existing dementia. Alzheimer s & Dementia. https://doi.org/10.1002/alz.043016
331. Heß, C., & Bassetti, C. L. (1994). [Neurology of consciousness and of consciousness disorders].. PubMed.
332. Hilton, C. (2015). Dementia, screening, targets, and incentives: Primum non nocere. British Journal of General Practice. https://doi.org/10.3399/bjgp15x685969
333. Hindle, J. V. (2010). Ageing, neurodegeneration and Parkinson's disease. Age and Ageing. https://doi.org/10.1093/ageing/afp223
334. Hiremath, B., kumar, D., Shreevathsa, S., & pujari, S. (2015). ALZHEIMER'S DISEASE : AN AYURVEDIC PERSPECTIVE. Journal of Ayurveda and Holistic Medicine.
335. Ho, M.-K., & Siu, A. Y.-C. (2010). High Altitude Medicine.
336. Hodges, J. R. (2010). Alzheimer’s disease and other dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.2442
337. Holtmann, G., Shah, A., & Morrison, M. (2017). Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview. Digestive Diseases. https://doi.org/10.1159/000485409
338. Housley, S. B., Patel, D., Nyabuto, E., & Reynolds, R. M. (2021). Spinal cord detethering without laminectomy or laminotomy. Surgical Neurology International. https://doi.org/10.25259/sni_942_2021
339. Hsiao, J. J., & Teng, E. (2013). Depressive Symptoms in Clinical and Incipient Alzheimer’s Disease. Neurodegenerative Disease Management. https://doi.org/10.2217/nmt.13.10
340. Hualde, M. E. G. (1986). Las alucinaciones en los niños no-psicóticos. Salud Mental.
341. Huckman, M. S. (2006). Imaging Dementing Illnesses. The Neuroradiology Journal. https://doi.org/10.1177/197140090601900405
342. Huss, A., & Vermeulen, R. (2014). Neurodegenerative Diseases and ELF-EMF. CRC Press eBooks. https://doi.org/10.1201/b16968-15
343. Ibach, B. (2007). Demenzerkrankungen - Behandlung von Verhaltensstörungen mit Neuroleptika. psychoneuro. https://doi.org/10.1055/s-2007-985199
344. Ibrahim, I. R., & Amar, K. (2007). Mild cognitive impairment. British Journal of Hospital Medicine. https://doi.org/10.12968/hmed.2007.68.10.27322
345. Ismail, B., Cantor‐Graae, E., & McNeil, T. F. (2001). Neurodevelopmental Origins of Tardivelike Dyskinesia in Schizophrenia Patients and Their Siblings. Schizophrenia Bulletin. https://doi.org/10.1093/oxfordjournals.schbul.a006902
346. Işıkay, S. (2014). A rare cause of basal ganglia calcification: Down syndrome. Gaziantep medical journal. https://doi.org/10.5455/gmj-30-151703
347. Jackson, P. (1995). Hospital doctors' work. BMJ. https://doi.org/10.1136/bmj.310.6985.952
348. Jacquy, J. (2010). [Treatment of Alzheimer's disease: the current situation?]..
349. Jahns, H., Vernau, K. M., Nolan, C. M., O’Neill, E. J., Shiel, R. E., & Shelton, G. D. (2020). Polyneuropathy in Young Siberian Huskies Caused by Degenerative and Inflammatory Diseases. Veterinary Pathology. https://doi.org/10.1177/0300985820934112
350. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
351. Jans, I. S., Oudewortel, L., Brandt, P. M., & Gool, W. A. V. (2015). Severe, Persistent and Fatal Delirium in Psychogeriatric Patients Admitted to a Psychiatric Hospital. Dementia and Geriatric Cognitive Disorders Extra. https://doi.org/10.1159/000381847
352. Jellinger, K. A. (2020). Pathobiological Subtypes of Alzheimer Disease. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000508625
353. Jenkins, T. M., Brockington, A., & Shaw, P. J. (2020). The motor neuron diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0604
354. Jessen, F. (2013). Prädiktion der Alzheimer-Demenz. Die Psychiatrie. https://doi.org/10.1055/s-0038-1670890
355. Jessen, F., & Rodriguez, F. S. (2018). Not all, but specific types of cognitive complaints predict decline to MCI. Neurology. https://doi.org/10.1212/wnl.0000000000005872
356. Jiménez, A., Organista‐Juárez, D., Rocha, L., Estudillo, E., Fernández-Sánchez, V., Cureño-Díaz, M. A., Guzmán‐Ruiz, M. A., & Guevara‐Guzmán, R. (2024). Dysfunction of olfactory structures: A conserved mechanism of neurodegeneration?. Brain Behavior and Immunity Integrative. https://doi.org/10.1016/j.bbii.2024.100053
357. Joray, S., Ghika, J., Gunten, A. V., Büla, C., Gold, G. E., & Assal, F. (2005). [Is there a treatment for Alzheimer's disease?].. PubMed.
358. Jordan, L. R. (2024). Complex emotional needs, overcontrol and death by suicide in older adults. FPOP Bulletin Psychology of Older People. https://doi.org/10.53841/bpsfpop.2024.1.166.33
359. Jossein, T., Ruchat, D., Regina, J., Chiabotti, P. S., & Fisch, L. (2023). Démence rapidement progressive : prise en charge par l’interniste. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2023.19.840.1598
360. Kaczmarek, O., Baek, S., Peraza‐Bonilla, S., Sethi, A., Bumstead, B., Zarif, M., & Gudesblatt, M. (2022). The Relationship of Self‐Reported Depression and Self‐Perceived Cognitive Function in People with Dementia Associated Disorders: A Complex Relationship That Requires More Than Perception and Self‐Report. Alzheimer s & Dementia. https://doi.org/10.1002/alz.064943
361. Kalimo, H., & Smith, M. (1986). Structural Aspects of Ischemic Brain Damage. https://doi.org/10.1007/978-3-7091-8859-0_35
362. Kalmár, S. (2009). Disturbance of perception in depressive disorders in the different diagnostical systems.. PubMed.
363. Kaplan, P. W. (1999). Assessing the Outcomes in Patients With Nonconvulsive Status Epilepticus: Nonconvulsive Status Epilepticus Is Underdiagnosed, Potentially Overtreated, and Confounded by Comorbidity. Journal of Clinical Neurophysiology. https://doi.org/10.1097/00004691-199907000-00006
364. Kaplan, P. W. (2003). Delirium and epilepsy. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2003.5.2/pkaplan
365. Kaplan, P. W., & Rossetti, A. O. (2011). EEG Patterns and Imaging Correlations in Encephalopathy. Journal of Clinical Neurophysiology. https://doi.org/10.1097/wnp.0b013e31821c33a0
366. Kastury, L. L., Golomb, J., Kluger, A., Boksay, I., Wisoff, J. H., Weiner, H. L., George, A. E., Ferris, S. H., & Reisberg, ‌. (2006). P4–140: Neuropsychologic deficits in normal pressure hydrocephalus. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2006.05.1879
367. Kataoka, K., Nakagawa, Y., & Hojo, H. (1984). Intractable Seizures in Infancy and Early Childhood Excluding West and Lennox-Gastaut Syndrome. Journal of the Japan Epilepsy Society. https://doi.org/10.3805/jjes.2.13
368. Katz, I. R. (1998). Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias.. PubMed.
369. Kaufman, F., Horton, E., Gott, P. S., Wolff, J. A., Nelson, M. D., Azen, C., & Manis, F. R. (1995). Abnormal Somatosensory Evoked Potentials in Patients With Classic Galactosemia: Correlation With Neurologic Outcome. Journal of Child Neurology. https://doi.org/10.1177/088307389501000109
370. Kemp, S., Goulding, P., Spencer, J., & Mitchell, A. J. (2005). Unusually rapid and severe cognitive deterioration after mild traumatic brain injury. Brain Injury. https://doi.org/10.1080/02699050500309353
371. Kerchner, G. A., & Rosenbloom, M. (2014). Frontotemporal Neurocognitive Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg65
372. Kessels, R. P. C., & Savage, G. (2015). Amnestic Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp060
373. Khan, S. I. (2021). Loss of appetite.. Preventive Nutrition and Food Science.
374. Khosroazad, S., Gilbert, C. L., Aronis, J. A., Daigle, K. M., Esfahani, M., Almaghasilah, A., Elias, M. F., Meuser, T., Kaye, L. W., Singer, C. M., Abedi, A., Hayes, M. J., & Ahmed, F. S. (2022). Sleep Movements and Respiratory Coupling as a Biobehavioral Marker for Early Alzheimer’s Disease in Independently Dwelling Adults. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-1898948/v1
375. Kim, H. A., Bisdorff, A., Bronstein, A. M., Lempert, T., Rossi-Izquierdo, M., Staab, J. P., Strupp, M., & Kim, J. (2019). Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria. Journal of Vestibular Research. https://doi.org/10.3233/ves-190655
376. Kim, M., Lee, K., Son, Y., Jeon, H., Kim, Y.-B., & Cho, Z. (2012). Increased Basal Forebrain Metabolism in Mild Cognitive Impairment: An Evidence for Brain Reserve in Incipient Dementia. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2012-120133
377. Kim, S. M. (2000). The Strategy of Clinical Procedure for Determining Brain Death. Korean Journal of Medical Ethics. https://doi.org/10.35301/ksme.2000.3.1.1
378. Kim, S., Lim, M.-G., Han, J.-S., Ahn, C.-H., & Jung, T. (2023). Rare or Overlooked Cases of Acute Acalculous Cholecystitis in Young Patients with Central Nervous System Lesion. Healthcare. https://doi.org/10.3390/healthcare11101378
379. Kirshner, H. S. (1984). Language Disturbance. Archives of Neurology. https://doi.org/10.1001/archneur.1984.04050170037012
380. Kish, S. J., & Hornykiewicz, O. (1984). Neurochemical Basis of Dementia in Parkinson’s Disease. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/s0317167100046382
381. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
382. Knipper, M., Singer, W., Schwabe, K., Hagberg, G., Hegner, Y. L., Rüttiger, L., Braun, C., & Land, R. (2022). Disturbed Balance of Inhibitory Signaling Links Hearing Loss and Cognition. Frontiers in Neural Circuits. https://doi.org/10.3389/fncir.2021.785603
383. Knopman, D. S. (2012). Subjective cognitive impairment. Neurology. https://doi.org/10.1212/wnl.0b013e31826c1bd1
384. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. DeckerMed Family Medicine. https://doi.org/10.2310/fm.1336
385. Knopman, D. S. (2017). Clinical Aspects of Non-Alzheimer Disease Dementias. https://doi.org/10.2310/neuro.1336
386. Knopman, D. S. (2021). Clinical Aspects of Alzheimer Disease. DeckerMed Medicine. https://doi.org/10.2310/im.1334
387. Knopman, D. S. (2021). Clinical Aspects of Alzheimer Disease. DeckerMed Transitional Year Weekly Curriculum™. https://doi.org/10.2310/tywc.1334
388. Knopman, D. S. (2021). Clinical Aspects of Alzheimer Disease. https://doi.org/10.2310/neuro.1334
389. Knupp, K. G., & Wirrell, E. (2014). Progressive myoclonic epilepsies. Neurology. https://doi.org/10.1212/wnl.0000000000000091
390. Koike, H., & Sobue, G. (2013). [Sjogren's syndrome-associated neuropathy].. PubMed.
391. Koike, H., & Sobue, G. (2013). Autoimmune autonomic ganglionopathy and acute autonomic and sensory neuropathy. Rinsho Shinkeigaku. https://doi.org/10.5692/clinicalneurol.53.1326
392. Konstantakopoulos, G. (2019). Insight across mental disorders: A multifaceted metacognitive phenomenon. Psychiatriki. https://doi.org/10.22365/jpsych.2019.301.13
393. Kop, W. J., & Gottdiener, J. S. (2011). The Interaction Between Psychologic Distress and Biobehavioral Processes in Cardiovascular Disease. https://doi.org/10.1002/9780470975138.ch1
394. Kopelman, M. D. (2000). Focal retrograde amnesia and the attribution of causality: An exceptionally critical view. Cognitive Neuropsychology. https://doi.org/10.1080/026432900750002172
395. Koros, H., & Papageorgiou, S. G. (2014). Early onset dementia.
396. Korostiy, V., & Dubenko, A. (2014). EPA-1295 - Dementia and depression in elderly patients - differential diagnosis and comorbidity. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78519-0
397. Kos, D., Kerckhofs, E., Nagels, G., D’hooghe, M., & Ilsbroukx, S. (2007). Origin of Fatigue in Multiple Sclerosis: Review of the Literature. Neurorehabilitation and neural repair. https://doi.org/10.1177/1545968306298934
398. Kramarz, C., Masingue, M., Bouhour, F., Vial, C., Latour, P., Vandendries, C., Maisonobe, T., Coebergh, J., Blake, J., Reilly, M. M., Stojkovic, T., & Rossor, A. M. (2025). A Case Series of Unilateral Peripheral Neuropathy. Journal of the Peripheral Nervous System. https://doi.org/10.1111/jns.70033
399. Kramer, J. H., & Miller, B. L. (2000). Alzheimer's Disease and Its Focal Variants. Seminars in Neurology. https://doi.org/10.1055/s-2000-13177
400. Kraus, G. E. (2024). Peripheral Neuropathies. Routledge eBooks. https://doi.org/10.4324/b23293-14
401. Krinsky‐McHale, S. J., & Silverman, W. (2013). Dementia and mild cognitive impairment in adults with intellectual disability: Issues of diagnosis. Developmental Disabilities Research Reviews. https://doi.org/10.1002/ddrr.1126
402. Krinsky‐McHale, S. J., Devenny, D. A., Kittler, P., & Silverman, W. (2008). Selective Attention Deficits Associated With Mild Cognitive Impairment and Early Stage Alzheimer's Disease in Adults With Down Syndrome. American Journal on Mental Retardation. https://doi.org/10.1352/2008.113:369-386
403. Krombach, J., Hörmann, S., Huber, C., Hölzle, P., & Förstl, H. (2021). Alt und depressiv oder dement? – Pseudodepression vs. Pseudodemenz. DMW - Deutsche Medizinische Wochenschrift. https://doi.org/10.1055/a-1180-2417
404. Kuiper, J. S. (2016). The importance of social relationships in the process of cognitive ageing.
405. Kukla, U., Łabuzek, K., Chronowska, J., Krzystanek, M., & Okopień, B. (2015). [Mental disorders in digestive system diseases - internist's and psychiatrist's insight].. PubMed.
406. Kulkarni, A. M., Rajput, K., Raglan, E., Abrams, D. J., & Bitner‐Glindzicz, M. (2012). Is gross motor delay secondary to bilateral vestibular hypofunction in Jervell and Lange-Nielsen syndrome?. Audiological Medicine. https://doi.org/10.3109/1651386x.2012.686165
407. Kumar, A., Sidhu, J., Goyal, A., Tsao, J. W., & Svercauski, J. (2021). Alzheimer Disease (Nursing).
408. Kumar, A., Verma, R., & Singh, P. (2023). Cognitive Challenges in Aging: Unmasking Malignancy-Related Altered Mental States in the Elderly. International Journal of Science and Research (IJSR). https://doi.org/10.21275/sr231107141448
409. Kumar, D., Shankar, M. S., Reddy, P. P., Kumar, B. R. S., & Sumalatha, N. (2014). A Review on Alzheimer's Disease. Research Journal of Pharmacology and Pharmacodynamics.
410. Kumar, M., & Bansal, N. (2021). A Revisit to Etiopathogenesis and Therapeutic Strategies in Alzheimer’s Disease. Current Drug Targets. https://doi.org/10.2174/1389450122666211118125233
411. Kučikienė, O., Lesauskaitė, V., Macijauskienė, J., Vainoras, A., Blaževičienė, A., Samėnienė, J., Alekna, V., Satkunskienė, D., Naudžiūnas, A., & Krutulytė, G. (2009). Dažniausi hospitalizuotų pagyvenusio amžiaus pacientų sveikatos sutrikimai.
412. Landers, D. M. (2002). Anorexia in Exercise and Sport. Medicine & Science in Sports & Exercise. https://doi.org/10.1097/00005768-200205001-01795
413. Landes, A. M. (2005). Prevalence of Apathy, Dysphoria, and Depression in Relation to Dementia Severity in Alzheimer's Disease. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.17.3.342
414. Lanzaro, M. (2017). A new syndrome? The sport identification addiction and the case of Italian football ultra-fanatical support. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.508
415. Larner, A. J. (2010). Epileptic seizures in neurodegenerative dementia syndromes.
416. Lato, M., Iberszer, K., Litwiniuk, M., Zaniuk, M., HURKAŁA, K., ANTONIK, D., Denys, B., Góra, K., Zimnicki, P., & Zdziennicki, W. (2023). use of SGLT2 inhibitors in the treatment of cognitive disorders. Journal of Education Health and Sport. https://doi.org/10.12775/jehs.2023.25.01.003
417. Latronico, N., Antonini, L., Taricco, M., Vignolo, L., & Candiani, A. (2000). [Approach to the patient in vegetative state. Part II: differential diagnosis].. PubMed.
418. Lau, E. Y. Y., & Nissen, L. (2019). SSRIs for mild cognitive impairment to Alzheimer's disease. Australian pharmacist.
419. Lawrence, R., & Thevasagayam, R. (2014). Controversies in the management of sudden sensorineural hearing loss: an evidence‐based review. Clinical Otolaryngology. https://doi.org/10.1111/coa.12363
420. Lee, J. H., Arcinue, E. L., & Ross, B. D. (1994). Organic Osmolytes in the Brain of an Infant with Hypernatremia. New England Journal of Medicine. https://doi.org/10.1056/nejm199408183310704
421. Leffa, D. T., Bellaver, B., Povala, G., Ferreira, P. C., Ferrari‐Souza, J. P., Lussier, F. Z., Soares, C., Zalzale, H., Bauer‐Negrini, G., Abbas, S., Karikari, T. K., Rohde, L. A., Molina, B. S. G., & Pascoal, T. A. (2024). Attention‐deficit/hyperactivity disorder impacts the development of neuropsychiatric symptoms in Alzheimer’s disease. Alzheimer s & Dementia. https://doi.org/10.1002/alz.089857
422. Leitner, D., Faustin, A., Verducci, C., Friedman, D., William, C., Devore, S., Wısnıewskı, T., & Devinsky, O. (2021). Neuropathology in the North American sudden unexpected death in epilepsy registry. Brain Communications. https://doi.org/10.1093/braincomms/fcab192
423. Leonard, J. V., & Morris, A. A. M. (2006). Diagnosis and early management of inborn errors of metabolism presenting around the time of birth. Acta Paediatrica. https://doi.org/10.1111/j.1651-2227.2006.tb02172.x
424. Leung, M., Thompson, B., Black, J., Dai, S., & Alsweiler, J. M. (2017). The effects of preterm birth on visual development. Clinical and Experimental Optometry. https://doi.org/10.1111/cxo.12578
425. Leurgans, S. E., Wilson, R. J., Boyle, P. A., & Bennett, D. A. (2011). Cognitive Decline in Prodromal Alzheimer Disease and Mild Cognitive Impairment. Archives of Neurology. https://doi.org/10.1001/archneurol.2011.31
426. Levenson, R. W., Sturm, V. E., & Haase, C. M. (2014). Emotional and Behavioral Symptoms in Neurodegenerative Disease: A Model for Studying the Neural Bases of Psychopathology. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev-clinpsy-032813-153653
427. León, J. S. T., Dulcey, L., Cala, M. A., Anaya, S. J. N., & Anaya, J. P. D. (2023). Debilidad neuromuscular aguda, aproximación diagnóstica y terapéutica de un complejo cuadro clínico de etiología variable.. Ciencia Latina Revista Científica Multidisciplinar. https://doi.org/10.37811/cl_rcm.v6i6.4222
428. León, T. (2024). Targeting AD and its comorbidities with combination therapies. Alzheimer s & Dementia. https://doi.org/10.1002/alz.083429
429. Lečić-Toševski, D. M., Pejović-Milovančević, M., Popović-Deušić, S., & Šušić (2007). [Psychiatric aspects of sleep].. PubMed.
430. Lichtenstein, S. V. (2015). Multiple Sklerose – welche Optionen bietet die Ernährungstherapie?. Aktuelle Ernährungsmedizin. https://doi.org/10.1055/s-0035-1552701
431. Ligier, F., & Kabuth, B. (2016). Between Neurology and Psychiatry, a Difficult Preliminary Diagnosis of Kleine-levin Syndrome: Case-report of a Young Girl. Journal of Child and Adolescent Behaviour. https://doi.org/10.4172/2375-4494.1000274
432. Lima, N. K. D. C. (2018). Hypertension and cognition decline: Is there an ultimate link?. Journal of Clinical Hypertension. https://doi.org/10.1111/jch.13401
433. Limongelli, G., D‘Alessandro, R., Maddaloni, V., Rea, A., Sárközy, A., & McKenna, W. J. (2013). Skeletal muscle involvement in cardiomyopathies. Journal of Cardiovascular Medicine. https://doi.org/10.2459/jcm.0b013e3283641c69
434. Liu, X., Chen, L., Ye, S., Liu, X., Zhang, Y., & Dong-sheng, F. (2024). Postural instability and lower extremity dysfunction in upper motor neuron-dominant amyotrophic lateral sclerosis. Frontiers in Neurology. https://doi.org/10.3389/fneur.2024.1406109
435. Liu‐Ambrose, T., Nagamatsu, L. S., Handy, T. C., & Leghari, A. (2008). DOES IMPAIRED CEREBELLAR FUNCTION CONTRIBUTE TO RISK OF FALLS IN SENIORS? A PILOT STUDY USING FUNCTIONAL MAGNETIC RESONANCE IMAGING. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2008.01984.x
436. Lj, T. (1988). Dementia update: diagnosis and neuropsychiatric aspects.. PubMed.
437. Llaría, M. M. M., Guamanarca, R. I. S., Loraque, N. B., Rubio, A. L., García, M. M., & Lupiañez, I. J. (2025). SÍNDROME DE CHARLES BONNET. A PROPÓSITO DE UN CASO.. Revista sanitaria de investigación.. https://doi.org/10.34896/rsi.2025.23.73.002
438. Long, J. M., & Day, G. S. (2018). Autoimmune Dementia. Seminars in Neurology. https://doi.org/10.1055/s-0038-1660480
439. Louis, E. D., & Bennett, D. A. (2007). Mild Parkinsonian signs: An overview of an emerging concept. Movement Disorders. https://doi.org/10.1002/mds.21433
440. Louzir, B., Msadek, F., Battikh, R., Abdelhafidh, N. B., Harzallah, O., Bekir, S., & Othmani, S. (2004). [Neuro-psychiatric disorders revealed pernicious disease without anemia. About three cases].. PubMed.
441. Love, M., & Geldmacher, D. (2018). Alzheimer’s Disease. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy20
442. Luby, J. L., Gaffrey, M. S., Tillman, R., April, L. M., & Belden, A. C. (2014). Trajectories of Preschool Disorders to Full DSM Depression at School Age and Early Adolescence: Continuity of Preschool Depression. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.2014.13091198
443. Lucendo, M. C., Bartolomé, M. V. P., Ladera, V., & Pérez, E. (2017). CAPACIDAD DE PLANIFICACIÓN EN PACIENTES CON DEMENCIA TIPO ALZHEIMER EN FUNCIÓN DEL GRADO DE SEVERIDAD.
444. Lyketsos, C. G., López, O. L., Jones, B. N., Fitzpatrick, A. L., Breitner, J. C., & DeKosky, S. T. (2002). Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment. JAMA. https://doi.org/10.1001/jama.288.12.1475
445. Lyketsos, C. G., Steele, C., Baker, L., Galik, E., Kopunek, S., Steinberg, M. H., & Warren, A. (1997). Major and minor depression in Alzheimer's disease: prevalence and impact. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.9.4.556
446. Léger, D. (2000). Public health and insomnia: economic impact.. PubMed.
447. López, N. R. (2016). INTERVENCIONES DE ENFERMERÍA PARA REDUCIR LA DESNUTRICIÓN Y PROMOVER LA ALIMENTACIÓN EN LAS PERSONAS MAYORES CON DEMENCIA. Revista Ene de Enfermería.
448. López, O. L., García‐Portilla, M. P., Becker, J. T., Reynolds, C. F., Sudilovsky, A., & DeKosky, S. T. (1995). Symptoms of Depression in Alzheimer's Disease, Frontal Lobe‐type Dementia, and Subcortical Dementia. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1995.tb38153.x
449. Löfgren, S., Verdier, K. D., Ek, U., & Fernell, E. (2016). Early childhood blindness – etiologies and comorbidity. Acta Ophthalmologica. https://doi.org/10.1111/j.1755-3768.2016.0700
450. Macedo, A. C., Balouch, S., & Tabet, N. (2017). Is Sleep Disruption a Risk Factor for Alzheimer’s Disease?. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-161287
451. Magallón, S., & Narbona, J. (2009). [Detection and specific studies in procedural learning difficulties].. PubMed.
452. Magistris, M., & Soichot, P. (2004). [Neuropathy versus neuronopathy: distinctive features].. PubMed.
453. Mah, L., Murari, G., Vandermorris, S., Verhoeff, N. P. L., & Herrmann, N. (2021). Characterizing the phenomenology of anxiety in older adults with subjective cognitive decline. Alzheimer s & Dementia. https://doi.org/10.1002/alz.055815
454. Majeske, M., Nistor, V., & Kellner, C. H. (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
455. Malaty, J., & Malaty, I. A. (2013). Smell and taste disorders in primary care.. PubMed.
456. Mann, D. M. A., & Yates, P. O. (1983). PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/j.1365-2990.1983.tb00320.x
457. Manwell, L., Tadros, M., Ciccarelli, T. M., & Eikelboom, R. (2022). Digital dementia in the internet generation: excessive screen time during brain development will increase the risk of Alzheimer's disease and related dementias in adulthood. Journal of Integrative Neuroscience. https://doi.org/10.31083/j.jin2101028
458. Marcello, S., & Silverstein, S. M. (2010). Schizophrenia. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0820
459. Marinescu, I., Enatescu, V., Ghelase, Ş. M., & Marinescu, D. (2017). Neurobiological arguments for a pathogenic multifactorial disconnective model of cognitive disorders from Alzheimer's disease in elderly people.. PubMed.
460. Marino, S., Ciurleo, R., Baglieri, A., Corallo, F., De, R., De, S., Guerrera, S., Timpano, F., Bramanti, P., & Nicola, S. D. (2012). Neuroimaging and Outcome Assessment in Vegetative and Minimally Conscious State. InTech eBooks. https://doi.org/10.5772/23003
461. Markand, O. N. (1986). Electroencephalogram in Dementia. American Journal of EEG Technology. https://doi.org/10.1080/00029238.1986.11080186
462. Marques, P. R. (2020). Alzheimer’s Disease & Dementia-From Pathophysiology To Clinic. International Journal of Aging Research. https://doi.org/10.28933/ijoar-2020-08-1005
463. Marrero, D. H., Pestano, M. M. A., Acosta, B. A., & Miranda, J. L. D. (2020). La ptosis no orgánica: a propósito de un trastorno.
464. Martin, L. J. (2002). Synaptic and Neuroglial Pathobiology in Acute and Chronic Neurological Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-105-3_25
465. Martins, E., Durães, J., Nogueira, C., Gomes, J. A., Vilarinho, L., & Macário, C. (2023). SERAC1 Deficiency- A New Phenotype. Endocrine Metabolic & Immune Disorders - Drug Targets. https://doi.org/10.2174/1871530323666230914114456
466. Martins, S., & Fernandes, L. (2012). Delirium in Elderly People: A Review. Frontiers in Neurology. https://doi.org/10.3389/fneur.2012.00101
467. Martín, E. S. S., Juanes, J., Montero, R., & Aguiar, C. S. (2012). Demencia frontotemporal asociada al cromosoma 17 y otros síndromes parkinsonianos asociados a demencia. Revista de Neurología. https://doi.org/10.33588/rn.54s04.2012520
468. Martín, M. S., Martín, R. S., Espinoza, K. S., Calvo, L. S., Valverde, G. F., López, L. S., Rivera, M. P., Cabrera, Y. P., & Merino, B. L. (2019). Terapias alternativas: retando al alzheimer. International Journal of Developmental and Educational Psychology Revista INFAD de psicología. https://doi.org/10.17060/ijodaep.2019.n2.v2.1891
469. Martínez, A. R., Argüelles, P. P., Cucurella, M. M., Llort, A. J., Camacho, J. A., & Plana, J. C. (2008). Manifestaciones neurológicas en el síndrome hemolítico urémico. Revista de Neurología. https://doi.org/10.33588/rn.4704.2008249
470. Martínez-Guzmán, O., Hernández-Ábrego, M. P., & Villanueva‐Mendoza, C. (2009). Síndrome de Allgrove: reporte de un caso.
471. Marín‐Medina, D. S., Camacho-Gomez, O. L., Martínez, J. A. E., Toro, C. J., & Sánchez‐Duque, J. A. (2024). Deprescripción en el anciano con demencia. Acta neurológica colombiana. https://doi.org/10.22379/anc.v40i2.1829
472. Masand, P. S. (2000). Novel Antipsychotics in the Treatment of Behavioral Disturbances and Psychoses Associated With Neurodegenerative Disorders. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v02n0302
473. Massey, A., Boag, M. K., Magnier, A., Bispo, D. P. C. F., Khoo, T. K., & Pountney, D. L. (2022). Glymphatic System Dysfunction and Sleep Disturbance May Contribute to the Pathogenesis and Progression of Parkinson’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms232112928
474. Matarrubia, M. F. (2016). La apatía en la demencia frontotemporal y la enfermedad de Alzheimer: estudio clínico y de neuroimagen funcional.
475. Mattos, A. C. M. T. D. (2018). Avaliação de parâmetros actimétricos em idosos saudáveis e com declínio cognitivo.
476. Maxfield, M., & Greenberg, J. (2020). Anticipated Stigma and Dementia-Related Anxiety in Middle-Aged and Older Adults. GeroPsych. https://doi.org/10.1024/1662-9647/a000234
477. Mayer, G., Frohnhofen, H., Jokisch, M., Hermann, D. M., & Gronewold, J. (2024). Associations of sleep disorders with all-cause MCI/dementia and different types of dementia – clinical evidence, potential pathomechanisms and treatment options: A narrative review. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2024.1372326
478. Mayes, A. R., & Boucher, J. (2008). Acquired memory disorders in adults: implications for autism. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511490101.005
479. Mayne, K., White, J. A., McMurran, C. E., Rivera, F. J., & Fuente, A. G. D. L. (2020). Aging and Neurodegenerative Disease: Is the Adaptive Immune System a Friend or Foe?. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2020.572090
480. Mayor, S. (2015). Signs of depression and apathy precede memory problems in Alzheimer's disease, study shows. BMJ. https://doi.org/10.1136/bmj.h190
481. Mazzoni, P., Kimhy, D., Khan, S., Posner, K., Maayan, L., Eilenberg, M., Walsh‐Messinger, J., Kestenbaum, C. J., & Corcoran, C. M. (2009). Childhood Onset Diagnoses in a Case Series of Teens at Clinical High Risk for Psychosis. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.2008.0105
482. McAleese, K. E., Colloby, S. J., Thomas, A., Al‐Sarraj, S., Ansorge, O., Neal, J., Roncaroli, F., Love, S., Francis, P. T., & Attems, J. (2021). Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia. Alzheimer s & Dementia. https://doi.org/10.1002/alz.12291
483. McCarty, H. J., Roth, D. L., Goode, K., Owen, J. E., Harrell, L. E., Donovan, K. A., & Haley, W. E. (2000). Longitudinal Course of Behavioral Problems During Alzheimer's Disease: Linear Versus Curvilinear Patterns of Decline. The Journals of Gerontology Series A. https://doi.org/10.1093/gerona/55.4.m200
484. McKay, J. H., & Cheshire, W. P. (2018). First symptoms in multiple system atrophy. Clinical Autonomic Research. https://doi.org/10.1007/s10286-017-0500-0
485. McKnight, R., Price, J., & Geddes, J. (2019). Delirium, dementia, and other cognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0034
486. McPherson, S. (2004). Apathy in Alzheimer’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-661-4_44
487. Mecarelli, O., & Vicenzini, E. (2019). Brain Death. Clinical Electroencephalography. https://doi.org/10.1007/978-3-030-04573-9_47
488. Medjkane, F., Bohet, M., Ister, M., Cohen, D., Parenti, A., Janati, M., Mention, K., Dobbelaere, D., & Jardri, R. (2021). Onset of psychiatric signs and impaired neurocognitive domains in inherited metabolic disorders: A case series. JIMD Reports. https://doi.org/10.1002/jmd2.12133
489. Meeusen, R., Duclos, M., Foster, C., Fry, A. C., Gleeson, M., Nieman, D. C., Raglin, J. S., Rietjens, G., Steinacker, J. M., & Urhausen, A. (2013). Prevention, Diagnosis, and Treatment of the Overtraining Syndrome. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0b013e318279a10a
490. Mehdizadeh, C., Moukus, A., Bannoud, M., Smith, M., & Ansari, S. A. (2023). Guillain-Barré Syndrome Presenting as Symmetrical Proximal Muscle Weakness: An Atypical Presentation. Cureus. https://doi.org/10.7759/cureus.50259
491. Meluzínová, H., Weber, P., Ambrošová, P., Kubešová, H. M., Polcarová, V., & Hrubanová, J. (2009). Alzheimerova demence – jeden z velkých geriatrických syndromů.
492. Mendez, M. F. (2006). The Accurate Diagnosis of Early-Onset Dementia. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/q6j4-r143-p630-kw41
493. Mendez, M. F. (2017). What is the Relationship of Traumatic Brain Injury to Dementia?. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-161002
494. Merchant, R. A., Goh, J., Chan, Y. H., Lim, J. Y., & Vellas, B. (2020). Slow Gait, Subjective Cognitive Decline and Motoric Cognitive Risk Syndrome: Prevalence and Associated Factors in Community Dwelling Older Adults. The journal of nutrition health & aging. https://doi.org/10.1007/s12603-020-1525-y
495. Mesquita, M., & Casartelli, M. (2017). Neonatal hyperbilirubinemia, acute bilirubin encephalopathy and Kernicterus: The conti-nuum is still valid in the 21st century. Pediatría (Asunción). https://doi.org/10.18004/ped.2017.agosto.153-158
496. Mestres, J. S. (2015). Demencia en el adulto joven. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
497. Mesulam, M. (2016). Primary Progressive Aphasia and the Left Hemisphere Language Network. Dementia and Neurocognitive Disorders. https://doi.org/10.12779/dnd.2016.15.4.93
498. Meyer, O., Meyer, S., & Kressig, R. W. (2010). Diagnostik des Delirs. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a000013
499. Michalska, A., Szejko, N., Jakubczyk, A., & Wojnar, M. (2016). Nonspecific eating disorders - a subjective review. Psychiatria Polska. https://doi.org/10.12740/pp/59217
500. Miller, N. R. (2019). Optic Neuritis. Neuro-Ophthalmology. https://doi.org/10.1007/978-3-319-98455-1_1
501. Miller, S. P., & Latal, B. (2009). Neurocognitive outcomes of term infants with perinatal asphyxia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511581281.050
502. Milovanović, S., Ćulafić, Đ. M., Leposavić, L., & Vojinovic, V. C. (2004). Hepatic encephalopathy in consultative psychiatry: Experience with chlomethiazole. Engrami.
503. Mimura, M. (2002). Managing the higher brain dysfunction. From the psychiatric point of view.. Shitsugoshō kenkyū/Shitsugoshou kenkyuu. https://doi.org/10.2496/apr.22.185
504. Mimura, M., Tominaga, I., Kashima, H., Honda, M., Kosaka, K., & Kato, Y. (1998). Presenile non-Alzheimer dementia with motor neuron disease and laminar spongiform degeneration. Neuropathology. https://doi.org/10.1111/j.1440-1789.1998.tb00073.x
505. Miranda, L. A., Lopes, M. L., Ribeiro, M. H., & Benincasa, M. (2014). Transtorno Alimentar e Relações familiares: estudo de caso.
506. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
507. Mishima, K. (2016). [Sleep Problem as a Prodrome and Risk Factor for Dementia].. PubMed. https://doi.org/10.11477/mf.1416200510
508. Mizutani, T., Nakamura, K., Enomoto, M., Sakata, M., & Yamada, S. (1998). Conditions of Alzheimer‐type dementia in the old‐old and oldest‐old patients with special reference to extreme conditions of brain aging. Neuropathology. https://doi.org/10.1111/j.1440-1789.1998.tb00083.x
509. Mnif, M., Marouene, H., Bellassoued, M., Rekik, N., Chouayakh, F., Zouari, N., & Abid, M. (2002). [Pure primitive dysautonomia or Bradbury-Eggleston syndrome. Report of 3 cases].. PubMed.
510. Mograbi, D. C., & Morris, R. G. (2013). Implicit awareness in anosognosia: Clinical observations, experimental evidence, and theoretical implications. Cognitive Neuroscience. https://doi.org/10.1080/17588928.2013.833899
511. Molko, N., Wilson, A. J. C., & Dehaene, S. (2005). La dyscalculie développementale, un trouble primaire de la perception des nombres. Revue française de pédagogie. https://doi.org/10.3406/rfp.2005.3362
512. Mondini, S., Lugaresi, E., Zucconi, M., Montagna, P., & Cirignotta, F. (1983). Staging of heavy snorers' disease. A proposal.. PubMed.
513. Montero‐Odasso, M., & Perry, G. (2019). Gait Disorders in Alzheimer’s Disease and Other Dementias: There is Something in the Way You Walk. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-190790
514. Monti, M. M., Laureys, S., & Owen, A. M. (2010). The vegetative state. BMJ. https://doi.org/10.1136/bmj.c3765
515. Moore, A., & Leis, A. A. (2014). Keep an Eye Out for Myasthenia Gravis Patients with an Eye Out. Frontiers in Neurology. https://doi.org/10.3389/fneur.2014.00112
516. Morais, L. C. S. L. (2004). DOENÇA DE ALZHEIMER E O PAPEL DOS RECEPTORES NICOTÍNICOS. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.17695/revnevol2n2p68
517. Moraiti, V., & Porfyri, G. N. (2024). Schizophrenia and Risk of Dementia: A Literature Review.. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1583
518. Morales, D. O. (2019). Muerte encefálica en pediatría..
519. Morales, G. A., Guturbay, I., Olaciregui, O., Navajas, D., & Carrera, B. (2009). Neuromuscular syndromes of the critically ill. Anales del Sistema Sanitario de Navarra. https://doi.org/10.23938/assn.0519
520. Morand, A., Gauthier, K., Mazerolle, M., Pèlerin, A., Rigalleau, F., Sayette, V. D. L., Eustache, F., Desgranges, B., Huguet, P., & Régner, I. (2020). L’effet de menace du stéréotype en situation d’évaluation neuropsychologique : enjeux cliniques. HAL (Le Centre pour la Communication Scientifique Directe). https://doi.org/10.1684/nrp.2020.0607
521. Moreira, G. F., Coscarelli, L. P., Jardim, M. C. D., Araújo, I. M. M., Grossi, B. D., Guidi, R. A., Menezes, Y. C. D. C., Silva, I. M., Calmon, M. Z., Neto, C. A. B., Santiago, D. S. D. P., Santos, V. H. R., Souza, L. L., & Silva, C. E. P. (2022). Atualizações sobre a doença de Alzheimer e seus estágios clínicos. Brazilian Journal of Health Review. https://doi.org/10.34119/bjhrv5n6-016
522. Moreira, I., Vieira‐Coelho, M. A., & Guimarães, J. (2025). Dopamine System Dysfunction in Alzheimer's Disease. Psychogeriatrics. https://doi.org/10.1111/psyg.70097
523. Moretti, R., Torre, P., Antonello, R. M., & Cazzato, G. (2005). Therapy of vascular dementia: perspectives and milestones. Therapy. https://doi.org/10.2217/14750708.2.4.649
524. Moretti, R., Torre, P., Antonello, R. M., & Pizzolato, G. (2006). Atypical neuroleptics as a treatment of agitation and anxiety in Alzheimer’s disease: risks or benefits. Expert Review of Neurotherapeutics. https://doi.org/10.1586/14737175.6.5.705
525. Morrison, B. M. (2016). Neuromuscular Diseases. Seminars in Neurology. https://doi.org/10.1055/s-0036-1586263
526. Morylowska-Topolska, J., Ziemiński, R., Molas, A., Gajewski, J., Flis, M., Stelmach, E., & Karakuła‐Juchnowicz, H. (2016). Schizophrenia and anorexia nervosa – reciprocal relationships. A literature review. Psychiatria Polska. https://doi.org/10.12740/pp/onlinefirst/63514
527. Mosimann, U. P., & McKeith, I. G. (2003). Dementia with lewy bodies - diagnosis and treatment. Schweizerische medizinische Wochenschrift. https://doi.org/10.4414/smw.2003.10028
528. Moura, G. S., Neves, L. M. T., Giorelli, A. S., Florido, P., & Gomes, M. D. M. (2013). Transtornos do sono: visão geral Sleep disorders: overview.
529. Moțățăianu, A., Andone, S., Maier, S., Chinezu, R., Roman, M., Dumitreasă, M., Bălaşa, R., & Ormenișan, I. (2025). Beyond Motor Decline in ALS: Patient-Centered Insights into Non-Motor Manifestations. Medicina. https://doi.org/10.3390/medicina61091694
530. Mukhopadhyay, S., & Banerjee, D. (2021). The complex conundrum of geriatric depression and dementias. Journal of Geriatric Mental Health. https://doi.org/10.4103/jgmh.jgmh_21_21
531. Mulroy, E., Baschieri, F., Magrinelli, F., Latorre, A., Cortelli, P., & Bhatia, K. P. (2021). Movement Disorders and Liver Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13238
532. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
533. Muthukumaran, D. (2011). A Study on Acute Symptomatic Seizures in the Elderly..
534. Méndez, A. V., Silva, P. L. N. D., Gonçalves, L. G. V., Chaves, S. C. D. S., Veiga, R. M., Mendez, A. E. R., Camilo, M. V. L., Mattos, L. C. D. A. N., Filho, M. R. S., Silva, R. D. G. D., Lima, G. F., Ferreira, C. S., & Santos, L. G. D. S. (2023). NEURONAL DAMAGE IN STATE EPILEPTICUS - LITERATURE REVIEW. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593752318094
535. Nabavi, S. M., & Sangelaji, B. (2015). Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients. Journal of Research in Medical Sciences. https://doi.org/10.4103/1735-1995.163984
536. Nabi, S. U., Dey, S., Gupta, G., Kumar, A., Vala, J., & Jan, M. H. (2010). A study of neuromuscular dysfunctions in geriatric dogs.. Haryana Veterinarian.
537. Nabila, B. I., Kurniawan, W. E., & Maryoto, M. (2022). GAMBARAN TINGKAT DEMENSIA PADA LANSIA DI ROJINHOME IKEDAEN OKINAWA JEPANG. Jurnal Studi Keperawatan. https://doi.org/10.31983/j-sikep.v3i2.8410
538. Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013). Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence. Journal of Neuroinflammation. https://doi.org/10.1186/1742-2094-10-142
539. Naranđa, F. S. (2019). Značaj Empty selle u procjeni funkcije hipofize.
540. Narayanan, L., & Murray, A. D. (2014). What is the role of neuroimaging in dementia? A review. Imaging. https://doi.org/10.1259/img.20120015
541. Narváez, A. J., & Diaz, Á. A. B. (2019). Intervenciones de enfermería para la atención de los cuidadores primarios de pacientes con enfermedad de Alzheimer. Cali 2019. Repositorio Institucional USC.
542. NASCIMENTO, R. T. L., LOPES, C. B., COTTA, D. D. S., ALENCAR, N. L. O. R. D., Valadão, A. F., & Motta, P. G. D. (2015). NEUROPATIA DIABÉTICA DOLOROSA - ASPECTOS CLÍNICOS, DIAGNÓSTICO E TRATAMENTO: UMA REVISÃO DE LITERATURA. Revista Uningá. https://doi.org/10.46311/2318-0579.43.euj1215
543. Nedelská, Z., Boeve, B. F., Ferman, T. J., Senjem, M. L., Przybelski, S. A., Lesnick, T. G., Knopman, D. S., Graff‐Radford, J., Jones, D. T., Savica, R., Drubach, D. A., Fields, J. A., Graff‐Radford, N. R., Lowe, V. J., Jack, C. R., Petersen, R. C., & Kantarci, K. (2019). P3‐427: MILD COGNITIVE IMPAIRMENT PROGRESSING TO DEMENTIA WITH LEWY BODIES: REGIONAL ATROPHY RATES AND RELATIONSHIP TO AV‐1451 UPTAKE. Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2019.06.3461
544. Neira, F. C., & Ortega, J. L. (2004). Antagonistas de los receptores glutamatérgicos NMDA en el tratamiento del dolor crónico. Revista de la Sociedad Española del Dolor.
545. Neligan, A., & Shorvon, S. (2010). Frequency and Prognosis of Convulsive Status Epilepticus of Different Causes. Archives of Neurology. https://doi.org/10.1001/archneurol.2010.169
546. Nelson, M., Andel, R., Martínková, J., Čechová, K., Marková, H., & Hort, J. (2020). Moderating Effect of Cognitive Reserve on Brain Integrity and Cognitive Performance. Innovation in Aging. https://doi.org/10.1093/geroni/igaa057.912
547. Nelson, P. T., Kryscio, R. J., Abner, E. L., Schmitt, F. A., Jicha, G. A., Mendiondo, M. S., Cooper, G. M., Smith, C. B., & Markesbery, W. R. (2009). Acetylcholinesterase Inhibitor Treatment is Associated with Relatively Slow Cognitive Decline in Patients with Alzheimer's Disease and AD + DLB. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2009-0926
548. Nestor, P. J. (2010). 007 Mild cognitive impairment. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2010.217554.7
549. Neubauer, B. A., Doose, H., & Petersen, B. (2000). The concept of hereditary impairment of brain maturation.. PubMed.
550. Newton, J. L. (2010). Systemic Symptoms in Non-Alcoholic Fatty Liver Disease. Digestive Diseases. https://doi.org/10.1159/000282089
551. Nguyen‐Michel, V., & Vecchierini, M. (2016). Exploration of sleep disorders in the elderly: which particularities?. Gériatrie et Psychologie Neuropsychiatrie du Viellissement. https://doi.org/10.1684/pnv.2016.0634
552. Nielson, K. A., Smith, J. C., Antuono, P., Lyons, J.-A., Hanson, R., Butts, A. M., Hantke, N., & Verber, M. (2013). Semantic Memory Functional MRI and Cognitive Function after Exercise Intervention in Mild Cognitive Impairment. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-130467
553. Nikpour, S. (2012). Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review.. PubMed.
554. Nisa, K. M., & Lisiswanti, R. (2016). Faktor Risiko Demensia Alzheimer. Jurnal Majority.
555. Nishioka, C., Poh, C., & Sun, S. (2015). Diffusion Tensor Imaging Reveals Visual Pathway Damage in Patients with Mild Cognitive Impairment and Alzheimer's Disease. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-141239
556. Nițescu, D., Nicolau, A., Caraiola, S., Predețeanu, D., Ionescu, R., & Tănăsescu, C. (2011). Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome?. PubMed.
557. Noachtar, S. (2012). EEG des Status epilepticus und seine Differentialdiagnosen. Klinische Neurophysiologie. https://doi.org/10.1055/s-0032-1301424
558. Noble, J. M. (2022). Alzheimer’s Disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190495688.003.0006
559. Noble, J. M. (2022). Dementia, Mild Cognitive Impairment, and Normal Changes of Aging. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190495688.003.0002
560. Noble, J. M. (2022). Introduction. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190495688.003.0001
561. Noble, J. M. (2022). Less Common Causes of Dementia. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190495688.003.0010
562. Noble, J. M. (2022). The Stages of Dementia. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190495688.003.0004
563. North, C. S., & Yutzy, S. H. (2018). Delirium and Dementia (Neurocognitive Disorders). Oxford University Press eBooks. https://doi.org/10.1093/med/9780190215460.003.0013
564. Nugent, M., & Ward, J. (2022). Familial aggregation of synaesthesia with autism (but not schizophrenia). Cognitive Neuropsychiatry. https://doi.org/10.1080/13546805.2022.2095897
565. Ogata, T., Sakakibara, R., Tateno, F., Tsuyusaki, Y., Tateno, H., Aiba, Y., Kishi, M., Inaoka, T., Terada, H., Doi, H., & Suzuki, Y. (2016). Mild Cognitive Impairment as the Initial Manifestation of Progressive Supranuclear Palsy. Journal of the American Geriatrics Society. https://doi.org/10.1111/jgs.14001
566. Oliveira, C. D. S., Nobre, J. D. C., Silva, A. L. T. D., Martins, J. D. A., & Vandesmet, L. C. S. (2020). MÉTODOS DE DIAGNÓSTICO PARA DETECÇÃO DE ALTERAÇÕES HISTOLÓGICAS NEURAIS DECORRENTES DO ALZHEIMER. Mostra Científica em Biomedicina.
567. Onyike, C. U. (2017). Assessment and diagnosis of the non-Alzheimer dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198701590.003.0127
568. Oscar‐Berman, M., & Mosher, S. M. (2010). Brain Injuries. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0143
569. Ospina, B., & Vélez, J. L. O. (2019). Espectro clínico y tratamiento del trastorno cognoscitivo y demencia asociada a la enfermedad de Parkinson. Acta neurológica colombiana. https://doi.org/10.22379/24224022248
570. Otter, M., Wieland, J., Kapitein, S., & Baas, R. (2014). [Diagnosing psychiatric disorders in people with (very) mild intellectual disabilities].. PubMed.
571. Pack, A. I., & Pien, G. W. (2010). Update on Sleep and Its Disorders. Annual Review of Medicine. https://doi.org/10.1146/annurev-med-050409-104056
572. Pagonabarraga, J., Álamo, C., Castellanos, M., Díaz, S., & Manzano, S. (2023). Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders. Brain Sciences. https://doi.org/10.3390/brainsci13020318
573. Palmer, B. W., McClure, F. S., & Jeste, D. V. (2001). Schizophrenia in Late Life: Findings Challenge Traditional Concepts. Harvard Review of Psychiatry. https://doi.org/10.1080/10673220127883
574. Palmer, S. C., Zwieten, A. V., Saglimbene, V., Ruospo, M., & Strippoli, G. F. (2022). Neurocognitive Disorders. https://doi.org/10.1002/9781119105954.ch75
575. Palop, J. J. (2009). Epilepsy and Cognitive Impairments in Alzheimer Disease. Archives of Neurology. https://doi.org/10.1001/archneurol.2009.15
576. Panfilova, E., Bobylova, M. Y., Kapustina, A. A., Braudo, T. A., Abramov, M. O., & Klepikov, N. I. (2017). Motor and sensory alalia: diagnostic difficulties. Russian Journal of Child Neurology. https://doi.org/10.17650/2073-8803-2017-12-4-32-42
577. Panza, F., Frisardi, V., Capurso, C., D’Introno, A., Colacicco, A. M., Seripa, D., Pilotto, A., Vendemiale, G., Capurso, A., & Solfrizzi, V. (2009). POSSIBLE PREDICTORS OF VASCULAR COGNITIVE IMPAIRMENT–NO DEMENTIA. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2009.02236.x
578. Paprocka, J., Jamroz, E., Szwed-Białożyt, B., Jezela‐Stanek, A., Kopyta, I., & Marszał, E. (2007). Angelman Syndrome Revisited. The Neurologist. https://doi.org/10.1097/01.nrl.0000253067.32759.aa
579. Paraskevas, G. P., Tsantzali, I., Paraskevas, P. G., Paraskevas, S. G., Efthimiopoulos, S., & Tsivgoulis, G. (2020). Atypical Presentations of Alzheimer’s Disease: Beyond Amnestic Dementia. Clinical and Experimental Investigations. https://doi.org/10.31487/j.cei.2020.03.03
580. Park, H. J. (2006). Motor delay : cerebral palsy. Korean Journal of Pediatrics. https://doi.org/10.3345/kjp.2006.49.10.1019
581. Park, J. H., Kim, H.-C., Lee, J. H., Kim, J. S., Roh, S. Y., Yi, C. H., Kang, Y. K., & Kwon, B. S. (2009). Development of Korean Academy of Medical Sciences Guideline for Rating Physical Disability of Upper Extremity. Journal of Korean Medical Science. https://doi.org/10.3346/jkms.2009.24.s2.s288
582. Parreira, G. R. (2014). ALZHEIMER: QUANDO O PASSADO DEIXA DE EXISTIR. 5ª JICE - JORNADA DE INICIAÇÃO CIENTÍFICA E EXTENSÃO.
583. Passantino, A., & Masucci, M. (2016). Congenital and inherited neurologic diseases in dogs and cats: Legislation and its effect on purchase in Italy. Veterinary World. https://doi.org/10.14202/vetworld.2016.437-443
584. Pathan, A. (2023). Limitations of Alzheimer’s Disease Medications. NeuroPharmac Journal. https://doi.org/10.37881/1.832
585. Pathan, A., & Alshahrani, A. (2018). Alzheimer’s Disease: Pharmacotherapy of noncognitive symptoms. NeuroPharmac Journal. https://doi.org/10.37881/1.311
586. Pavlović, A., Pavlović, D., Aleksić, V., & Šternić, N. (2013). Vascular dementia: Facts and controversies. Srpski arhiv za celokupno lekarstvo. https://doi.org/10.2298/sarh1304247p
587. Pennisi, M., Bramanti, A., Cantone, M., Pennisi, G., Bella, R., & Lanza, G. (2017). Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2017.00498
588. Peracino, A., & Pecorelli, S. (2016). The Epidemiology of Cognitive Impairment in the Aging Population: Implications for Hearing Loss. Audiology and Neurotology. https://doi.org/10.1159/000448346
589. Perdigón, L. J. M., Pérez, P. V., Niño, R., & Rodríguez, D. (2018). Desórdenes en el espectro de la neuropatía auditiva (DENA). ACTA DE OTORRINOLARINGOLOGÍA & CIRUGÍA DE CABEZA Y CUELLO. https://doi.org/10.37076/acorl.v40i3.212
590. Pereira, K. K., & Marinho, V. (2015). Uso de anticolinesterásicos na doença de Alzheimer. Debates em Psiquiatria. https://doi.org/10.25118/2236-918x-5-3-3
591. Pereira, S. M. P., Guimarães, S. K. G., Marques, A., & Borges, S. (2008). Electroconvulsivotherapy in the elderly, indications, risks and side-effects. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2008.01.611
592. Perez‐Polo, R. (1991). Nerve Growth Factor and Aging: A Hypothesis. Birkhäuser Boston eBooks. https://doi.org/10.1007/978-1-4899-6738-1_50
593. Perri, R., Carlesimo, G. A., Serra, L., Caltagirone, C., & IT, T. E. D. G. O. T. (2005). Characterization of Memory Profile in Subjects with Amnestic Mild Cognitive Impairment. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803390490919317
594. Pessoa, R. M. D. P., Maximiano‐Barreto, M. A., Lambert, L., Leite, É. D. M., & Chagas, M. H. N. (2023). The frequency of psychotic symptoms in types of dementia: a systematic review. Dementia & Neuropsychologia. https://doi.org/10.1590/1980-5764-dn-2022-0044
595. Piagkou, M., Demesticha, T., Piagkos, G., Georgios, A., & Panagiotis, S. (2010). Lingual Nerve Entrapment in Muscular and Osseous Structures. International Journal of Oral Science. https://doi.org/10.4248/ijos10063
596. Piccolo, A. C., Campos, L. M. G., & Audi, M. (2025). RELAÇÃO ENTRE A QUALIDADE DO SONO, PERCEPÇÃO CORPORAL E OS SINTOMAS MOTORES E SENSITIVOS EM PESSOAS COM ESCLEROSE MÚLTIPLA REMITENTE-RECORRENTE. Aracê.. https://doi.org/10.56238/arev7n8-002
597. Pignalberi, C., Ricci, R. P., & Santini, M. (2002). [Psychological stress and sudden death].. PubMed.
598. Pizzi, C., Santarella, L., Manfrini, O., Chiavaroli, M., Agushi, E., Cordioli, E., Costa, G. M., & Bugiardini, R. (2013). [Ischemic heart disease and depression: an underestimated clinical association].. PubMed. https://doi.org/10.1714/1308.14461
599. Polanczyk, G. V., Casella, E. B., Miguel, E. C., & Reed, U. C. (2012). Attention deficit disorder/hyperactivity: a scientific overview. Clinics. https://doi.org/10.6061/clinics/2012(10)01
600. Polito, A., & Annane, D. (2008). Adrenal glands/corticosteroids and multiple organ dysfunction syndrome. Journal of Organ Dysfunction. https://doi.org/10.1080/17471060802339703
601. Potvin, O., Hudon, C., Grenier, S., & Préville, M. (2010). Non-essential symptoms of depression and cognitive impairment no dementia (CIND) in community-dwelling elders without dysphoria or anhedonia. International Psychogeriatrics. https://doi.org/10.1017/s1041610210001419
602. Potvin, S., Stavro, K., & Pelletier, J. (2012). Paradoxical Cognitive Capacities in Dual Diagnosis Schizophrenia: The Quest for Explanatory Factors. Journal of Dual Diagnosis. https://doi.org/10.1080/15504263.2012.648549
603. Poujois, A., & Woimant, F. (2019). Challenges in the diagnosis of Wilson disease. Annals of Translational Medicine. https://doi.org/10.21037/atm.2019.02.10
604. Poujois, A., Perret‐Liaudet, A., & Thomas-Antérion, C. (2010). Le piège de la maladie d'Alzheimer à présentation dysexécutive. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2010.0071
605. Poujois, A., Perret‐Liaudet, A., & Thomas-Antérion, C. (2010). Le piège de la maladie d'Alzheimer à présentation dysexécutive. Revue de neuropsychologie. https://doi.org/10.3917/rne.025.0028
606. Powers, J. M. (1995). PRESIDENTIAL ADDRESS. Journal of Neuropathology & Experimental Neurology. https://doi.org/10.1097/00005072-199509000-00014
607. Powers, J. M. (1995). The pathology of peroxisomal disorders with pathogenetic considerations.. PubMed.
608. Powlishta, K. K., Storandt, M., Mandernach, T., Hogan, E., Grant, E., & Morris, J. C. (2004). Absence of Effect of Depression on Cognitive Performance in Early-Stage Alzheimer Disease. Archives of Neurology. https://doi.org/10.1001/archneur.61.8.1265
609. Pradeep, V. A. J. (2013). Study on Neurological Soft Signs in patients with ObsessiveCompulsive Disorder..
610. Pradhea, T. A., Dwikarlina, I., Putra, A. W., Agustina, L., & Nardian, D. F. (2024). Gangguan Kognitif Pasca-Stroke – Tinjauan Sistematik. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v51i12.1239
611. Prasad, A. S. V. (2020). Physiological Basis of Memory Dysfunction in Alzheimer’s Disease – An Overview. International Journal of Biochemistry Research & Review. https://doi.org/10.9734/ijbcrr/2020/v29i230168
612. Pratibha, S. (2010). Etiology of Late Onset Seizures.
613. Preuss, U. W., Siafarikas, N., Petrucci, M., & Wong, W. S. (2009). Depressive Störungen bei Demenzen und milder kognitiver Beeinträchtigung: Komorbidität, Ursache oder Risikofaktor?. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0028-1109454
614. Priya, P. R., Kumar, C. A., & Ramya, L. (2023). STUDY OF NERVE CONDUCTION ABNORMALITIES IN ASYMPTOMATIC TYPE II DIABETIC INDIVIDUALS. International Journal of Scientific Research. https://doi.org/10.36106/ijsr/1701916
615. Probst, A., & Tolnay, M. (2002). La démence frontotemporale : aspects cliniques et morphologiques. Schweizer Archiv für Neurologie und Psychiatrie. https://doi.org/10.4414/sanp.2002.01276
616. Profenno, L. A., & Tariot, P. N. (2003). Pharmacologic Management of Agitation in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000074278
617. Putri, P. R. N. E. (2020). Asuhan keperawatan diabetes mellitus tipe 2 dengan ulkus diabetik pada ny. J di upt puskesmas rawat inap sungai pakning.
618. Pyszora, N., Fahy, T., & Kopelman, M. D. (2014). Amnesia for violent offenses: factors underlying memory loss and recovery.. PubMed.
619. Pérez, J. A. H., Botina, A. D. M., Hormiga, M. P., & Sánchez, B. E. B. (2017). Trastornos de la alimentación: Anorexia nerviosa y bulimia nerviosa. RFS Revista Facultad de Salud. https://doi.org/10.25054/rfs.v9i1.1827
620. Pérez, J. M., Prudencio, S. F., Navarro, A. G., Comi, M. L., & Pascual, R. A. (2013). Evolución y seguimiento de los trastornos del espectro autista. Revista de Neurología. https://doi.org/10.33588/rn.56s01.2012655
621. Qin, Y., Wu, Z., & Lei, W. (2024). Sleep Disorders in Alzheimer’s Disease. Journal of Sleep Medicine & Disorders. https://doi.org/10.47739/sleepmedicine.1140
622. Quijano‐Roy, S., & Banda, M. G. D. L. (2018). Distrofias musculares congénitas. Revista Médica Clínica Las Condes. https://doi.org/10.1016/j.rmclc.2018.08.002
623. Qureshi, H. J., & Javaid, M. K. (2021). PHATHOPHYSIOLOGY OF ALZHEIMER’S DISEASE. Journal of Akhtar Saeed Medical & Dental College. https://doi.org/10.51127/jamdcv01i01ra01
624. Rada, A., & Bien, C. G. (2023). What is autoimmune encephalitis‐associated epilepsy? Proposal of a practical definition. Epilepsia. https://doi.org/10.1111/epi.17699
625. Radmanović, M. B., & Burgić, S.-S. (2020). Comorbidity in Children and Adolescents with ADHD. IntechOpen eBooks. https://doi.org/10.5772/intechopen.94527
626. Rafnsson, S. (2010). Major types of cardiovascular diseases and cognitive function: A review of patient and population-based investigations.
627. Rahman, S., Footitt, E., Varadkar, S., & Clayton, P. T. (2012). Inborn errors of metabolism causing epilepsy. Developmental Medicine & Child Neurology. https://doi.org/10.1111/j.1469-8749.2012.04406.x
628. Ralls, F. M., Cutchen, L., & Grigg‐Damberger, M. (2022). Recognizing New-Onset Sleep Disorders in Autoimmune Encephalitis Often Prompt Earlier Diagnosis. Journal of Clinical Neurophysiology. https://doi.org/10.1097/wnp.0000000000000820
629. Rani, P., Singh, K., Arjuna, A., & Devi, S. M. (2017). GENETIC DISORDER ALZHEIMER. Asian Journal of Pharmaceutical and Clinical Research. https://doi.org/10.22159/ajpcr.2017.v10i12.18684
630. Rao, N., & Suhas, S. (2019). Neurocognitive deficits in obsessive–compulsive disorder: A selective review. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_517_18
631. Raudino, F. (2016). Alzheimers’ Disease and Epilepsy: A Literature Review. Archives of Neuroscience. https://doi.org/10.5812/archneurosci.39578
632. Rechenek-Białkowska, M., & Jarząbek-Bielecka, G. (2022). Wybrane zagadnienia związane z zaburzeniami zdrowia psychicznego i seksualnego w medycynie rodzinnej na przykładzie zespołu Gansera. Medycyna Rodzinna. https://doi.org/10.25121/mr.2022.25.2.55
633. Reed, U. C., Marie, S. K. N., Vainzof, M., Gobbo, L. F., Gurgel, J., Carvalho, M. S., Resende, M. B. D. D., Espíndola, A. Á. D., Zatz, M., & Diament, A. J. (2000). Heterogeneity of Classic Congenital Muscular Dystrophy With Involvement of the Central Nervous System: Report of Five Atypical Cases. Journal of Child Neurology. https://doi.org/10.1177/088307380001500306
634. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
635. Reisberg, ‌., Ferris, S. H., Kluger, A., Franssen, E., Węgiel, J., & Leon, M. J. D. (2007). Mild cognitive impairment (MCI): a historical perspective. International Psychogeriatrics. https://doi.org/10.1017/s1041610207006394
636. Remes, A. M., Vanninen, R., Jokinen, H., Hallikainen, M., & Erkinjuntti, T. (2013). [Posterior variant of Alzheimer's disease and other atypical symptom pictures].. PubMed.
637. Reséndiz-Aparicio, J. C., Pérez-García, J. C., Olivas‐Peña, E., García-Cuevas, E., Roque-Villavicencio, Y. L., Hernández-Hernández, M., Castro-Macías, J. I., & Rayo-Mares, J. D. (2023). Guía clínica. Definición y clasificación de la epilepsia. DELETED. https://doi.org/10.24875/rmn.m19000052
638. Reula, L. M., García, H. S., & Fernández, A. P. (2017). Relationship Between Early Maladaptive Schemes and Traumatic Childhood Experiences with Suicidal Behavior in Adults. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2017.01.2199
639. Riaz, Y., & Sergi, C. (2021). Feeding Disability In Children.
640. Ribes, A., González, M. J. M., & Cazorla, Á. G. (2008). [Adult-onset metabolic diseases].. Anales del Sistema Sanitario de Navarra.
641. RIED, L. M. (2018). RELAÇÃO ENTRE A DEPRESSÃO E A DEMÊNCIA DO TIPO ALZHEIMER. https://doi.org/10.17771/pucrio.acad.36288
642. Robinson, A., Roncaroli, F., Davidson, Y. S., Minshull, J., Heal, C., Montaldi, D., Payton, A., Horan, M. A., Pendleton, N., & Mann, D. M. A. (2020). Mid to late‐life scores of depression in the cognitively healthy are associated with cognitive status and Alzheimer's disease pathology at death. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.5470
643. Rocha, E. A., Mehta, N., Távora‐Mehta, M. Z. P., Roncari, C. F., Cidrão, A. A. D. L., & Elías, J. (2021). Disautonomia: Uma Condição Esquecida – Parte 1. Arquivos Brasileiros de Cardiologia. https://doi.org/10.36660/abc.20200420
644. Rocha, E. L. D. (2019). O OLHAR DAS DIFICULDADES DE APRENDIZAGEM DECORRENTES DA ASFIXIA PERINATAL POR MEIO DA NEUROPSICOLOGIA HISTÓRICO CULTURAL. Estudos IAT.
645. Rodrigues, D. S., Luís-Ferreira, F., Sarraipa, J., & Jardim‐Gonçalves, R. (2018). Behavioural Monitoring of Alzheimer Patients with Smartwatch based System. https://doi.org/10.1109/is.2018.8710487
646. Rollin‐Sillaire, A., Delbeuck, X., Pollet, M., Mackowiak, M., Lenfant, P., Noël, M., Façon, T., Leleu, X., Pasquier, F., & Rhun, É. L. (2013). Memory loss during lenalidomide treatment: a report on two cases. BMC Pharmacology and Toxicology. https://doi.org/10.1186/2050-6511-14-41
647. Romero, J. M. B. (2004). Un estudio clínico sobre la hipótesis secuencial de la clasificación endogena-neurótica de la depresión.
648. Ronco, C., McCullough, P. A., Anker, S. D., Anand, I. S., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., Daliento, L., Davenport, A., Haapio, M., Hillege, H. L., House, A. A., Katz, N., Maisel, A. S., Mankad, S., Zanco, P., ... Ponikowski, P. (2010). Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contributions to nephrology. https://doi.org/10.1159/000313745
649. Rosenberg, P. B., Mielke, M. M., Appleby, B. S., Oh, E. S., Leoutsakos, J., & Lyketsos, C. G. (2010). Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/gps.2535
650. Rosenblat, J. D., Mansur, R. B., Danielle, S., Baskaran, A., & McIntyre, R. S. (2014). Depression, Diabetes and Dementia. Key issues in mental health (Online)/Key issues in mental health (Print). https://doi.org/10.1159/000365529
651. Rossor, A. M., Carr, A., Devine, H., Chandrashekar, H. S., Pelayo‐Negro, A. L., Pareyson, D., Shy, M. E., Scherer, S. S., & Reilly, M. M. (2017). Peripheral neuropathy in complex inherited diseases: an approach to diagnosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp-2016-313960
652. Rowe, R. K., Schulz, P., He, P., Mannino, G., Opp, M. R., & Sierks, M. R. (2024). Acute sleep deprivation in mice generates protein pathology consistent with neurodegenerative diseases. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2024.1436966
653. Rozzini, L., Chilovi, B. V., Conti, M. Z., Delrio, I., Borroni, B., Trabucchi, M., & Padovani, A. (2007). Neuropsychiatric Symptoms in Amnestic and Nonamnestic Mild Cognitive Impairment. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000111133
654. Rucci, J. M., & Feinstein, R. E. (2014). Neurocognitive Disorders and Mental Disorders Due to Another Medical Condition. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199326075.003.0005
655. Ruff, R. M., Silver, C., Iverson, G. L., BARTH, J., BROSHEK, D., Bush, S. B., Koffler, S. P., & Reynolds, C. W. (2007). Learning disabilities: The need for neuropsychological evaluation. Archives of Clinical Neuropsychology. https://doi.org/10.1016/j.acn.2007.09.006
656. Röhr, S., Villringer, A., Angermeyer, M., Luck, T., & Riedel‐Heller, S. G. (2017). Outcomes of stable and unstable reports of subjective cognitive decline – results from the Leipzig Longitudinal Study of the Aged (LEILA75+). Das Gesundheitswesen. https://doi.org/10.1055/s-0037-1605826
657. Sabo-Graham, T., & Seay, A. R. (1998). Consultation with the Specialist: Management of Status Epilepticus in Children. Pediatrics in Review. https://doi.org/10.1542/pir.19.9.306
658. Sadek, J., Pergam, S. A., Harrington, J., Echevarria, L., Davis, L. E., Goade, D., Harnar, J., Nofchissey, R. A., Sewell, C. M., Ettestad, P., & Haaland, K. Y. (2009). Persistent neuropsychological impairment associated with West Nile virus infection. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803390902881918
659. Sadowski, M. (2010). Toward improving the diagnosis of Alzheimer's Disease.
660. Sagar, V. V. S. S., Ghule, A., Talwar, D., Kumar, S., & Acharya, S. (2021). Heavy Metal Encephalopathy Masquerading as Hepatic Encephalopathy – A Case Report. Journal of Evolution of Medical and Dental Sciences. https://doi.org/10.14260/jemds/2021/232
661. Saguil, A. (2005). Evaluation of the patient with muscle weakness.. PubMed.
662. Saitoh, S. (2015). Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome. Journal of Pediatric Epilepsy. https://doi.org/10.1055/s-0035-1554787
663. Sanei, S., & Chambers, J. A. (2021). EEG Analysis of Neurodegenerative Diseases. https://doi.org/10.1002/9781119386957.ch15
664. Santos, M. O., Pinto, S., Silveira, F., Gromicho, M., Alves, I., Castro, J., Castro, I., & Carvalho, M. D. (2025). Amyotrophic Lateral Sclerosis Associated With Severe Sensory Neuronopathy: Case Series. Journal of Clinical Neuromuscular Disease. https://doi.org/10.1097/cnd.0000000000000520
665. Santos, R. S., Camargo, C. H. F., Abdulmassih, E. M. D. S., & Teive, H. A. G. (2015). Dysphagia in Parkinson’s Disease. InTech eBooks. https://doi.org/10.5772/60983
666. Santos, R. X., Correia, S. C., Wang, X., Perry, G., Smith, M. A., Moreira, P. I., & Zhu, X. (2010). A Synergistic Dysfunction of Mitochondrial Fission/Fusion Dynamics and Mitophagy in Alzheimer's Disease. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-2010-100666
667. Sater, R., Gudesblatt, M., Kresa-Reahl, K., Brandes, D., & Sater, P. (2015). The relationship between objective parameters of sleep and measures of fatigue, depression, and cognition in multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. https://doi.org/10.1177/2055217315577828
668. Sava, A.-A., & Chainay, H. (2013). Effets des émotions sur la mémoire dans la maladie d’Alzheimer et le vieillissement normal. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2013.0281
669. Sazonov, S. (2014). EPA-0651 – The complexity of psychopathological symptom as a possible indication of mental disease's etiology. European Psychiatry. https://doi.org/10.1016/s0924-9338(14)78023-x
670. Scarmeas, N., Honig, L. S., Choi, H., Cantero, J., Brandt, J., Blacker, D., Albert, M., Amatniek, J., Marder, K., Bell, K. L., Hauser, W. A., & Stern, Y. (2009). Seizures in Alzheimer Disease. Archives of Neurology. https://doi.org/10.1001/archneurol.2009.130
671. Schapiro, M. B., Luxenberg, J. S., Kaye, J., Haxby, J. V., & Friedland, R. P. (1989). Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages. Neurology. https://doi.org/10.1212/wnl.39.10.1349
672. Schlemmer, T. (2023). The Evaluation of Oxygen Need. International Journal of Nursing and Health Care Research. https://doi.org/10.29011/2688-9501.101443
673. Schmahmann, J. D. (2014). The Differential Diagnosis of Rapidly Progressive and Rare Dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199928453.003.0015
674. Schneider, A., Seritan, A. L., Tassone, F., Rivera, S. M., Hagerman, R. J., & Hessl, D. (2013). Psychiatric Features in High-Functioning Adult Brothers With Fragile X Spectrum Disorders. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12l01492
675. Schneider, B., Weber, B., Maurer, K., & Frölich, L. (2002). Problematik der Beurteilung depressiver Symptome Demenzkranker. Psychiatrische Praxis. https://doi.org/10.1055/s-2002-22042
676. Schneider, L. S., & Abou‐Saleh, U. B. M. T. (2002). Neurochemistry. https://doi.org/10.1002/0470846410.ch72
677. Schott, J. M. (2020). Alzheimer’s disease and other dementias. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0574
678. Schultz, C., Tredici, K. D., & Braak, H. (2004). Neuropathology of Alzheimer’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-661-4_2
679. Schurch, B. (2000). Blasendysfunktion nach spinalen und peripheren Nervenläsionen [Bladder dysfunction after spinal and peripheral nerve lesions].. Therapeutische Umschau. Revue thérapeutique.
680. Schölzel-Dorenbos, C. J. (2006). MILD BEHAVIORAL IMPAIRMENT: A PRODROMAL STAGE OF FRONTOTEMPORAL LOBAR DEGENERATION. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2005.00575_11.x
681. Scinto, L. F. M., & Daffner, K. R. (2000). Early Diagnosis of Alzheimer’s Disease. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-005-6
682. Selkoe, D. J. (2009). Unraveling the Molecular Basis of Alzheimer`s Disease Yields Novel Therapies: A Personal Retrospective. Journal of medical sciences. https://doi.org/10.2174/1996327000902030098
683. Seltzer, B. (2004). Are Alzheimer’s Patients Aware of Their Deficits?. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-661-4_45
684. Sepúlveda, A. D. (2007). Deterioro y Demencia, Orientación para médicos no especialistas. Dementia and Impairment, Directions for no specialist physicians.. Cuadernos de neuropsicología.
685. Sepúlveda, A. D. (2007). DETERIORO Y DEMENCIA. Orientación para médicos no especialistas.. DOAJ (DOAJ: Directory of Open Access Journals).
686. Serino, J., Martins, J., Vieira, B., Menezes, C., Lemos, J. A., & Ribeiro, M. I. (2014). Atrofia Cortical Posterior- uma possível causa para as queixas visuais. Revista Sociedade Portuguesa de Oftalmologia. https://doi.org/10.48560/rspo.6648
687. Serrano, J. L., Vila, S., Vidal, R. C., Padilla, E. B., Lamora, N. S., Mollà, L., Rodríguez, A. M., & López, L. M. M. (2017). COMORBILIDAD ENTRE DEPRESIÓN Y CONDUCTAS IMPULSIVAS: UN CASO DE URGENCIA NEGATIVA.
688. Sesarini, C. (2015). GABAergic neurotransmission alterations in autism spectrum disorders. Neurotransmitter. https://doi.org/10.14800/nt.1052
689. Shah, P., & Hoyme, H. E. (2020). FETAL ALCOHOL SPECTRUM DISORDERS. https://doi.org/10.1002/9781119432692.ch26
690. Shapoval'iants, O. S. (2012). [Diagnostics and treatment of polyglandular syndrome of adults].. PubMed.
691. Sharma, N., & Kolekar, H. M. (2017). Diagnosis of Vascular Cognitive Impairment Using EEG. Indian Journal of Public Health Research & Development. https://doi.org/10.5958/0976-5506.2017.00454.5
692. Sharma, P., Dubey, A., Das, D., Ivaturi, N. V., Kumar, D., & Rajput, M. (2023). Marchiafava–Bignami Disease: A Rare Finding in Alcohol Dependence Syndrome. Journal of Marine Medical Society. https://doi.org/10.4103/jmms.jmms_5_23
693. Sharma, U., Anjali, S., Surendra, V., Taj, N., & Manjunatha, P. M. (2019). Parkinson’s Disease: A Brief Outlook.
694. Sharma, V., Sharma, P., Deshmukh, R., & Singh, R. (2015). Age Associated Sleep Loss: A Trigger For Alzheimer's Disease. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. https://doi.org/10.5455/bcp.20140909070449
695. Shaw, J. S., Huang, P. C., Rosenberg, P. B., & Peters, M. E. (2025). Motor symptoms in autopsy‐confirmed Alzheimer's disease increase the risk of progression to severe cognitive impairment. Alzheimer s & Dementia. https://doi.org/10.1002/alz.70039
696. Shea, T. B., & Remington, R. (2018). Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-170794
697. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
698. Sheikh, M., & Galvin, J. E. (2018). Neurocognitive Disorders With Lewy Bodies. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy21
699. Shibasaki, H., & Hallett, M. (2016). Psychogenic Neurologic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190240974.003.0026
700. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Disorders of Increased Muscle Stiffness or Overactivity. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0009
701. Shiha, G., & Mousa, N. (2019). Minimal Hepatic Encephalopathy: Silent Tragedy. IntechOpen eBooks. https://doi.org/10.5772/intechopen.88231
702. Shorvon, S. (2012). The Causes of Epilepsy. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199659043.003.0006
703. Siao, C.-J., & Tsirka, S. E. (2002). Extracellular proteases and neuronal cell death.. PubMed.
704. Sidarta, E., Sari, T., & Nataprawira, S. M. D. (2025). Demensia : Patofisiologi, Faktor Resiko dan Peran Inflamasi dalam Perkembangan Penyakit. Termometer Jurnal Ilmiah Ilmu Kesehatan dan Kedokteran. https://doi.org/10.55606/termometer.v3i1.4801
705. Siegler, J. E., & Galetta, S. (2021). Editors' Note: Association of Age at Onset and First Symptoms With Disease Progression in Patients With Metachromatic Leukodystrophy. Neurology. https://doi.org/10.1212/wnl.0000000000012505
706. Siemiński, M. (2017). Zaburzenia snu w chorobie Alzheimera. Polski Przegląd Neurologiczny.
707. Silva, A. F. D., Felix, H. C. D. O., Santos, G. M. D., Mafra, S. L. L., Santos, A., Barbosa, D. S. A. D. C., Lima, E. S. R. D., & Santos, W. M. D. V. (2024). DOENÇA DE ALZHEIMER: UMA REVISÃO BIBLIOGRÁFICA. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218. https://doi.org/10.47820/recima21.v5i5.5225
708. Silva, L. I. F. D., Souza, L. M., Gonzales, M. F., & Jurado, S. R. (2015). SLEEP DISORDERS IN CHILDHOOD. Simpósio Internacional de Neurociências da Grande Dourados.
709. Silva, N. D., Singhapathirana, S., & Silva, C. E. D. (2019). Miller Fisher Syndrome presenting as unilateral abducens nerve palsy: A case report. Research Square (Research Square). https://doi.org/10.21203/rs.2.9144/v1
710. Silver, R. M., & Airoldi, J. (2016). 27. Inherited thrombophilia. CRC Press eBooks. https://doi.org/10.1201/9781315200910-28
711. Sinclair, L. I., Ballard, C., & Bennett, D. A. (2023). Differential gene expression analysis in individuals with depression in Alzheimer’s disease using RNAseq. Alzheimer s & Dementia. https://doi.org/10.1002/alz.078153
712. Singh, A., & Jha, A. (2021). Cholinesterase Inhibitors Used for the Management of Alzheimer’s Disease: A Review. Journal of Pharmaceutical Research International. https://doi.org/10.9734/jpri/2021/v33i60a34463
713. Singh, S., & Adam, P. (2015). What can be done to slow progression of Alzheimer's disease in the elderly?. Evidence-Based Practice. https://doi.org/10.1097/01.ebp.0000540940.04507.0e
714. Sinha, A., & Sinha, A. (2018). Mild Cognitive Impairment and its Diagnosis to Progression to Dementia with Several Screening Measures. The Open Psychology Journal. https://doi.org/10.2174/1874350101811010142
715. Sinon, C. G., Arora, S., Rodriguez, A. D., & García, P. S. (2019). Special considerations: Alzheimer’s disease. CRC Press eBooks. https://doi.org/10.1201/9781351046473-19
716. Sivadasan, A., Cortel‐LeBlanc, M. A., Cortel‐LeBlanc, A., & Katzberg, H. (2024). Peripheral nervous system and neuromuscular disorders in the emergency department: A review. Academic Emergency Medicine. https://doi.org/10.1111/acem.14861
717. Skelton, W. P., & Skelton, N. K. (1991). Alzheimer's disease. Postgraduate Medicine. https://doi.org/10.1080/00325481.1991.11701056
718. Skike, C. E. V., Goodlett, C. R., & Matthews, D. B. (2019). Acute Alcohol and Cognition: Remembering What It Causes Us to Forget. Author eBooks.
719. Smith, E. E., Crites, S., Wang, M., Charlton, A., Zwiers, A., Sekhon, R., Sajobi, T. T., Camicioli, R., McCreary, C. R., Frayne, R., & Ismail, Z. (2021). Cerebral Amyloid Angiopathy Is Associated With Emotional Dysregulation, Impulse Dyscontrol, and Apathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.121.022089
720. Smith, J., & Seirafi, J. (2013). Delirium and Dementia.
721. Smith, P. J., Attix, D. K., Weldon, B. C., Greene, N. H., & Monk, T. G. (2009). Executive Function and Depression as Independent Risk Factors for Postoperative Delirium. Anesthesiology. https://doi.org/10.1097/aln.0b013e31819b5bc2
722. Sossauer, L., Schnider, A., & Leemann, B. (2018). [Neurological consequences and complications of alcohol consumption].. PubMed.
723. Sotolongo-Costa, O., Gaggero‐Sager, L., Maestú, F., Becker, J. T., & Sotolongo‐Grau, Ó. (2014). A catastrophe theory approach to cognitive decline. arXiv (Cornell University).
724. Spira, A. P., Chen-Edinboro, L. P., Wu, M. N., & Yaffe, K. (2014). Impact of sleep on the risk of cognitive decline and dementia. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000106
725. Stamouli, E., & Politis, A. (2016). Pro-inflammatory cytokines in Alzheimer’s disease. Psychiatriki. https://doi.org/10.22365/jpsych.2016.274.264
726. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
727. Steinberg, M. H., & Rosenberg, P. B. (2017). Cognitive Impairment and Depression in Older Patients. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199959549.001.0001
728. Stella, F., Canineu, P. R., Souza, L. C. D., & Forlenza, O. V. (2014). C URRENT OPINION Neuropsychiatric symptoms in the prodromal stages of dementia.
729. Stella, F., Radanovic, M., Balthazar, M. L. F., Canineu, P. R., Souza, L. C. D., & Forlenza, O. V. (2014). Neuropsychiatric symptoms in the prodromal stages of dementia. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000050
730. Stewart, A. A., Bydon, M., McGirt, M. J., Ramos, R. D. L. G., Gokaslan, A. K., & Bydon, A. (2014). Spinal Cord: Anatomical Overview and Selected Pathologies. Encyclopedia of Life Sciences. https://doi.org/10.1002/9780470015902.a0021402.pub2
731. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
732. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
733. Stores, G. (2009). What is sleep?. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199560837.003.0003
734. Storr, H. L., & Savage, M. O. (2007). Adrenal disorders. CRC Press eBooks. https://doi.org/10.1201/b13275-40
735. Stratyner, H. B. (2006). Multi-factorial Approaches to Substance Use Disorders and Addiction. CNS Spectrums. https://doi.org/10.1017/s109285290001498x
736. Strippoli, G. F., Montinaro, V., Manno, C. S., Palma, M., Lepore, V., Schena, F., & Pertosa, G. B. (2002). [Chorea in hemodialysis: Is chorea just a neurological syndrome or is it related to uremia or dialysis?].. PubMed.
737. Strupp, M., Straumann, D., & Helmchen, C. (2021). Nystagmus: Diagnosis, Topographic Anatomical Localization and Therapy. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/a-1525-0030
738. Stump, D. A. (2007). Deformable emboli and inflammation: temporary or permanent damage?. PubMed.
739. Subramaniam, S., Blake, D. T., & Constantinidis, C. (2021). Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-210425
740. Subramanian, P., & Palanisamy, V. (2023). Neurocognitive Disorder. Pondicherry Journal of Nursing. https://doi.org/10.5005/jp-journals-10084-13167
741. Sugimoto, A., Futamura, A., & Kawamura, M. (2013). [Epilepsy and cognitive dysfunction].. PubMed.
742. Suhonen, J., Pirttilä, T., Erkinjuntti, T., Koponen, H., Makkonen, M., Puurunen, M., Raivio, M., Rinne, J. O., Rosenvall, A., Strandberg, T., Vanninen, R., Vataja, R., Duodecimin, S. L., Fennican, S. G., Yhdistyksen, S. N., Yhdistyksen, S. P., & Työryhmä, S. Y. Y. A. (2010). [Update on current care guidelines. The diagnosis and medical treatment of memory disorders].. PubMed.
743. Sunderland, T., Molchan, S., Little, J. T., Bahro, M., Putnam, K., & Weingartner, H. (1997). Pharmacologic challenges in Alzheimer disease and normal controls: cognitive modeling in humans.. PubMed.
744. Sutton, F., Bârcă, D., Komoltsev, I., Craiu, D., Guekht, A., Oertzen, T. J. V., & Cock, H. R. (2020). Testing blood and CSF in people with epilepsy: a practical guide. Epileptic Disorders. https://doi.org/10.1684/epd.2020.1191
745. Suzuki, Y. (2012). Mild Cognitive Impairment. Journal of Nihon University Medical Association. https://doi.org/10.4264/numa.71.385
746. Sørensen, C. B., Kåreholt, I., Kalpouzos, G., Udeh‐Momoh, C., Holleman, J., Aspö, M., Hagman, G., Kivipelto, M., Solomon, A., & Sindi, S. (2023). Sleep disturbances, cortisol, and neuroimaging correlates among memory clinic patients. Alzheimer s & Dementia. https://doi.org/10.1002/alz.078205
747. Tang‐Wai, D. F., Josephs, K. A., & Petersen, R. C. (2005). Alzheimer's disease: overview. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544873.029
748. Tartaglione, I., Paturzo, M. G., Picazio, S., Malvone, C., Biasio, D. D., Roberti, D., Gennaro, F. D., Contieri, M., Librizzi, G., Pirozzi, M. A., Esposito, F., Perrotta, S., & Manara, R. (2025). Cognitive impairment in hereditary spherocytosis. British Journal of Haematology. https://doi.org/10.1111/bjh.70088
749. Tedrus, G. M. A. S., Fonseca, L. C., Letro, G. H., Bossoni, A. S., & Bastos, S. A. (2009). Dementia and mild cognitive impairment in Parkinson's disease. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2009000600038
750. Teixeira, A. L., Gregg, A., Gentry, M. T., Gujral, S., Rapp, E., Oberlin, L. E., Ajilore, O., Weisenbach, S. L., & Patrick, R. (2025). Cognitive Deficits in Late-Life Depression: From Symptoms and Assessment to Therapeutics. FOCUS The Journal of Lifelong Learning in Psychiatry. https://doi.org/10.1176/appi.focus.20240046
751. Teixeira, A. L., Rocha, N. P., & Gatchel, J. R. (2023). Behavioral or neuropsychiatric symptoms of Alzheimer's disease: from psychopathology to pharmacological management. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1055/s-0043-1777774
752. Thai, L. J., Grundman, M., & Klauber, M. R. (1988). Dementia. Neurology. https://doi.org/10.1212/wnl.38.7.1083
753. Thaisetthawatkul, P., & Dyck, P. J. B. (2023). Asymmetric Diabetic Neuropathy: Radiculoplexus Neuropathies, Mononeuropathies, and Cranial Neuropathies. Contemporary diabetes. https://doi.org/10.1007/978-3-031-15613-7_10
754. Thakur, N., Black, M., Russo, S. N., & Koenig, M. K. (2022). Neurometabolic Diseases. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197574317.003.0020
755. Théaudin, M., Ochsner, F., Adam, C., Echaniz‐Laguna, A., Magy, L., Fayolle, D., Vicino, A., Hübers, A., & Péréon, Y. (2022). Diagnostiquer une neuropathie des petites fibres. Revue Médicale Suisse. https://doi.org/10.53738/revmed.2022.18.779.803
756. Tolani, S. (2021). Impact of Major Depressive Disorder on Psychiatric Comorbidity of Females in Low Income Countries. Clinical and Experimental Psychology. https://doi.org/10.35248/2471-2701.21.7.244
757. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
758. Toone, B. (2000). Cerebral dysfunction and psychotic symptoms in Alzheimer's disease. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.69.2.148
759. Torpy, J. M. (2010). Delirium. JAMA. https://doi.org/10.1001/jama.304.7.814
760. Tosto, G., Monsell, S. E., Hawes, S. E., Bruno, G., & Mayeux, R. (2015). Progression of Extrapyramidal Signs in Alzheimer’s Disease: Clinical and Neuropathological Correlates. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150244
761. Trevisan, C., & Maggi, S. (2021). Are cognitive disorders more common in geriatric diabetic patients? What factors contribute to cognitive decline?. Journal of Gerontology and Geriatrics. https://doi.org/10.36150/2499-6564-n450
762. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
763. Tunas, S. D., Dinç, G. Ş., Göker, Z., & Üneri, Ö. Ş. (2016). Özgül Öğrenme Güçlüğü Etiyolojisinde Akut Dissemine Ensefalomiyelit (Adem ) Etken Olabilir mi.
764. Tune, L. E. (1998). Depression and Alzheimer's disease. Depression and Anxiety. https://doi.org/10.1002/(sici)1520-6394(1998)8:1+<91::aid-da14>3.0.co;2-m
765. Tur, C., & Thompson, A. J. (2015). Early accurate diagnosis crucial in multiple sclerosis.. PubMed.
766. Unknown (2003). Medico-legal aspects of epilepsy. CRC Press eBooks. https://doi.org/10.1201/b14346-17
767. Unknown (2003). Neurobiology of Alzheimer’s Disease. CRC Press eBooks. https://doi.org/10.3109/9780203912485-41
768. Urazán, D. T., Barragán, A. G., Hernández, K. D. C. P., & Gamboa, D. J. (2023). Afasia primaria progresiva variante no fluente/agramática. Acta neurológica colombiana. https://doi.org/10.22379/anc.v39i3.853
769. Uzoni, A., Ciobanu, O., Sandu, E., Bugă, A. M., & Popa‐Wagner, A. (2015). Aging, inflammation and depressive behavior: a review. Reviews in Health Care. https://doi.org/10.7175/rhc.v6i2.1170
770. Valeiņa, S., Krūmiņa, Z., Sepetiene, S., Andzane, G., Sture, E. A., & Taylor, D. (2016). Fabricated or Induced Illness Presenting as Recurrent Corneal Lesions, Cataracts, and Uveitis. Journal of Pediatric Ophthalmology & Strabismus. https://doi.org/10.3928/01913913-20160122-01
771. Valikova, T. A., Fyodorova, I. M., & Paimursina, N. Y. (2002). The clinical manifestations of nervous system mesenchyme syphilis. Bulletin of Siberian Medicine. https://doi.org/10.20538/1682-0363-2002-2-77-82
772. Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2017). Depression is linked to dementia in older adults.. PubMed.
773. Vallée, J.-P. (2010). Docteur, je perds la mémoire…. Médecine.
774. Vance, D. E. (2012). Potential factors that may promote successful cognitive aging. Nursing Research and Reviews. https://doi.org/10.2147/nrr.s32229
775. Verhey, F. R., & Visser, P. J. (2013). [Use of cerebrospinal fluid (CSF) biomarkers for Alzheimer's type dementia: diagnosis in mild cognitive impairment].. PubMed.
776. Verma, N., Doctor, D., & Raval, N. (2014). Leigh's Disease: A case Report.
777. Vermeulen, M., & Huizinga, T. (2006). [Neurological or psychiatric symptoms in patients with systemic lupus erythematosus (SLE): terminological problems, pathogenesis, diagnosis and therapy].. PubMed.
778. Vernino, S., & Vincent, A. (2013). Autoimmune and paraneoplastic autonomic neuropathies. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198566342.003.0054
779. Verny, M. (2000). Approche diagnostique d'un syndrome démentiel chez le sujet âgé. La Revue de gériatrie.
780. Vieira, N. C., Macedo, M. B. D. C., Júnior, J. C. M., Tiraboschi, L. C., & Oliveira, T. G. D. S. (2020). Demência secundária à lesão cerebral traumática em região frontotemporal: um relato de caso. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v99i4p394-399
781. Vilibić, M., Jukić, V., Vidović, A., & Brečić, P. (2013). Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.. PubMed.
782. Vitiello, M. V. (2006). Sleep disturbances in Alzheimer’s disease. Birkhäuser-Verlag eBooks. https://doi.org/10.1007/3-7643-7440-3_11
783. Vlajić, N. (2016). Psihofarmaci u oboljelih od demencije.
784. Vogel, A., Waldorff, F. B., & Waldemar, G. (2010). Impaired Awareness of Deficits and Neuropsychiatric Symptoms in Early Alzheimer’s Disease: The Danish Alzheimer Intervention Study (DAISY). Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.2010.22.1.93
785. Vogelaere, F. D. (2012). Contributions of functional magnetic resonance imaging in the early detection of Alzheimer's disease.
786. Volpe, B. T. (1997). Delayed Neuronal Degeneration Results from Endogenous Glutamate Excess. Annals of the New York Academy of Sciences. https://doi.org/10.1111/j.1749-6632.1997.tb48390.x
787. Vucic, S. (2016). Sensory and autonomic nervous system dysfunction in amyotrophic lateral sclerosis. Neuropathology and Applied Neurobiology. https://doi.org/10.1111/nan.12336
788. Wadsworth, L. P., Lorius, N., Donovan, N. J., Locascio, J. J., Rentz, D. M., Johnson, K. A., Sperling, R. A., & Marshall, G. A. (2012). Neuropsychiatric Symptoms and Global Functional Impairment along the Alzheimers Continuum. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000342119
789. Walker, L., & Attems, J. (2024). Mixed pathologies of the ageing and neurodegenerating brain. CRC Press eBooks. https://doi.org/10.1201/9781003389699-40
790. Walsh, T. J. (2010). Functional Visual Loss.. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195389685.003.0016
791. Webber, A. (2010). Paediatric hyperopia, accommodative esotropia and refractive amblyopia. Clinical and Experimental Optometry. https://doi.org/10.1111/j.1444-0938.2010.00537.x
792. Wenning, G. K., & Quinn, N. (1994). Multisystematrophie. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-1017967
793. Wesensten, N. J., & Balkin, T. J. (2013). The challenge of sleep management in military operations.. PubMed.
794. White, L. R., Hemmy, L. S., Flanagan, M. E., Kawas, C. H., Corrada, M. M., Edland, S. D., & Montine, T. J. (2018). P1‐111: RESISTANCE, RESERVE, AND RESILIENCE: SYSTEMS THAT DEFEND AGAINST AGE‐RELATED COGNITIVE DECLINE—OBSERVATIONS FROM THE HONOLULU‐ASIA AGING STUDY (HAAS). Alzheimer s & Dementia. https://doi.org/10.1016/j.jalz.2018.06.114
795. Widyaningsih, H., Lestyari, S. I., Yuliana, A. R., Wanarsih, B. D., Hartini, S., & Faridah, N. (2024). Pemberdayaan lansia melalui program deteksi dini gangguan fungsi kognitif. Jurnal PADE Pengabdian & Edukasi. https://doi.org/10.30867/pade.v6i2.2114
796. Wieling, W., Thijs, R. D., Dijk, N. V., Wilde, A. A., Benditt, D. G., & Dijk, J. G. V. (2009). Symptoms and signs of syncope: a review of the link between physiology and clinical clues. Brain. https://doi.org/10.1093/brain/awp179
797. Wierenga, C. E., & Bondi, M. W. (2011). Dementia and Alzheimer's Disease: What We Know Now. Generations.
798. Wijdicks, E. F. M. (2025). “Blacked Out and Slumped Down”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544976.003.0007
799. Wilkins, A., & Scolding, N. (2008). Protecting axons in multiple sclerosis. Multiple Sclerosis Journal. https://doi.org/10.1177/1352458508091370
800. Willroth, E. C., James, B. D., Graham, E. K., Kapasi, A., Bennett, D. A., & Mroczek, D. K. (2022). Well-being and Cognitive Resilience to Dementia-related Neuropathology. https://doi.org/10.31234/osf.io/sbh85
801. Wilson, D. S., & Nutt, P. D. J. (2013). Insomnia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199674558.003.0003
802. Woloshin, S., & Kesselheim, A. S. (2022). What to Know About the Alzheimer Drug Aducanumab (Aduhelm). JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2022.1039
803. Wong, A. (2008). Saccadic Dyskinesia, Other Involuntary Eye Movements, and Gaze Deviations. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195324266.003.0015
804. Wong, V., & Chung, B. H. (2006). Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?. Current Pediatric Reviews. https://doi.org/10.2174/157339606776894621
805. Woodford, H. J., George, J., & Jackson, M. (2015). Non-convulsive status epilepticus: a practical approach to diagnosis in confused older people. Postgraduate Medical Journal. https://doi.org/10.1136/postgradmedj-2015-133537
806. Woods, B., Clare, L., Tuokko, H., & Hultsch, D. F. (2006). Cognition-based therapies and Mild Cognitive Impairment.. https://doi.org/10.4324/9780203782996-22
807. Wright, C. B., Vonsattel, J. P., Bell, K. L., & Honig, L. S. (2006). Dementia with Cerebrovascular Disease. Science of Aging Knowledge Environment. https://doi.org/10.1126/sageke.2006.10.dn1
808. Wu, D., Liu, X., Yao, X., Yang, Y., Zhang, J., Yang, H., & Sun, W. (2022). Analysis of electroclinical features of nonconvulsive status epilepticus: a study of four cases. Acta Epileptologica. https://doi.org/10.1186/s42494-021-00073-x
809. Yan, R. M., Cardonne, M. M., Reyes, E. J. M., & Leyva, A. G. (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
810. Yang, T., Guo, R., Ofengeim, D., Hwang, J.-Y., Zukin, R. S., Chen, J., & Zhang, F. (2021). Molecular and Cellular Mechanisms of Ischemia-Induced Neuronal Death. Stroke. https://doi.org/10.1016/b978-0-323-69424-7.00005-3
811. Yavuz, M. S., Atayay, İ. G., Ezenci, M., Yavuz, Ş., Güner, M., & Pehlivan, M. (2024). None. Alzheimer’s & Neurodegenerative Diseases. https://doi.org/10.24966/and-9608/vol10iss1
812. Yokoi, T. (2023). Alzheimer’s Disease is a Disorder of Consciousness. Gerontology and Geriatric Medicine. https://doi.org/10.1177/23337214231159759
813. Yu, S. P., Choi, E., Jiang, M. Q., & Wei, L. (2024). Acute and chronic excitotoxicity in ischemic stroke and late-onset Alzheimer’s disease. Neural Regeneration Research. https://doi.org/10.4103/nrr.nrr-d-24-00398
814. Zago, S. (2004). S. ZagoM. CorboB. PolettiL. AdobbatiV. Silani Aspetti cognitivi dei pazienti con malattie del motoneurone GRUPPO DI STUDIO MALATTIE DEL MOTONEURONE.
815. Zanni, G. R., & Wick, J. Y. (2007). Differentiating Dementias in Long-Term Care Patients. The Consultant Pharmacist. https://doi.org/10.4140/tcp.n.2007.14
816. Zavecz, Z., Shah, V. D., Murillo, O. G., Vallat, R., Mander, B. A., Winer, J. R., Jagust, W. J., & Walker, M. P. (2023). NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology. BMC Medicine. https://doi.org/10.1186/s12916-023-02811-z
817. Zawilska, J. B., Santorek‐Strumiłło, E., & Kuna, P. (2010). [Nighttime eating disorders--clinical symptoms and treatment].. PubMed.
818. Zelnik, N., Pacht, A., Obeid, R., & Lerner, A. (2004). Range of Neurologic Disorders in Patients With Celiac Disease. PEDIATRICS. https://doi.org/10.1542/peds.113.6.1672
819. Zhang, Z., & Lim, M. J. R. (2024). Incident Dementia After Spontaneous Intracerebral Hemorrhage. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-240111
820. Zhao, H., Wang, Y., Cui, L., Wang, H., Liu, S., Liang, T., Liu, D., Qiu, J., Chen, L., & Sun, Y. (2024). Sensorineural hearing loss and cognitive impairment: three hypotheses. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2024.1368232
821. Zhao, S., Scholcz, A., Rouse, M. A., Klar, V., Ganse‐Dumrath, A., Toniolo, S., Broulidakis, M. J., Ralph, M. A. L., Rowe, J. B., Garrard, P., Thompson, S., Irani, S. R., Manohar, S., & Husain, M. (2025). Self- versus caregiver-reported apathy across neurological disorders. Brain Communications. https://doi.org/10.1093/braincomms/fcaf235
822. Zickgraf, H. F., Richard, E., Zucker, N., & Wallace, G. L. (2020). Rigidity and Sensory Sensitivity: Independent Contributions to Selective Eating in Children, Adolescents, and Young Adults. Journal of Clinical Child & Adolescent Psychology. https://doi.org/10.1080/15374416.2020.1738236
823. Zieschang, T., & Schütze, S. (2023). Allgemeine Aspekte demenzieller Erkrankungen. Deleted Journal. https://doi.org/10.1007/s00108-022-01462-1
824. Zigman, W. B., Schupf, N., Devenny, D. A., Miezejeski, C. M., Ryan, R., Urv, T. K., Schubert, R., & Silverman, W. (2004). Incidence and Prevalence of Dementia in Elderly Adults With Mental Retardation Without Down Syndrome. American Journal on Mental Retardation. https://doi.org/10.1352/0895-8017(2004)109<126:iapodi>2.0.co;2
825. Özugur, S. (2016). Quantification of synapse loss in human brains with mixed Alzheimer’s and Lewy body disease.
826. Šumarac-Dumanović, M., Micić, D., Macut, Đ. P., Kendereški, A., Zorić, S., Cvijović, G., & Pejković, D. (2002). Hipoglikemijski sindromi - dijagnostički i terapijski pristup i prikaz dva slučaja. ABC - časopis urgentne medicine.
827. Živković, S., & Shipe, C. (2004). Electrodiagnostic Evaluation of Motor Neuron Disorders. American Journal of Electroneurodiagnostic Technology. https://doi.org/10.1080/1086508x.2004.11079458
828. Оstroumova, Т. М., & Koberskaya, N. N. (2020). Near-moderate cognitive decline. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2020-2-92-97